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1 INTRODUCTION 
 
 
1.1 INTRODUCTION 
 
For a long time the use of narcotics has been limited in Europe to medical practice. Drug addiction only 
appeared at the end of the 19th century and significantly increased since the extraction of morphine and its 
use during the war of 1870. Then, in the sixties of the 20th century it started to affect youth and very 
quickly a massive emergence of hard drugs could be observed, touching members of all social classes. 
(Science & Vie, n°217, 2001) 
 
Ecstasy, which gained popularity in the seventies, designated originally a substance called MDMA, or 3,4-
methylendioxymethamphetamine. Nowadays, the term is used more generally for all amphetamine type 
substances sold in form of tablets on the illicit market. Although, MDMA remains the most common active 
substance found in ecstasy tablets, a variety of other psychotropic components have made their 
appearance during the last decades – methamphetamine (MA), 3,4-methylendioxyamphetamine (MDA), 
3,4-methylenedioxyethylamphetamine (MDEA), 4-bromo-2,5-dimethoxyphenylethylamine (2C-B), 2,5-
dimethoxy-4-methylamphetamine, etc. 
 
Contrary to the other "common narcotics", such as cocaine or heroine, ecstasy is by definition a tablet and 
therefore has to be treated differently. Similarly, the main substance of ecstasy is mixed with other 
components. The difference in the case of tablets is that these components are not defined as cutting 
agents, but as excipients. The term is of pharmatechnological origin and designates substances 
necessary to produce solid forms of drugs, such as tablets and capsules. The important point for 
investigation is that once excipients are added to the active substance and the tablet is pressed, its 
composition hardly ever changes (eventually decomposition or very slight changes in quantities – 
depending on the quality of the tablet). Therefore, a seized tablet presents the same composition as that 
of the initial production. 
 
 
Fig 1 – Schema of illicit tablet production. 
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The production of ecstasy can be summarized in two steps – 1) synthesis of the active substance, and 2) 
addition of excipients (and eventually adulterants) followed by the compression. These two steps can be 
carried out by the same laboratory or by separate laboratories. Consequently, tablets of same visual 
appearance might not present the same composition and vice versa.  This must be taken into account 
when trying to compare and to group ecstasy seizures. 
 
Considering the schema in Fig 1, comparison of ecstasy tablets can be done at different levels : 
1) by trace analysis of the active substance characterised by the way of synthesis – this was 
investigated for amphetamine in the (SMT, 2003), and is currently examined for MDMA in the 
CHAMP project (CHAMP, in progress). 
2) by considering only physical characteristics, such as logo, colour, diameter, etc. Christian Zingg 
has investigated this problematic during his PhD project (Zingg, 2005). 
3) finally, it is possible to consider the additional substances – excipients. Dyes have been examined 
in the PhD project of (Goldmann, 2000). Herein, carbohydrates (used as diluents and binders) and 
fatty acids (components of stearates which are used as lubricants) are the focus of the research. 
 
The aim of comparison at any level is to establish eventual links (of physical or chemical nature) between 
different samples. By characterising the samples, it is possible to differentiate a certain number of them 
and furthermore to classify them into groups which in turn will allow identifying the potential source of 
production. This information can be used to estimate for how long a laboratory was in production, as well 
as to know how the illicit drug was distributed and to what extent. This form of intelligence allows a 
strategic vision of the illicit drugs market and is usually understood under the name of Drug Profiling.  
 
 
1.2 AIMS – HYPOTHESES 
 
The purpose of the presented research project is to evaluate the potential of the two types of excipients 
chosen – carbohydrates and fatty acids – for providing useful intelligence in the context of ecstasy 
profiling. This task requires the consideration of a number of hypotheses which will be detailed hereafter. 
 
1) Similarities with pharmaceutical production 
 
Since ecstasy is a drug in form of tablets, first information about production steps and possible ingredients 
has been searched in the domain of pharmaceutical technology. However, it had to be shown that this 
was a reliable source. 
 
Tablets first appeared for medical use and their production is a speciality of pharmaceutical technology. It 
is logical to presume that producers of illicit tablets would search for basic principles of tablet production in 
this domain, since information is easily found. This is also corroborated by findings through seizures of 
illicit laboratories. A collection of these findings has been realised by Europol (Fig 2) and the material 
discovered strongly indicates similarities with pharmaceutical procedure : 
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Fig 2 – Detailed procedure of ecstasy production (Europol, 2004). 
 
However, no information is given about the use of excipients – what types of excipients are found on illicit 
production sites, what recipes are used, and so forth. Thanks to literature and chemical analysis of 
ecstasy tablets it can be demonstrated that, indeed, the term excipient – with regard to pharmaceutical 
applications – is more appropriate than cutting agent. 
 
Additionally, in the following chapters it will be shown that these pharmacologically inactive substances 
are not only added to increase volume (such as cutting agents for powder drugs like heroin and cocaine), 
but that they are essential for the production of the tablets and that therefore illicit producers actually use 
basic pharmaceutical recipes for ecstasy production. 
 
Nonetheless, recipes of illicit producers are much simpler than in pharmaceutical technology and a smaller 
number of excipients are used as well. On the other side, it does not need many substances to obtain 
variation between production batches. Employing a few excipients mixed in various quantities will result in 
a high number of possible composition combinations.  
 
 
2) Variation between producers 
 
In general, illicit producers are supposed to use substances easily available in bulk quantities, and which 
present characteristics allowing efficient production (e.g. applicable to direct compression). The first 
condition is fulfilled by most excipients because they are not only used in pharmaceutical technology, but 
also in other industrial sectors. Unlike for active substances, no particular control is applied to these 
components and prices are much lower. The criterion of direct compression excipients, e.g., does 
however slightly limit the number of available substances. 
 
Presuming that a recipe for an excipient mixture resulting in tablets of good quality is not so easily 
modified (besides that there is no reason for it), producers will probably stick to one once they have found 
it. Consequently, compression batches for one producer should not considerably vary for the same recipe. 
When picking up the production schema again (Fig 3), the situation would correspond to batch 1 and 2 
made on press Y with excipient amounts x1 ≈ x2 and y1 ≈ y2. 
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Fig 3 – Schema of illicit tablet production. 
 
Ideally for ecstasy profiling, different illicit producers would also use different recipes and different 
excipients, and this would increase the variation between them to the maximum. Unfortunately, producers 
may know each other and/or share similar sources of information about tablet production. Additionally, a 
rather normal situation would be one producer asking another for his recipe as it produces good quality 
tablets.  
 
However, three origins of variability between producers can be observed : first, of course, is the choice of 
excipients, then the used amount, and finally, the source of excipients. As a consequence, three levels of 
analysis have to be considered, providing specific information passing from one level to the next – 
qualitative analysis, quantitative analysis and trace analysis. 
 
The optimisation of the qualitative analysis represents the basis of this research project. Relative 
quantification has been used for the purpose of sample grouping. However, trace analysis which would 
allow characterisation of the source of an excipient, is beyond the scope of this research. Nevertheless, 
the possibility of observing differences in cellulose and lactose standards due to different origin will be 
demonstrated in Chapter 7. 
 
 
3) Possibility of ecstasy classification by the use of excipients 
 
Preliminary classes have been created by Christian Zingg (2005), who has considered physical 
characteristics and general composition of ecstasy tablets which means determination of the active 
substance, its quantification and determination of eventually present adulterants (rare) and/or diluents.  
 
By studying two types of excipients there should be sufficient information to create classes as well. It has 
to be verified whether the same classes than those found by Zingg can be determined, or if different 
classes are observed.  
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This approach requires specification of intra- and intervariability. Intravariability is the variation of a 
characteristic in one compression batch and should be low. High variation is due either to the failure of the 
method to give reproducible results, or to the inhomogeneity of the tablet mixture. It is also important to 
remember that an analysed characteristic should be variable between different batches and that this so-
called intervariability should be higher than the intravariability.  
 
The classes found through excipient analysis would express a link at the level of the blend right before 
compression – this is important to emphasise as these might be different from classes found through 
impurity analysis of the active substance, situated at the level of synthesis. Therefore, if two samples are 
found to belong to the same class, this can signify that they originate from the same compression batch, 
or from the same tablet producer having used one excipient mixture for more than one compression. In 
either case the origin of the tablets would be the same. Consequently, the information given by the 
excipients is of strategic importance as it might point towards a production site. 
 
Furthermore, the created classes might allow identification of eventual links between police seizures. 
These links might be used for the allocation of several seizures to one dealer, and for the establishment of 
links between, until then independent, dealers through the tablets. Taking this thought even further, these 
links might allow the visualisation of an entire net of distribution of ecstasy tablets which does not 
necessarily stop at the Swiss borders.  
 
 
 
 
 
 
 
 
 
2 THEORETICAL PART 
 
 
2.1 ECSTASY GENERALITIES1  
 
 
2.1.1 History 
 
MDMA has been licensed in 1914 by the German company Merck, however without being 
commercialised. It has been developed as an appetite suppressant, but no use has been noted in the 
licence. It reappeared in 1953 when the American Army tested it for military use. Finally, it got "public" in 
1965 thanks to Alexander Shulgin who focused his research on this type of substances. He has 
synthesised up to 178 other psychotropic molecules of the family of phenethylamines and has tested them 
himself at various dosages. In 1991, he has published a book where all his work and experiments have 
been described – PIHKAL – Phenethylamines I Have Known And Loved. (Shulgin and Shulgin, 1991) 
However, MDMA had already been before the publication of this book in the circles of psychotherapists 
who started to apply this substance for therapeutic use back in 1977. This type of application lasted 
almost a whole decade until, in 1985, the DEA (Drug Enforcement Administration) of the United States 
banned it as measure of urgency by emphasising a risk for public health. Thus, MDMA has been classified 
permanently into the Schedule I group (USA), only containing substances of dangerous character, 
creating dependency and without medical recognition. In Switzerland MDMA has been used by therapists 
until 1994. At this moment the substance was already very popular and often consumed at rave parties. Its 
production and distribution was provided by clandestine networks principally originating in Europe, 
although the number of seized laboratories has decreased (Fig 6). Until today Europe is the principal 
producer of amphetamine type substances, except for methamphetamine which is mainly produced in the 
United States and South-East Asia (Fig 4 to Fig 6). 
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Fig 4 – Number of seized illicit laboratories producing amphetamine (ONU). 
                                                     
1 (Sauer and Weilemann, 1997; Walder, 1994; Freese et al, 2002) 
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Fig 5 – Number of seized illicit laboratories producing methamphetamine (ONU). 
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Fig 6 – Number of seized illicit laboratories producing ecstasy type substances (ONU). 
 
 
2.1.2 Pharmacological aspects  
 
The chemistry of MDMA and the other amphetamine type substances is based on the chemical structure 
of phenylethylamine. This common bond is represented in Fig 7. 
 
It is possible to distinguish three groups among ecstasies – 1) amphetamine and methamphetamine, 2) 
the methylenedioxyamphetamine derivatives, and 3) the hallucinogens (2CB, DOB, etc) which are much 
less frequent than the first two except derivatives from serotonin. They can be differentiated by their 
appearance, the form of ingestion and effects. Indeed, when considering the relevant literature the three 
groups are in general treated individually.  
 
Amphetamine is principally found in powder form and methamphetamine as crystals or small pills ("Thai 
pills"). Their effects are stimulant and can be hallucinogenic, not as much as the group of hallucinogens, 
but more than the methylenedioxy type derivatives. These are characterised as tablets of variable 
appearance and their entactogenic effects. This term has been proposed in 1986 to distinguish MDMA 
from other types of substances. It means empathogenic, euphoric, and stimulant effects, such as 
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increased socialibility, increased desire to touch and love, enhanced tactile sensations (it feels good to 
touch things) or a feeling of "oneness" with the crowd. (Internet1, 2006) 
 
 
 
Fig 7 – Chemical structures deriving from phenylethylamine (Sauer and Weilemann, 1997), with:  transformations 
into 2-CB and DOB,  transformations into MDA, MDMA, MDEA and MBDB,  theoretical transformations in the 
group of catecholamines and  similarity with serotonin. 
 
 
On the whole, phenylethylamine and its derivatives make intellectual tasks easier by helping to 
concentrate, and physical tasks as well by decreasing sleepy feelings. This explains why these 
substances were used by both, intellectuals and sportsmen/women. However, differences in their working 
mechanism, consisting principally in the use of different neurotransmitters – dopamine (amphetamine) or 
serotonin (MDMA) – result in preferences for either one or the other.  
 
Common adverse side effects of MDMA ingestion include rise in blood pressure and heart rate, 
nystagmus (eye-wiggling), trismus (jaw tension), bruxia (teeth grinding), sweating, agitation, a post-peak 
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crash, muscle tension, headaches, nausea & vomiting, dry-mouth, liver problems, water retention, fatigue, 
confusion, mood swings, black outs, etc. While these effects have been known for years, there hasn't 
been much data about the prevalence of these various side effects. (Internet2, 2006)  
 
Recently there have been increasing studies of MDMA and the neurotoxic (permanent damage of nerve 
terminals in the brain) effects it may cause. The main concern revolves around the long term effects of 
MDMA on the serotonergic system. High doses or repeated administration of MDMA cause serotonin 
nerve terminal degeneration and serotonin axonal degeneration in animals. Lower doses results in 
decreases of serotonin neural markers, such as brain tissue levels, reduced density of serotonin reuptake 
transporters, and reduced activity of tryptophan hydroxylase. (Internet3, 2006) 
 
The pharmacological aspects of the discussed substances can be found in the PhD research report of Till 
Goldmann (2000) or the internet website – (Internet1, 2006). As for the chemical aspects, more detailed 
information can be found on the same website, as well as in PhD research reports of Eric Lock (SMT, 
2003; Lock, 2005) and Christian Zingg (2005). 
 
 
2.1.3 Illicit tablets2  
 
Ecstasies are tablets and have been examined as such several times during the past decades. The 
observation of visual characteristics, such as size, colour, design (logo), weight and so on, can be 
fundamental. In the medical domain, sample description of prescription drugs and remedies is used to 
identify products. Lists and tables have been created to facilitate this work (Identa, 2002). Similarly, in 
forensic investigation the first description of items originating from the crime scene is of utmost importance 
as it could give evidence of what has happened.  
 
In order to dispose of these visual and physical characteristics, as well as major chemical characteristics, 
a database has been created at the IPS by Christian Zingg in collaboration with the WD Zürich 
(Wissenschaftlicher Dienst) and contains seizures coming from two different regions in Switzerland (the 
Italian and French part - Ticino and Romandie – and Zürich), which are shown in Fig 8. 
 
Comparison of ecstasy tablets requires knowledge of tablet production, if appropriate interpretation of 
observed characteristics is desired. In both, licit and illicit production, two major steps can be distinguished 
:  
 
- the first step consists of the preparation of the mixture of the active substance with the excipients, 
- the second of the compression of this mixture. 
 
                                                     
2 (Marquis, 2000; Gomm and Hughes, 1991; Bauer et al, 1999; Le Hir, 1997; Kummer, 1998) 
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Fig 8 – Swiss map emphasising cantons sending their seizures to the IPS. 
 
 
A more detailed description of the procedure with regard to illicit production is given in Appendix I. Here it 
will just be emphasised that the quality of the resulting tablet largely depends on the composition of the 
original mixture to compress. The importance of the excipients will be demonstrated in the following 
chapters. However, an overview of possible problems due to an inappropriate use of excipients is 
presented in Table 1. 
 
Although this table has been taken from a book about pharmaceutical technology and it might be stricter in 
application than illicit producers might follow in producing tablets, the latter also encounter this kind of 
problems and have to find appropriate solutions. A study of excipients is an important part of this research. 
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Problem Causes and solutions 
Insufficient mechanical 
strength 
o low pressure 
o inappropriate binder or insufficient quantity 
o excessive amount of starch 
o excessive amount of lubricant 
o low humidity, overly dry mixture 
o insufficient plasticity 
Capping (Fig 9) o low humidity – improved by adding a wetting agent 
o air inclusions – can be resolved by use of a particular press or by reduction of 
compression speed and/or pressure 
o mixture elasticity – can be resolved by adding a substance that increases 
deformability, such as microcrystalline cellulose 
o inhomogeneities producing differences in axial and radial strength – can be 
resolved by granulation of the mixture or by particle size reduction of the 
components  
Sticking of mixture to punches 
and die walls (Fig 9) 
o insufficient amount of lubricant and "anti-sticking" substance 
o too much moisture  
o low melting point due to eutectic mixture – can be resolved by adding an adsorbing 
or drying agent, such as silica 
Insufficient disintegration time o inappropriate disintegrator 
o insufficient amount or absence of disintegration accelerator 
o hydrophobic mixture, or not enough wetting agent 
o poor porosity (excessive pressure) 
o presence of soluble substances which suppresses the action of disintegration 
accelerators by osmotic effect 
Dosage variations  o inhomogeneous flow of mixture to compress – can be resolved by optimisation of 
particle size or by adding of silica 
Table 1 – Possible problems during tablet manufacture (Bauer et al, 1999) 
 
   
Fig 9 – Examples of Capping (at the left) and Sticking (at the right), ecstasy database IPS-WD. 
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2.2 EXCIPIENTS3 
 
 
The theoretical aspects about excipients have been researched in the pharmaceutical literature, 
particularly in the field of galenics where preparation forms for drugs are treated. It will be shown later that 
the basics can be found in illicit tablet production as well. 
 
 
2.2.1 Generalities  
 
"The excipients, which can also be called auxiliary substances, are raw materials designed to enter into 
the composition of pharmaceutical preparations on a different basis than the active substances. They are 
conceived to give preparations a particular form or to be incorporated. Excipients correspond either to a 
chemical entity, or to a more or less complex mixture of synthetic or natural origin. Products of natural 
origin are used either directly, or after having been processed chemically." (Le Hir, 1997) 
 
The excipients have three functions : 
 
- to facilitate administration of active substances, 
- to improve efficiency of the active substances, 
- to ensure stability and consequently conservation until the fixed limit of use. 
 
In pharmaceutical applications they have to meet the following requirements : 
 
- inertia in relation to the active substance, the packing material and the organism, 
- constancy in physical and chemical quality in time, 
- they have to present the appropriate microbiological purity for their application. 
 
The choice of an excipient is often a compromise between several risks. Excipients are seldom produced 
only for pharmaceutical use, where requirements are generally higher than in other domains. Thus, they 
are often chosen in the food sector. The application of an excipient can be variable and it is not rare to find 
excipients with several functions. 
 
Excipients are generally defined by their physicochemical properties, and by their technological character. 
Only the former are described in the excipient monographs in pharmacopoeias. As for the latter, 
requirements have to be adapted for every production and the producers must fix the acceptance limits. 
 
 
                                                     
3 (Bauer et al, 1999; Le Hir, 1997; Gurny, 1998/99; Gibson, 2001; Davies, 2001; Wasan, 2005) 
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2.2.2 Excipients in tablets 
 
Tablet preparation requires particular powder/grain qualities in terms of physical and mechanical 
properties. The granule quality must be such as to ensure ease of powder blending and the fluidity for the 
precise filling of the compression chamber. Additionally granulation particles must present sufficient quality 
to give the tablet enough stickiness or plasticity for it to hold together and stay together as a solid dosage 
form. 
 
For these reasons, most of the active substances require the presence of excipients and additionally a 
granulation step before compression to ensure good cohesiveness and easy disintegration.  
 
 
2.2.2.1 Types of excipients 
 
Excipients are classified by their function in tablet production : 
 
1) DILUENTS – diluents have the function to fill up the volume when the amount of the active substance is 
insufficient to form a tablet of acceptable size. They are inert powders which are chosen from case to 
case depending on their accessory properties. 
 
2) BINDERS – they hold particles together in the tablet that would otherwise be loose, fluffy and hard to 
consolidate into tablets. This is especially important for certain timed release products where the 
binder acts as a matrix from which the drug is gradually released. Their presence also allows reducing 
the compression force. 
 
3) LUBRICANTS – their usage is threefold : 
- improve the fluidity of the grain, 
- decrease sticking of grain to punches and die, 
- reduce frictions between particles during compression. 
Generally, the lubricant is added to the blend right before compression, in form of a very fine powder 
covering particle surfaces.  
 
4) DISINTEGRATORS – they allow acceleration of tablet disintegration, and hence dispersion of the active 
substance in water or gastric juices. They favour penetration of water into the tablet and thus allow it 
to breaking apart. 
 
5) OTHERS – wetting agent, buffer, dyes, flavourings, absorbing and adsorbing agents. 
 
The choice of an excipient mixture appears to be rather complex and is similar to tentative research, 
taking into account possible incompatibilities, desired administration mode and dosage method of the 
active substance. Decision about excipient ratios requires several tests and for every one, controls of 
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hardness, disintegration, conservation, etc. have to be realised. A basic tablet recipe in pharmacology – 
developed without active substance – looks like this (Bauer et al, 1999) :  
 
I starch (disintegrator)    10-20% 
 binder4      1-15% 
 lactose (diluent)     ad 100% 
 
II starch (disintegrator)    10% 
 talc (lubricant)     5-8% 
 Mg stearate     0.5% 
 or stearic acid (lubricant)    1% 
 
In general, tablet blends are constituted of an inner phase (I) and an outer phase (II). The inner phase with 
the diluent, binder and eventually a disintegrator corresponds to the actual granule. The components of 
the outer phase are added just before compression. A rule of thumb says that the ratio between inner and 
outer phase must be between 80 : 20 and 90 : 10, with regard to optimal fluidity and tap density. 
 
 
2.2.3 Excipients in illicit tablets5 
 
Tablets produced in clandestine laboratories can often be characterised by their unusual and crude 
appearance, although formulations are similar to those used in pharmaceutical production. The basic 
principles are the same – an active substance (amphetamine and/or derivative) is mixed with some 
excipients which constitute the bulk of the blend. Like in pharmacy, excipients include diluents, binders, 
lubricants, disintegrators and dyes. However, in illicit production a recipe does not necessarily contain 
every type of excipient and use different quantities as well. An example of a possible amphetamine tablet 
formulation is given below : 
 
Amphetamine 5mg 
Diluent 170mg 
Binder 5mg 
Lubricant 2mg 
Disintegrator 20mg 
Dye 0.03mg 
 
 
The result would be a tablet of about 200mg with an amphetamine content of 2.5%. Generally, 
amphetamine content is not that low, but it is not unusual to observe this kind of percentages. It is 
important to notice the great presence of excipients, and particularly of diluent, in this formulation 
                                                     
4 The most important binders in grain production and their corresponding usual concentrations (percentage in a dry 
grain blend) are : «starch glue» –  5-15% ; gelatine – 1-3% ; polyvinylpyrrolidone –  3-5% ; cellulose ether – 1-5% 
5 (Gomm and Hughes, 1991; Tillson and Johnson, 1974; Gomm and Humphreys, 1975) 
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example. Illicit tablets usually contain common and largely available diluents, which can be 
pharmaceutical excipients such as lactose, or simply milk powder or various forms of calcium carbonate.  
 
 
2.2.3.1 Excipients observed in illicit tablets
6
 
 
Even though excipients are regularly detected in ecstasy tablets, there is surprisingly little forensic 
literature concerning their use for ecstasy discrimination. Data is even almost inexistent when it comes to 
excipient ratios in illicit tablets. The few information found will be noted hereafter and consist more in a 
listing of excipients than in a description of tablet fabrication.  
 
For a better understanding the observed substances will be classified according to pharmaceutical criteria 
into the four types of excipients – diluent, binder, lubricant and disintegrator.  Substances noted in italic 
font were often detected in our laboratory, and those with a (*) were often cited in literature compared to 
the others. 
 
 
DILUENTS 
 
They are also often used for their alkaline character. Some diluents are good binders as well.  
 
Lactose* Glucose* 
Sucrose* Maltose 
Fructose Sorbitol* 
Mannitol* Cellulose* 
Kaolin Methylcellulose* 
Vitamin C Talc* 
Ca carbonate Na bicarbonate* 
Ca phosphate* (dibasic or tribasic) Ca sulphate* (anhydrous and bihydrate) 
 
 
BINDERS 
 
They are often used in powder or liquid form and can be observed as combinations of two or more 
binders. Many only possess good cohesiveness, whereas the granulation requires also good solubility. 
The following binders were found in illicit tablets :  
 
Agar Gum Cellulose* Acacia 
Gelatine Methylcellulose Dextrine Glucose 
Starch* Flour Urea Waxes 
Carbohydrates (lactose, sucrose, mannitol) Pitch Stearates* 
 
                                                     
6 (Sondermann and Kovar, 1999; King, 1997; Marquis, 2000; Gomm and Humphreys, 1975; Rhodes and Thornton, 
1979; Giroud et al, 1997; Le Hir, 1997; Kibbe, 2000) 
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LUBRICANTS 
 
Every tablet production requires the presence of lubricants, especially when binders are used as well. 
They are necessary for a good fluidity and unproblematic ejection of the tablets.  
  
Stearates* Talc* Stearic acid Mineral oil Vegetable oil 
Colloidal silica Starch* Cellulose* Boric acid Na stearyl fumarate 
 
DISINTEGRATORS 
 
There are only few disintegrators of good quality compared to the other excipient types. Generally, starch 
is used exclusively, in form of powder or occasionally as fine grains.  
 
Starch*, diatomaceous earth, Maizena® type products 
 
More detailed characteristics of the most frequent excipients are described in Appendix II. 
 
 
2.2.4 Synthesis 
 
The first observation to be made is that all these substances are of very different chemical nature, which 
excludes immediately simultaneous analysis. There are inorganic components, carbohydrates, oils, acids, 
etc. However, some substances are more frequent than others – one of these is the group of 
carbohydrates. This can be explained by their multifunctionality (diluents + binders), their suitability for 
direct compression (without granulation step), and their availability in commerce. Since they are also 
regularly detected in our laboratory, focus on this type of substances is certainly justified.  
 
Starch has been often cited in literature, but was actually very seldom observed in our laboratory. It was 
not regularly sought, but occasional tests showed its presence only a very few times.  
 
Finally, stearates appeared to be interesting as they were often cited, and regularly detected in ecstasy 
tablets analysed by our laboratory as well. They were also observed in a more negative context, as they 
are reason for difficulties in extraction of traces of active substances by forming emulsions. Stearates are 
composed of fatty acids, principally palmitic and stearic acid, which are the acids usually detected by GC-
MS analysis. Thus, it seems to be more appropriate to use the term fatty acids from now on.  
 
The following two chapters will contain a description of the physical and chemical properties of 
carbohydrates and fatty acids, in view of possibilities of chemical analysis in ecstasy tablets. 
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2.3 CARBOHYDRATES 
 
It has to be reminded that carbohydrates, as well as other excipients, are not produced exclusively for 
pharmaceutical use, but are taken from productions for the food industry. Therefore, research has 
principally been focused on analysis of food additives where carbohydrates are not surprisingly very 
frequent.  
 
In food analysis the carbohydrates are classified as follows (Southgate, 1991):  
 
 
 
 
 
 
 
 
 
 
1) carbohydrates used and metabolised as carbohydrate by the organism 
2) are considerably broken-down, but not completely, by symbiotic bacteria yielding fatty acids and thus do not 
provide carbohydrates to the organism  
 
 
2.3.1 Generalities7 
 
The empirical chemical formula for carbohydrates is CnH2mOm. Monosaccharides (MS) correspond to the 
carbohydrates consisting in one entity which cannot split further by hydrolysis. They are classified by the 
number of carbons (e.g. 5C = pentose, 6C = hexose) and by the position of their carbonyl group (e.g. 
aldose, ketoses). Monosaccharides are the building blocks for oligosaccharides (2 – 7 MS) and 
polysaccharides (> 7 MS). 
 
Monosaccharides Hexoses – Glucose, Fructose, Galactose 
Disaccharides Sucrose, Maltose, Lactose 
Polysaccharides Cellulose, Starch 
Polyalcohols / Polyols Sorbitol, Inositol, Mannitol, Xylitol 
 
Examples of the chemical structure of some carbohydrates are represented in Appendix III with their 
complete chemical name. 
 
                                                     
7 (Southgate, 1991; Belitz et al, 2004; MSDA, 2001) 
Carbohydrates 
Sugars 
Dextrins 
Starches 
Pectins 
Hemicelluloses 
Celluloses 
Lignin 
Available carbohydrates1) 
Unavailable carbohydrates ≡ dietary fibre2) 
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Disaccharides are furthermore distinguished between reducers and non-reducers : 
 
- reducer : free hemiacetal or hemicetal function, 
- non-reducer : the glycosidic bond blocks hemiacetal functions. 
 
The most common food sweetener in the industrialized world – sucrose – is a non-reducer and therefore 
generally analysed by different ways than other sugars. For comparison lactose and sucrose molecules 
are shown in Fig 10. 
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Fig 10 – Lactose on the left – Sucrose on the right. 
 
 
Polyols as well are to be considered apart. They are generally formed by the corresponding mono- or 
oligosaccharides by hydrogenation (glucose  sorbitol; fructose  sorbitol and mannitol; xylose  
xylitol). The aldo and keto groups of the saccharides are reduced to hydroxy groups and thus form polyols. 
Hence, they do not have any reductive properties anymore. 
 
As for the polysaccharides, only cellulose will be mentioned, while starch will not be studied further. 
Cellulose was certainly first known in paper production, but is now also a widely used excipient in 
pharmaceutical technology. It is used in the form of powdered cellulose which is a white, odourless and 
tasteless powder of various particle sizes. It is produced by purification and mechanical size reduction of 
α-cellulose obtained as a pulp from fibrous plant materials. The other form often used is microcrystalline 
cellulose which is a purified, partially depolymerised cellulose that occurs as a white-coloured, odourless, 
tasteless, crystalline powder composed of porous particles. It is manufactured by controlled hydrolysis, 
with dilute mineral acid solution, of α-cellulose. (Kibbe, 2000) 
 
As might have been noticed different terms can be used with regard to carbohydrates. In general, the 
terms are used as follows:  
- sugars – all mono-, di- and oligosaccharides, 
- polysaccharides – by definition, 
- polyols – polyalcohols, or sugar-alcohols. 
(Sturgeon, 2000; Peris-Tortajada, 2000) 
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2.3.2 Solubility8 
 
In general, all sugars and polyols are soluble in water, some of them even extremely soluble. The 
solubility is reduced in some alcohols (ethanol or methanol), but not anymore when using heated aqueous 
alcohol solutions. Their solubility in organic non-polar solvents such as ether, chloroform and benzene is 
insignificant, exceptions can be observed with pyridine.  
 
As for the polysaccharides, the situation changes completely. Celluloses are practically insoluble in water, 
dilute acids and most organic solvents although it disperses in most liquids. Some polysaccharides have 
good swelling power and solubility in hot and cold water (e.g. starch, guaran gum). They are slightly 
soluble in 5% sodium hydroxide solution, and under colloidal form also in water. Substituted cellulose, e.g. 
methylcellulose, may however show dissolution in water with solubility depending on the grade of 
substitution. 
 
 
2.3.3 Chemistry9 
 
As already mentioned, the reductive function is rather important for carbohydrates. It is the most used 
property in sugar analysis. Free components with this function will reduce alkaline solutions of metallic 
salts in oxides or free metals. Factors influencing this reaction are heating speed, alkalinity and reagent 
strength. it should be noticed that the non-reducing sugar do not have the free lactol group therefore lack 
the ability to react with alcohols and amines. 
 
Another chemical property of carbohydrate is the methyl ether formation which is important for structure 
analyses of polysaccharides, but also for the analysis of mixed mono- and disaccharides. The interest in 
ether formation lies in the preparation of volatile compounds for gas chromatographic analysis. 
 
Finally, carbohydrates can form complexes. Optical rotations of carbohydrates are improved when put in 
solution with boric acid. The carbohydrates can form borate complexes, which are used for their 
separation by electrophoretic analysis. 
 
 
2.3.4 Analytical Methods 
 
The choice of an appropriate analytical method depends among others on the qualitative composition of 
the sample, and the requirements of the analysis. There are a number of options available from a simple 
condensation reaction to the separation and analysis of individual components. When it comes to 
quantitative analysis of mixtures, a need in instrumental methods becomes evident, as they are more 
precise and accurate. (Southgate, 1991) 
                                                     
8 (Southgate, 1991; Kibbe, 2000; Belitz et al, 2004) 
9 (Southgate, 1991; Belitz et al, 2004) 
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2.3.4.1 Thin-Layer Chromatography (TLC)  
 
Thin-Layer Chromatography (Sturgeon, 2000; Blackwood and Chaplin, 2000) is a sensitive and economic 
analytical method. It is principally used for qualitative analysis, but recent developments in automatisation 
of spot deposition made it interesting for quantitative analysis as well. Additionally, the arrival of HPTLC 
plates (High Performance Thin Layer Chromatography) allowed better resolution and reproducibility. 
 
For quantitative analysis the TLC plate is placed under a scanner which measures the absorption or 
fluorescence at one or more wavelengths. The result is a sort of chromatogram presenting peaks 
corresponding to the spots on the plate, and is then treated as such.  Calibration curve is obtained by 
standards deposited on the same plate. 
 
Although analysis time is very long compared to the instrumental techniques, this is caught up by the 
possibility of eluting up to 20 samples simultaneously. Additionally, requirements in material are low and 
the procedure is simple.  
 
 
2.3.4.2 Gas chromatography (GC)  
 
Gas chromatography (Sturgeon, 2000; Southgate, 1991) is a widely used analytical method for a long 
time. It provides effective separation and analysis and has been applied to carbohydrate analysis before 
the arrival of other methods like HPLC or Capillary Electrophoresis. However, carbohydrates are polar and 
not sufficiently volatile to be analysed directly and need to be derivatised before GC analysis. It is 
therefore very important to study derivatisation possibilities with regard to the aim of the analysis. There 
exist several types of derivatisation – methyl formation has already been mentioned, other possibilities are 
the formation of aldol acetates or silylation, which is the method used in our laboratory for routine analysis. 
 
Some derivatisation methods, such as silylation, may produce derivatives corresponding to the equilibrium 
mixture of the individual sugars. Monosaccharides, for instance, exist in their aldose and ketose forms in 
aqueous solution which form an equilibrium between the two ring (pyranose and furanose) and acyclic 
forms. Therefore, it is possible to obtain up to four peaks for one sugar. This may result in rather complex 
chromatograms and presents a disadvantage in routine analysis. However, this can be avoided by 
applying other derivatisation methods and additionally, these secondary peaks may also help identifying 
sugars, as their mass spectra are very similar. 
 
 
2.3.4.3 High Performance Liquid Chromatography (HPLC)  
 
HPLC (Peris-Tortajada, 2000) has been applied to carbohydrate analysis since the 1970's and ever since 
performance of columns has constantly improved so that it is possible now to obtain complete separation 
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of a mono- and disaccharides mixture in most foodstuff. However, a certain investment for the 
instrumentation is required and detection as well as quantification of carbohydrates can be difficult. 
 
Several separation systems have been developed and tested. Ion exchange chromatography, including 
anion- and cation-exchange resins, has been used for a long time in carbohydrate analysis. However, this 
technique has recently been superseded by the use of partition systems, mainly because the former 
involves long analysis times as well as the need to operate the column at high temperatures. Progress in 
column quality, on the other side, made the HPAEC (High Performance Anion-Exchange 
Chromatography) system the most frequently used for separation of monosaccharides and polyols. 
 
Refractive index detection is still the most widely used method for carbohydrates, in spite of its lack of 
sensitivity. It has the advantage of being universal and some of its drawbacks can be overcome by 
appropriate sample preparation. However, new detection methods, such as pulsed amperometric 
detection and mass detection, gain increasing popularity in reason of their high performance. 
 
 
2.3.4.4 Capillary electrophoresis (CE)  
 
Capillary electrophoresis (Blackwood and Chaplin, 2000; Cancalon, 2000) is relatively new as its major 
progresses have only been achieved in the 1990's. Compared to the other techniques, publications about 
carbohydrate analysis are less frequent. However, the technique allows fast and efficient separation, it 
functions with long-lasting and economic capillaries and requires only small sample volumes and little 
solvent. 
 
In general, separation of carbohydrates can be realised in two ways. The first procedure, also the most 
frequently used, works with normal polarity (positive) and uses neutral or basic buffers. The second 
applies negative polarity and acid buffers are used. The major difference between the two is that in the 
first method the electro-osmotic flow largely influences the separation of the compounds, whereas in the 
second the flow is almost eliminated. 
 
Since the carbohydrates are not charged, methods have to be adapted. Good migration can be obtained 
by ionisation of the hydroxyl groups at high pH, by complexation with borate or alkaline earth metal ions, 
by derivatisation with reagents containing ionisable functions and by partitioning into micelles using a 
pseudo-stationary phase (MEKC). However, the last one cited seems not to be appropriate according to 
(Xu et al, 1995), since the high hydrophilic property of sugars prevents the use of micellar separation 
systems. 
 
Like in HPLC detection has long been problematic. Several methods exist including fluorescence, 
absorption in the UV/Vis region, electrochemical detection, mass spectrometry and immunologic essays.  
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2.3.5 Synthesis 
 
Comparing these different techniques, it immediately appears that TLC is the only non-instrumental 
technique, a feature which makes it attractive when no other means are available. However, separation of 
carbohydrate mixtures is not as effective as with the other techniques and visualisation of polyols can be 
problematic.  
 
HPLC and CE are rather similar techniques and absolutely comparable in terms of quality. However, after 
long years of studies HPLC is the technique of choice for carbohydrate analysis and CE has still to prove 
its value. Thus, the most applied techniques these days are HPLC and GC, as they are providing efficient 
analyses with high precision and sensitivity. 
 
In more recent years, HPLC has probably replaced GC as the most commonly used technique, at least as 
witnessed by the relative volume of publications in this area. However, although HPLC presents several 
advantages in carbohydrate analysis, GC instrumentation and methods have evolved and both techniques 
are comparable now. This is demonstrated in Table 2. 
 
 
HPLC GC 
More suitable for the determination of medium- and high-
molecular-weight polysaccharides 
Far more sensitive 
Shorter (50%) analysis time Allows separation of α and β anomers a)  
Higher recoveries with more accuracy Preferable for monosaccharides 
Directly applicable to sugar samples Derivatisation required 
a) this can be an advantage as much as a drawback – it depends on the purpose of the analysis 
Table 2 – Comparison between HPLC and GC in carbohydrate analysis (Peris-Tortajada, 2000) 
 
 
It must be added that all three instrumental techniques present autosampling devices, which means that 
between forty (CE) and over a hundred (GC) samples can be analysed in sequence without the need of 
the analyst's presence. 
 
In conclusion, it is impossible to determine which technique is the best for carbohydrate analysis. The 
choice entirely depends on the type of carbohydrates to analyse, on the purpose of the analysis and the 
means available. In this research project, all techniques but HPLC have been tested. 
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2.4 FATTY ACIDS10 
 
Fatty acids are the components of lipids or fat. The lipids form a complex class of compounds which can 
be defined as being insoluble in water and soluble in organic solvents. In the past they have been defined 
as fatty acid derivatives.  Their can be either of plant origin (fruits, grains), or animal origin (deposit in 
animal tissue, milk, and aquatic fauna). 
 
Lipids are often separated in three groups – the fatty acids, the simple lipids and the complex lipids. Major 
constituents of lipids are the triglycerides which are triesters of glycerol with three fatty acid chains (long-
chain aliphatic monocarboxylic acid). They are part of the simple lipids beside other compounds formed by 
fatty acids and alcohols (sterol or longer alcohols). Free fatty acids (FFA) also are part of this group. 
 
 
2.4.1 Generalities 
 
There exist more than forty fatty acids in nature. In general, they are carboxylic monoacids which contain 
an even number of carbon atoms (4-24), present straight aliphatic chains that are not ramified or 
substituted. They are either saturated or unsaturated :  
 
- saturated fatty acids : do not contain any double bonds or other functional groups along the chain 
- unsaturated fatty acids : can contain up to six double bonds; mono-unsaturated fatty acids contain one 
double bond, poly-unsaturated fatty acids more than one; the double bonds can occur in a cis or trans 
configuration, but in nature cis configuration is the predominant form and double bonds are situated at 
the 3n carbons with starting n=2 (no conjugated).  
 
A fatty acid is composed of the following two parts : 
 
- a methyl group and its carbon chain which is insoluble in water, but soluble in oil; 
- a carboxyl group which is responsible for the acid character of the molecule; this part is soluble in 
water, but not in oil. 
 
The classification of the fatty acids is based on the length of the alkyl chain and on the number, position 
and configuration of the double bonds. A more detailed explanation is given in Appendix IV. 
 
 
2.4.2 Physicochemical Properties 
 
Fatty acids possess a carboxyl group which confers them acidic properties. Thus, most short-chain fatty 
acids present a pKa situated between 4 and 5. However, this parameter is influenced by the chemical 
                                                     
10 (Christie, 1982; Belitz et al, 2004) 
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structure of the fatty acid, in particular by the chain length and the number of double bonds. Long-chain 
fatty acids, for instance, have much higher pKa values than the shorter ones (Fig 11).  
 
An explanation of it is that for longer chains, the van der Waals interactions between the chains is higher, 
bringing the molecules closer to each other. This way the carboxylic acids are also packed closer, 
shielding the hydrogen atom between the two oxygen atoms. The closer the molecules, the more strongly 
the hydrogen atom is shielded and consequently the higher is the pKa. (Kanicky and Shah, 2002) 
 
 
 
Fig 11 – Schematic representation of C18 fatty acid monolayers at the air/water interface – influence of the 
insaturation. (Kanicky and Shah, 2001) 
 
 
It can be guessed from Fig 11 that solubility is also strongly influenced by this particular chemical 
structure. Short fatty acids present considerable solubility in water compared to their corresponding 
hydrocarbons, which is due to the presence of the carboxyl group. An increase in chain length results in 
diminished solubility in water. However, the carboxyl group has sufficient influence to permit the fatty acids 
forming a monomolecular layer at the air/water interface with the carboxyl group in water and the chains in 
air, generally oriented perpendicular to the surface. 
 
As for solubility in organic solvents, it is correlated to the polarity of the solvent. In non-polar solvents, 
solubility of the fatty acids depends on temperature, a correlation which diminishes by increasing polarity. 
Again short-chain fatty acids present in general better solubility than longer ones. Completely non-polar 
solvents are not recommended, but as we will see later are often used for extraction. 
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To conclude, the melting point depends on the number, the position and configuration of the double 
bonds. Presence of double bonds will decrease the melting point, and a double bond at the beginning of 
the chain will decrease it more than one at the end of the chain. Considering the curvature (Fig 11) 
resulting from the presence of double bonds this becomes quite obvious. 
 
 
2.4.3 Fatty Acid Analysis11 
 
Fatty acids are generally analysed by gas chromatography and have therefore to be transformed in 
volatile compounds – the most common transformation is the formation of Fatty Acid Methyl Ester 
(FAME). Consequently, studies mostly treat sample preparation rather than analytical methods. Often 
extraction, or its avoiding, is also investigated, since fatty acids happen to be analysed in food matrix and 
have therefore to be extracted. The general procedure is represented in Fig 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 12 – Procedure for lipid analysis (Carrapiso and Garcia, 2000) 
 
 
2.4.3.1 Fatty acids derivatisation
12
 
 
Fatty acids are transformed in FAME, without altering the chemical structure or the geometry of the double 
bonds. When starting with lipids, the first step consists in saponification, where fatty acids are separated 
from glycerol, sterol or other, and the second step is their esterification (methylation). As this procedure 
takes time, alternative methods have been proposed, consisting in direct transesterification – 
                                                     
11 (Marini, 2000; Shantha and Napolitano, 1992; Eder, 1995; Brondz, 2002; Seppanen-Laakso et al, 2002) 
12 (Marini, 2000; Shantha and Napolitano, 1992; Seppanen-Laakso et al, 2002; Carrapiso and Garcia, 2000) 
LIPID EXTRACTION 
Solvent extraction 
New techniques (SPE, microwave 
extraction) 
FAME SYNTHESIS 
Acid or base catalysis 
Combined catalysis 
Others 
CHROMATOGRAPHIC ANALYSIS 
Usual Methods In situ Methods 
SAMPLE PREPARATION 
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H+ or OCH3‾
 
simultaneous hydrolysis and esterification requiring only one reagent. The reaction can take place in acid 
or basic media and can be described by the following equation. 
 
 
 R´−CO−OR´´ + CH3−OH     R´−CO−OCH3 + R´´−OH 
 
 
When analysing free fatty acids, saponification is not necessary. Methylation, or esterification, only occurs 
in acid media and can be described by the following equilibrium. 
 
 R´−CO−OH + CH3−OH     R´−CO−OCH3 + HOH 
 
 
Transesterification appears to be advantageous, but has for long time been associated with problems 
such as incomplete transformation, modification of original composition of fatty acids, contamination of the 
GC column by the reagent, incomplete extraction of FAME and loss of short-chain FAME because of their 
volatility. However, progresses have been made and the method is increasingly applied in food analysis. 
  
 
Acid esterification 
 
Fatty acids are esterified, or complex lipids transesterified, by heating them in an excess of methanol 
anhydrous in presence of an acid catalyser. The most common catalysers used in methanol are HCl, 
H2SO4 and BF3. However, non-polar lipids are not soluble in methanol and another organic solvent has to 
be added.  
 
 
Basic transesterification 
 
Basic derivatisation is fast and does not require any heating. Its drawback, however, is that it does not 
transform free fatty acids, and the saponification of eventually present ester groups. The latter can result 
in formation of emulsion which can hinder FAME recovery. The procedure is similar to acid reaction, but 
uses a basic catalyser instead, e.g. sodium methoxide. Comparison with acid reaction is presented in 
Table 3. 
 
 
 
 
 
 
H+ 
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 Acid Basic 
Temperature High Ambient 
Time Min - h Sec - min 
Esterifying power medium - high No 
Transesterifying power Low High 
Risk of  saponification Low High 
Water interference Low High 
Table 3 – Characteristic of catalytic medium in esterification/transesterification reactions (Carrapiso and Garcia, 2000) 
 
 
Others 
 
One alternative is the combination of acid and basic reaction, which reduces reaction time and derivatises 
both, free fatty acids and lipids. This method is recommended by the MSDA (Manuel Suisse des Denrées 
Alimentaires – Swiss Food Manual, 2001) and applied at the Laboratoire Cantonal of Lausanne. First the 
extracted fat is reacted with sodium methoxide – basic transesterification – then the acid catalyser is 
added (BF3) and finally the FAME are extracted with hexane.  
 
Free fatty acids can also be transformed by exchange with N,N-dimethylformamide dimethyl acetal in 
pyridine or by use of strong quaternary ammonium salts such as trimethyl(m-trifluorotolyl)ammonium 
hydroxide (TMTFTAH), tetramethylammonium hydroxide (TMAH), trimethylphenylammonium hydroxide 
(TMPAH), (m-trifluoromethylphenyl)trimethylammonium hydroxide or trimethylsulfonium hydroxide 
(TMSH). Fatty acids form quaternary ammonium salts which decompose during injection in the gas 
chromatograph. (Butte, 1983; Shantha and Napolitano, 1992; Metcalfe and Wang, 1981; McCreary et al, 
1978; Misir et al, 1985) 
 
Another method often cited in literature is using diazomethane (CH2N2) for transformation of lipids. 
Although it seems to be one of the principal procedures, it is also immediately rejected because of its high 
toxicity, especially when there are alternatives. 
 
Finally, the derivatisation method applied in our laboratory – trimethylsilylation – can also be used for fatty 
acids. The proof is that fatty acids are actually detected when analysing ecstasy tablets. However, it 
seems that pyridine is necessary for good derivatisation. It is not often cited in literature, generally only 
with regard to short-chain fatty acids, and a reason might be that the derivates strongly tend to hydrolyse. 
(Harris, 1975; Schulte, 1993; Blau and King, 1977) 
 
 
2.4.4 Synthesis 
 
In the case of fatty acid analysis sample preparation appears to be particularly important. Several methods 
can be found in literature and there does not exist a true consensus about which one gives the best 
results. Not surprisingly, this strongly depends on the type of lipids to analyse which largely varies in the 
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domain of animal and vegetable food. In the case of ecstasy, fatty acids are not very complex and the 
problematic lies more in the amount available, as a traditional tablet weighs between 200 and 300mg 
containing 3% of stearate at most. 
 
Samples in food analysis are often larger and generally, transformation takes place directly on the lipid 
extract, which in itself is already bigger than an ecstasy tablet. Possible derivatisation procedures have 
therefore to be examined with regard to their application on small amounts of powder containing also other 
components as fatty acids. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
3 METHOD DEVELOPMENT 
 
 
3.1 INTRODUCTION 
 
Both the excipients chosen – sugars and fatty acids – are detected by routine analysis on a gas 
chromatograph coupled to a mass spectrometer. However, the method used is a screening method and 
allows obtaining information about the active substance present and determining any adulterants or 
sugars eventually present as well.  
 
Sugars might be detected by the screening method, but the separation is not satisfying and identification 
can be difficult since the mass spectra of sugars are very similar. Additionally, the analysis results in two 
or more peaks for one sugar, which is inconvenient for quantitative purpose. 
 
Fatty acids are the components of stearates and are present in small quantities in tablet composition 
(~3%). Considering a chromatogram of a typical ecstasy tablet obtained with the screening method, the 
two peaks of palmitic (C16) and stearic acid (C18) are very small. This fact and the eventual presence of 
other fatty acids in smaller quantities lead to the conclusion that extraction followed by concentration is 
necessary.  
 
Keeping in mind that sugars and fatty acids will be used for drug profiling purpose, a more selective 
method has to be developed. Therefore an important part of this research was to optimise the analysis of 
these two types of substances. 
 
 
3.2 CARBOHYDRATES 
 
3.2.1 Choice of the analytical method 
 
Principal techniques are Thin-Layer Chromatography (TLC), High Performance Liquid Chromatography 
(HPLC), Capillary Electrophoresis (CE) and Gas Chromatography (GC). TLC is a good technique because 
it is inexpensive, simple and allows a simultaneous analysis of up to 20 samples. Especially the launching 
of HPTLC plates resulted in an improvement of the performance in terms of resolution. However, analysis 
of 9 sugars13 found in ecstasy and other illicit drugs showed only incomplete separation. Additionally other 
problems have been observed with regard to the time of one elution (up to 4 hours) and variation of 
migration distances. Sugars analysed within a mixture (with other sugars or other substances) would 
                                                     
13 Glucose, Mannose, Fructose, Lactose, Sucrose, Maltose, Sorbitol, Inositol, Mannitol 
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present another retention index than the corresponding standard analysed alone. Finally, it has been 
observed that the analysis of ecstasy tablets containing two sugars resulted in the detection of only one of 
them. Altogether these difficulties prevented from further investigations in the use of this technique. 
 
Considering the literature about analysis of carbohydrates, HPLC seems to be the technique of choice. 
Nevertheless, it has not been tested because our institute does not possess such an instrument and other 
techniques of comparable quality were available. Therefore, research has been focused on capillary 
electrophoresis first. The technique appeared to be inappropriate for this research and will not be 
discussed here, but the interested reader can learn about the details in Appendix V. Thus, the technique 
to be finally applied in this project was gas chromatography coupled to mass spectrometry (GC-MS). 
 
Gas chromatography coupled to mass spectrometry is routinely applied for illicit drug analysis at the IPS 
(Institut de Police Scientifique). There are methods developed for every type of drug such as cocaine, 
heroin, ecstasy and a general screening method if the drug type is unknown before analysis. These 
methods were developed to identify first of all the active substance, but also the possibly present cutting 
agents or adulterants.  Therefore it is important to realise that sugars are already detected by these 
methods. However, identification is not always easy because mass spectra are almost identical and some 
sugars present more than one peak of various sizes.  
 
Thus, the aim of the method development for carbohydrates was twofold – firstly to improve the separation 
and identification of the principal sugars, and secondly to reduce secondary peaks for better quantitation. 
With this aim in view, the study has focused on the research of an appropriate derivatisation agent and the 
optimisation of GC conditions. 
 
 
3.2.2 Preliminary tests 
 
First of all the choice of sugar standards was reviewed and it was decided to take the eight sugars 
detected in the ecstasy tablets analysed in our laboratory (a database exists since 1996) – sucrose, 
lactose, mannitol, glucose, xylitol, sorbitol, inositol and maltose. An equal amount of each sugar was 
taken, mixed together and homogenised in a mortar.  
 
Since sugars are polar and non-volatile they cannot be analysed directly by GC, but have to be derivatised 
beforehand. Therefore an important part of the work was to investigate which agent was the most 
appropriate. After a review of relevant literature, a number of methods have been chosen for tests in 
function of : 
 
o Suitability for the selected sugars 
o Preparation time 
o Simplicity of preparation 
o Amount of ecstasy powder necessary 
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The resulting preparations to be tested are listed in Table 4.  
 
Weigh-in Preparation method Reference 
4-5mg 500µl CHCl3/Pyridine (5:1) + 100µl MSTFA, 1hour at 80°C IPS 
4-5mg 500µl acetonitrile + 100µl MSTFA/2% TMCS, 30min at 70°C (Romolo, 2003) 
4-5mg 500µl CHCl3/Pyridine (5:1) + 100µl TMSI, 1hour at 80°C (Romolo, 2003) 
4-5mg 500µl Pyridine + 150µl TMSI, 1hour at 80°C (Cotte et al, 2003) 
10mg 
1ml Hydroxylamine/aniline (50mg/ml), 10 min at 60°C, 300µl BSTFA, keep 10 
min at room temperature 
(Rojas-Escudero et 
al, 2004) 
2-3mg 4 drops 1-methylimidazole + 5 drops acetic anhydride, after 5 min add 1ml CHCl3 (Dujourdy, 2004) 
2-3mg 1ml pyridine + 200µl HMDS + 100µl TMCS, vortex for 30s, analyse after 5min 
(Sweeley et al, 
1963) 
10mg 40µl pyridine + 50µl BSTFA/1%TMCS, 30min at 80°C (Selles et al, 2002) 
0.5mg 
200µl pyridine + 200µl TMSI + 200µl TMCS + 200µl heptane + 400µl H2O, take 
100µl of the upper phase for analysis 
(Villamiel et al, 
1998) 
2-3mg 500µl pyridine + 450µl HMDS + 100µl TFA, vortex for 30s, analyse after 30min (Brobst, 1972) 
MSTFA - N-Methyl-N-(trimethylsilyl)trifluoroacetamide, TMCS - Trimethylchlorosilane, TMSI – 1-(Trimethylsilyl)imidazole, BSTFA – 
N,O-bis-(trimethylsilyl)-trifluoroacetamide, HMDS – Hexamethyldisilazane, TFA – Trifluoroacetic Acid  
Table 4 – Tested preparation methods and references. 
 
 
For these first tests, analyses were realised on an Agilent GCD-MS with a DB1 column. Instrumental 
conditions were applied as noted in the publication corresponding to the derivatisation method as much as 
possible. If no conditions were given with the derivatisation method, then one of the four routine methods 
cited before has been applied (the one for cocaine happened to give optimal results in terms of separation 
and peak quality  method COC) next to a method taken from the publication of (Cotte et al, 2003) ( 
method SUGAR).   
 
The chromatograms of the sugar mixture were compared visually by considering : 
 
- if the number of peaks detected corresponded to the number of sugars in the mixture, 
- the quality of separation, particularly concerning the separation of mannitol/sorbitol and 
lactose/sucrose, 
- the quality of the peak shapes (symmetry, broadness). 
 
From these comparisons resulted a selection of two derivatisation methods for further investigation :  
 
1) CHCl3/pyridine + TMSI (Romolo, 2003) 
2) pyridine + HMDS + TMCS (Sweeley et al, 1963) 
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It was decided to use both derivatisation agents to determine better instrumental conditions. Additionally to 
the quality of separation of the eight sugars, time of analysis would have to be considered as well. 
 
 
3.2.3 Instrumental conditions 
 
Since the beginning of derivatisation tests, our laboratory could acquire two new Agilent gas 
chromatographs 6890-MS and it was possible to employ one of them for this research. Hence the 
separation methods had to be tested on the new instrument, which appeared to be much more sensitive.  
 
It has to be emphasized that the routine method for cocaine still gave better results, in terms of sugar peak 
separation, than the method applied to ecstasy tablets. Indeed when analysing ecstasy containing sorbitol, 
this one is easily mistaken for mannitol even when comparing with the relevant sugar standard, since 
retention times and mass spectra are almost identical. The same can be said for lactose and sucrose, but 
fortunately the second peak of lactose helps in identification. But this is the reason why new or modified 
methods have been compared to the cocaine method. 
 
Summarizing the situation at the end of the preliminary tests, the method taken from (Cotte et al, 2003) 
(method SUGAR) certainly achieved a better separation of the eight sugars than the cocaine method 
(method COC). The latter had, however, the advantage of being less time-consuming and the question 
appeared if a slightly better separation was worth a 45 min analysis. The same observation was made on 
the new instrument. 
 
An alternative was found in a publication by (Troyano et al, 1996), in form of a method suitable for 
trimethylsilyl derivatives of carbohydrates on a similar instrument and same column (DB1). The results 
were comparable to both the SUGAR and the cocaine method. The separation of the couple 
mannitol/sorbitol was better, and that of lactose/sucrose slightly worse than with the SUGAR method. As 
for the analysis time, it was only a few minutes longer than the cocaine method. Even though there was no 
significant improvement, the method provided a good basis to work on. Thus, it was decided to try out a 
number of modifications of the temperature program and gas flow, as these were two factors directly 
affecting separation (Rouessac and Rouessac, 1998).  
 
Temperature Program – Peak retention times depend upon relationships between pressure, flow rate, 
oven temperature, column dimensions, and stationary phase. The temperature will change the viscosity of 
the stationary phase inside the column and will influence the partition coefficients of analytes and as a 
result their separation. The changes undertaken are represented in Fig 13. 
 Method Development 39 
 
150
170
190
210
230
250
270
290
0 5 10 15 20 25 30 35
Minutes
°C Troyano et al (1996) SUCMOD5
Pentoses & Hexoses
Hexosamines
Disaccharides
 
Fig 13 – Initial and modified temperature program for GC analysis of sugars. 
 
Gas Flow – As the name says it, in gas chromatography gas is the mobile phase, but has no interaction 
with the substances. However, its influence on dispersion in the column is important, and consequently on 
efficiency and sensitivity of detection as well. The optimal gas flow depends on the internal diameter of the 
column and on the type of gas. The carrier gas on our instrument was helium and optimal velocities are 
estimated to be between 30-40cm/s. 
 
After several tests, the gas flow was kept at 1ml/min (average velocity at 38cm/s) as proposed in the 
original method, but the temperature program was changed and a method could be determined providing 
a separation of all eight sugars, a reduction of secondary peaks and a comparable analysis time to the 
cocaine method applied at the laboratory (Appendix VI). Details of the chosen method can be seen in 
Table 5. 
 
 
 
 
Fig 14 – Mixture of 8 sugars prepared both by HMDS method and analysed by the routine cocaine (red) and the new 
developed method – Sucmod5 (blue). 
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The analyses of the same sample preparation (HMDS) of the sugar mixture by the cocaine and the 
modified carbohydrate method are represented in Fig 14. It can be seen that separation is better with the 
modified method, particularly for the couples mannitol/sorbitol and lactose/sucrose.  
 
The difference in abundance can be explained by the fact that the two preparations were not analysed the 
same day, but in an interval of two months and weigh-ins were very different (factor of almost 2.5). It has 
also to be mentioned that the preparation analysed by the cocaine method does not contain any Internal 
Standard, as this was only a punctual qualitative analysis to verify separation. 
 
Method Sucmod5 
Sample introduction  
– Split 
– Volume 
– Total flow 
– Injector T  
 
20 : 1 
1µl 
24ml/min 
275°C 
Gas saver 15ml/min after 2min 
Carrier gas Helium 
Column  
– Type 
– Mode 
– Average velocity 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm (film) 
Constant flow 
38cm/sec 
Oven T-program 
175°C (1min), 5°C/min, 180°C (10min), 10°C/min, 250°C 
(10min), 5°C/min, 270°C (2min) 
GC-MS interface T 275°C 
MS information  
– Solvent delay 
– Mass range 
– Sample rate 
– MS quad T 
– MS source T 
 
2.5 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
Table 5 – Instrumental conditions for the sugar analysis by GC-MS. 
 
 
3.2.4 Determination of the derivatisation agent 
 
Now that the analytical method for the analysis of sugars was fixed, it was possible to compare the two 
derivatisation methods obtained after the preliminary tests. As until now they have only been applied to a 
standard mixture of carbohydrates, it was decided to test them on real ecstasy tablets. It was important to 
examine if the matrix would have an influence on the analytical result. For further comparison, 
derivatisations were investigated with regard to linearity and amount of yield. 
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3.2.4.1 Ecstasy 
 
Six large ecstasy seizures were chosen in order to have enough tablets available for method testing. Their 
composition was obtained with the routine method applied to ecstasy street samples and is presented in 
Table 6. 
 
Logo Internal No Sample Size  Active Substance (%) Diluent 
Peace and Love L1635 19 MDMA (44%) Lactose 
Flying Bird, Peace L989 17 MDMA (38%) Lactose 
"S" L995B 18 MDMA (35%) Lactose (B) 
Rolling Stone's L985C 18 MDMA (29%) Sorbitol 
Elephant L985A 19 MDMA (21%) Sorbitol 
Sparrow Z9 15 Amphetamine (7%) Lactose 
Table 6 – Ecstasy test samples and their general composition. 
 
The additional "B" next to lactose for sample L995B is used in our database to indicate that the second 
peak of lactose is of the same size or higher than the first one. This phenomenon will be investigated in 
another chapter as it is due to the α- and β-form of lactose and both forms are used as excipients (cf. Ch 7 
– Additional Studies). In this project, this second peak will always be referred to as lactose2.  
 
For the comparison of the derivatisation methods, five tablets were taken from every seizure, then crushed 
and homogenised in an agate mortar. Two weigh-ins per tablet were taken and analysed in order to obtain 
10 measures per seizure and derivatisation method. The obtained peak areas were then normalised with 
regard to the sum of areas and the relative standard variation (RSD) was calculated for every peak. 
 
 
100×=
Mean
STDEVA
RSD  
 
 
Both methods worked well on ecstasy street samples and produced chromatograms with reproducible 
retention times. For a better comparison, the RSD values obtained for every ecstasy sample were 
averaged per peak and method. The result is represented in the Fig 15. Mannitol was taken into account 
as well for it is regularly detected together with sorbitol. The latter is not shown in Fig 15 because of its 
very low values for both preparation methods. Lactose is always present under the form of two peaks and 
therefore the two would be used. 
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Fig 15 – Comparison of RSD values between TMSI and HMDS preparations. 
 
 
As expected the RSD values would be higher for smaller peaks and very low for the principal peaks. But 
when comparing the two derivatisations, HMDS appears to perform slightly better – except for the 
principal peak of lactose where its RSD value is a little higher than the one obtained with TMSI. 
 
3.2.4.2 Yield 
 
Three sugar standards were chosen with regard to their frequency in ecstasy tablets, which is established 
through statistical evaluation of the ecstasy database created by a collaboration of the IPS and the WD 
Zürich (Wissenschaftlicher Dienst Zürich). The corresponding evaluation is represented in the graph below 
(Fig 16). 
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Fig 16 – Extract of statistical evaluation of the ecstasy database of the IPS-WD with regard to diluents 
 
 
In Fig 16 it can be seen that lactose is by far the most frequently observed diluent, followed by sorbitol. 
Sucrose and glucose have been regularly detected, but are altogether rather rare. The frequency of 
mannitol is principally due to a large seizure in 2000. Considering these statistics, it was decided to take 
lactose, sorbitol and sucrose (to have one of the rare sugars as well) for the task. 
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Mixtures of MDMA and the three selected sugars, respectively, were prepared at four different 
concentrations. The sugar content – 50, 60, 70 and 80% - was fixed with regard to commonly observed 
MDMA concentrations. As can be seen in Fig 17 below, the mean value is situated between 25 and 35 %, 
with a standard deviation giving a range from 10 to 50%. 
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Fig 17 – Representation of mean MDMA concentrations, evaluated from the ecstasy database of the IPS-WD. 
 
 
The mixtures were homogenised in an agate mortar, derivatised by both methods to investigate and then 
two weigh-ins per mixture were analysed. In order to be able to compare the two derivatisation methods, 
the sugar peak areas were first normalised to the concentration (of the mixture in the solution) and then to 
the internal standard (Heneicosane). The first one was necessary because of the relatively high difference 
in volume between the TMSI preparation – 0.6ml – and the HMDS preparation – 1.3ml. The second is 
done to avoid instrumental errors and/or variations and it is commonly applied in comparison between 
chromatograms. The results are presented in the Fig 18 to Fig 20. 
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Fig 18 – Comparison for lactose/MDMA mixtures. 
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Fig 19 – Comparison for sorbitol/MDMA mixtures. 
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Fig 20 – Comparison for sucrose/MDMA mixtures. 
 
 
From the graphs above (Fig 18 to Fig 20) it can be seen that the responses are linear for both methods, 
which indicates that they both work well. But additionally, it appears that the yield obtained with the HMDS 
preparation is higher for each sugar used.  
 
 
3.2.5 Conclusion 
 
Considering the results of the two tasks realised for the determination of the derivatisation agent, the 
method taken from (Sweeley et al, 1963), HMDS combined with TMCS, appears to give optimal results. 
The relative standard deviation (RSD) for the areas of all the sugar peaks in the examined ecstasy tablets 
is similar or better than with TMSI derivatisation. Furthermore, yield appeared to be higher as well. 
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Additionally, the preparation is as easy as for TMSI derivatisation, but much shorter in time since no 
heating is necessary. It will therefore be applied for the analysis of the ecstasy samples.  
 
2-3mg + 1ml pyridine + 200µl HMDS + 100µl TMCS, 30s vortex, analyse after 5min (Sweeley et al, 1963) 
 
The instrumental method used with this derivatisation is summarized in Table 7 
 
Method Sucmod5 
Sample introduction  
– Split 
– Volume 
– Total flow 
– Injector T  
 
20 : 1 
1µl 
24ml/min 
275°C 
Gas saver 15ml/min after 2min 
Carrier gas Helium 
Column  
– Type 
– Mode 
– Average velocity 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm (film) 
Constant flow 
38cm/sec 
Oven T-program 
175°C (1min), 5°C/min, 180°C (10min), 10°C/min, 250°C 
(10min), 5°C/min, 270°C (2min) 
GC-MS interface T 275°C 
MS information  
– Solvent delay 
– Mass range 
– Sample rate 
– MS quad T 
– MS source T 
 
2.5 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
Table 7 – Instrumental conditions for the sugar analysis by GC-MS. 
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3.3 FATTY ACIDS 
 
3.3.1 Introduction 
 
Fatty acids are present in nearly all ecstasy tablets analyzed in our laboratory, so it was only natural to 
focus research on these substances. But, as it has already been mentioned, their concentration in the 
tablet mixture is very small, which becomes obvious when considering the chromatogram in Fig 21. It is 
difficult to exploit two peaks of this size – error will increase compared to the high peaks, and other fatty 
acids entering in the composition of stearates are not detected. Thus, method development has been 
focused on extraction and eventual concentration of fatty acids.  
 
 
3.3.2 Choice of the analytical method 
 
The choice of the analytical method has been much easier than in the case of carbohydrates, because 
there is a sort of consensus that gas chromatography is the technique of choice. However, in general the 
detector cited in references is the flame ionization detector (FID), whereas in this project a mass 
spectrometer has been used. This can be explained by the fact that for long time the FID has been much 
more sensitive and therefore more appropriate for fatty acid analysis. But technical advances made the 
new generation of mass spectrometers as sensitive.  
 
Fatty acid separation can be realized on non-polar, polar and strongly polar columns. However, it is 
recommended to use polar columns for better separation of unsaturated fatty acids. Since stearates, used 
in ecstasy production, are principally composed of saturated fatty acids this point becomes less important 
and there is no reason not to use non-polar columns such as those employed in our laboratory (DB1). 
 
Instrumental conditions have been taken from (Butte, 1983) as they appeared to give good separation, 
detecting fatty acids ranging from six to twenty carbons (C8 to C20 - caprylic to arachidic acid) and giving 
reproducible retention times. Additionally, analysis time is rather short.  
 
 
3.3.3 Extraction and derivatisation technique 
 
Extraction and derivatisation have to be considered together as preparation methods for fatty acids in 
generally include both. They are either applied in sequence or simultaneously (in situ). 
 
3.3.3.1 Test sample  
 
Unlike in the method development for carbohydrates no standards have been used in the case of fatty 
acids. Commercially available standard mixtures appeared to be too expensive for our purpose and were 
only used for peak identification. Additionally, standards would be inappropriate for extraction tests. 
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Finally, pure fatty acid standards, which would have been necessary to produce blends similar to ecstasy 
tablets, tend to be an oily substance making it very difficult to make precise weigh-ins.  
 
In the beginning it was not clear yet how much powder would be needed for effective extraction and 
research for a test sample aimed at a large ecstasy seizure. A suitable sample was found in a seizure 
containing thirty tablets, all already scraped or broken for analytical purpose. They were all ground and 
mixed together resulting in ~7g available "ecstasy powder". The composition is as follows: 
 
 
Logo Internal No Active Substance (%) Diluent 
Hammer & Sickle, "CCCP" L267 MDEA (45%) Lactose 
 
 
An analysis with the screening method for ecstasy proofed that the seizure actually contained fatty acids, 
presenting the typical peaks of palmitic (C16) and stearic acid (C18) (Fig 21).  
 
 
 
Fig 21 – Test sample 267 analyzed by routine method for ecstasy tablets; MDEA nd – MDEA non derivatised, MDEA 
d – MDEA derivatised. 
 
 
3.3.3.2 Extraction followed by derivatisation 
 
The approach was to proceed to a liquid/liquid extraction of the fatty acids first and then to derivatise with 
MSTFA – a derivatisation agent used for routine analysis in our laboratory. The procedure generally 
applied goes as follows :  
 
The powder was put in solution with 1ml of acid buffer (NaH2PO4 / H3PO4; 0.1 M). After dissolution a 
volume of 200µl of organic solvent was added, shaken and let to rest. The organic phase was removed 
and evaporated under a nitrogen stream. Then 200µl of a chloroform/pyridine (5:1) solution and 100µl of 
MSTFA were added. The solution was heated for 60min at 85°C before analysis to have derivatisation 
take place. 
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Solvents tested  
 
According to the solubility of fatty acids and the solubility of the solvent in water, three have been tested: 
hexane, heptane and dichloromethane. In the beginning they were simply tested for their aptitude to 
dissolve magnesium stearate and stearic acid standards, and their inaptitude to dissolve MDMA standard 
(the only one available in sufficient quantity) by putting a few mg of relevant standard in about 1ml organic 
solvent.  
 
Since all three appeared to be appropriate, they were tested for an extraction of the test sample according 
to the procedure described above. Hexane and heptane are very similar from a chemical point of view and 
consequently gave similar results. However, it was of no use to keep them both and therefore heptane has 
been rejected because of its longer evaporation time.  
 
Extraction with dichloromethane gave good results as well, although its evaporation was also longer. But 
giving a good extraction yield and being a chemical alternative to hexane, it was kept for further 
investigation. 
 
 
Acid / base extraction 
 
The major part of the performed extraction tests have been realized with an acid buffer at pH 2.34 
(NaH2PO4 / H3PO4; 0.1 M). The acid buffer seemed to be appropriate because stearates are composed of 
acids (cf. Ch 2 – Theoretical Part), and the major substances (active substance and sugars) should 
dissolve too, since the buffer is aqueous and regularly used for ecstasy quantification. The results were 
indeed very satisfying because extraction of fatty acids alone could be achieved and their detection by GC 
improved.  
 
However, the alternative of basic extraction was tested and the procedure was taken from (Palhol et al, 
2002). Even though the paper deals with impurity profiling of MDMA, the very good detection of fatty acids 
in their chromatograms made us try their method on the test sample. The buffer used in this test was a 
carbonate buffer of pH 10 (K2CO3 / KHCO3; 0.5M). Both solvents, hexane and dichloromethane, were 
applied for this extraction. An example of the resulting chromatograms is shown in Fig 22. 
 
The basic extraction was tested three times – twice using the amount of powder recommended in the 
paper (150mg), and the third time using only 25mg. The chromatograms shown below represent the result 
of the first test, as indeed for the other two extractions only traces of fatty acids could be detected. There 
is no explanation why the second and the third time, the extraction did not work. However, even 
considering the first result alone, extraction might have worked very well, but the MDEA peaks are terribly 
large and fatty acids could be hidden by these or other peaks of impurities/by-products. Hence the basic 
extraction has been abandoned. 
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Fig 22 – Chromatograms after hexane (blue) and dichloromethane (red) extraction in alkaline conditions. 
 
 
Sample amount  
 
For the first tests an amount of 25mg of test sample was judged to be sufficient – considering that the 
usual amount of stearates in ecstasy mixtures is about 3%, the final concentration would be of more than 
1mg/ml which is sufficient to be detected by GC analysis. 
 
However it was decided to test higher quantities of powder in order to verify if new peaks would result. 
Additionally, linearity of responses could be checked. Thus, extractions have been performed with 
amounts of 25, 50 and 100mg.  
 
No new peaks have been detected compared to the analysis with the amount of 25mg. As for linearity of 
the responses, the peak areas of palmitic and stearic acids have been normalized to the sum of areas and 
the results are represented in the Fig 23.  
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Fig 23 – Graphic representation of C16 (palmitic acid) and C18 (Stearic acid) responses in function of the amount of 
ecstasy powder for hexane and dichloromethane preparations. 
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Obviously, there is an irregular response for hexane extraction, whereas dichloromethane extraction is 
almost linear and gives, as it seems for the amount of 25 and 100mg, also a higher yield.  
 
Thus, the first conclusion to draw from these observations is that an amount of 25mg seems to be 
sufficient for the extraction of fatty acids, and this for both solvents tested. But then, irregularities have 
been observed with regard to hexane extraction and yield seems to be better with dichloromethane as 
well.  
 
 
Elimination of evaporation step 
 
Every additional step in an analytical method will increase the error in the results. In the procedure 
presented in the beginning, the aim of the evaporation was to remove the whole organic phase in order to 
obtain maximum yield of fatty acids. However, the removal of the organic phase is never complete and 
this is a certain source of error.  
 
As in the end a standardization of the procedure in view of quantitative application was aimed at, this 
source of error had to be minimized. One possibility was to fix the volume organic phase to remove, to 
skip evaporation and to add the derivatisation agent directly to the removed solvent. For the 
dichloromethane extraction this modification was also desirable because the evaporation time is much 
longer than with hexane. 
 
For comparison of the results before and after the modification of the procedure, three replicas have been 
extracted and analyzed. The peak areas of palmitic and stearic acid have been normalized to the sum of 
areas, including the internal standard, and the RSD has been calculated and is represented in Fig 24.  
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Fig 24 – Comparison of RSD values for hexane and dichloromethane preparations before and after modification of the 
procedure. 
 
 
It can be seen that the improvement for the dichloromethane extraction has been significant. On the other 
hand, for hexane the results were similar or worse. An explanation could be that hexane forms with the 
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acid buffer two neatly separated phases, where it is much easier to remove the whole volume of organic 
phase without producing a great error.  The separation of the dichloromethane and aqueous phase is by 
far not as neat and the organic solvent showed tendency of forming bubbles. Additionally, the evaporation 
was not only long but maybe also incomplete as the appearance after evaporation was very different from 
that of hexane after evaporation and seemed to still contain solvent. Thus the realized modification would 
have much more influence on the dichloromethane extraction.  
 
The fact of adding the derivatisation agent directly to the extraction solvent did not have a negative 
influence on the results and took place just as with the chloroform/pyridine solution. 
 
 
Preliminary conclusion 
 
The application of liquid/liquid extraction followed by derivatisation is a suitable preparation method for 
fatty acid analysis in ecstasy tablets. A chromatogram after dichloromethane extraction is shown in Fig 25. 
 
 
 
Fig 25 – Chromatogram of the test sample after dichloromethane preparation. 
 
 
The various observations resulting from the realized experiments are represented in Table 8.  
 
Solvent Advantages Disadvantages 
Dichloromethane 
- good yield 
- small RSD 
- works without evaporation step 
- organic phase is under aqueous phase 
and has tendency of forming bubbles 
- leaks from pipette 
- traces of MDEA impurities 
Hexane 
- very good separation of the two phases 
- fast evaporation 
- extracts exclusively fatty acids 
- yield slightly lower 
- higher RSD (though in acceptable limits) 
- performs worse without evaporation step 
Table 8 – Advantages and drawbacks of dichloromethane and hexane preparation. 
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Considering the various points noted in the table above, preference was given to dichloromethane 
extraction. Its advantages with regard to yield, reduced RSD and decrease of preparation steps were 
valued as more important than the advantages for hexane. And the negative observations made with 
dichloromethane were acceptable as they did not seem to significantly influence the performance of the 
extraction.  
 
 
3.3.3.3 Derivatisation followed by extraction 
 
The principle is based on the in-situ transesterification, which means that saponification (separation from 
the glycerides) and esterification (formation of FAME – Fatty Acid Methyl Ester) take place in one solution. 
The FAMEs have to be extracted afterwards for GC analysis. 
 
Official method 
 
The author had the possibility to dispose of the infrastructure and knowledge of the Laboratoire Cantonal 
of Lausanne. This laboratory is in charge of food control in the canton of Vaud and has been accredited. 
The aim of the stay there was to test their dosage of fatty acids by applying it to ecstasy tablets.  
 
The procedure is based on the base-catalyzed transesterification. Lipids are heated with a solution of 
sodium methoxide for a few minutes. When no fat is visible anymore bortrifluoride is added and heated for 
another minute. Finally, the FAMEs are extracted with hexane after having added some sodium chloride 
and analyzed on a GC-FID.  
 
The tests have been realized with 150mg of ecstasy powder per sample and with standard solutions. 
Unfortunately, results were incoherent in both cases. First, no peaks at all were detected, and then the 
standard solutions were tested and gave incoherent results as well, as not all standards were observed. 
Results got better after a few tests, but were still very irregular in terms of peak height. The person in 
charge in the laboratory suggested that the procedure is appropriate for glyceride analysis only, in the 
form of which fatty acids are usually present in food (Fig 26). Thus, it might not be suitable for ecstasy 
where the fatty acids are present as salts, in form of stearates (Fig 26). 
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Fig 26 – On the left the schematic structure of a triglyceride, on the right that of Mg stearate is shown, with R1, R2 and 
R3 representing the alkyl chains. 
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Indeed, confirmation has been found in literature where often it is pointed out that base-catalyzed 
transesterification methods might be less suitable for free fatty acids. (Shantha and Napolitano, 1992; 
Eder, 1995; Carrapiso and Garcia, 2000; Brondz, 2002) 
 
 
Alternative method 
 
After some research in the relevant literature a method has been found in a study about harbor seals by 
(Iverson et al, 1997) and has been tested on the test sample. The procedure applied in the study is 
described hereafter. 
 
The sample is mixed with 1.5ml bortrifluoride (8%) in methanol and 1.5ml hexane, capped under nitrogen 
and heated for 1h at 100°C. The FAMEs are extracted into hexane, concentrated and analyzed. For the 
test on the ecstasy sample only one modification has been undertaken – the concentration of bortrifluoride 
in the used solution was of 14% instead of 8%. The very first test using an 8% solution gave very bad 
results and so when it was tested again in parallel with another method (Park and Goins, 1994) designed 
with a 14% BF3 solution, this one was used for both. Since the results appeared to be much better than 
expected the concentration of 14% was kept for the ongoing studies. The sample weigh-in proposed in the 
paper was of over 100mg of lipids. This is a rather high amount, thus smaller weigh-ins of ecstasy powder 
have been tested – 100, 50 and 25mg. 
 
The results of these first tests were very promising. Indeed, the quality of the chromatograms in terms of 
yield and number of peaks was very similar to those obtained with the dichloromethane extraction. 
Additionally, the method appeared to be especially robust – the chromatograms were of good quality even 
for samples where problems had been encountered during preparation (partial evaporation of hexane in 
the oven, spilling out of some solution when passing under nitrogen) and one would expect failure of 
analysis. Therefore it was decided to further investigate this method and to optimize it. 
 
Optimization 
 
Despite the apparent robustness of the method, potential sources of errors had to be minimized. The 
greatest risk in the procedure consisted in the evaporation of the solvent mixture in the oven. Thus, the 
material had to be adapted and stabilized (the vials tended to jump out of the rack).  
 
To reduce the risk of evaporation, crimp seal vials (Fig 27) have been tried as they are routinely used with 
volatile solvents in sample preparations and they are known to withstand heat. Unfortunately, only the 
volume of 1.5ml was available and tests with adapted volume sizes did not give satisfying results. Another 
problem was the fact that the crimp seals had to be removed for the continuation of the procedure and this 
is a frequent source of accidents. 
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Fig 27 – On the left: Crimp Seals with PTFE/Rubber Septa; On the right : green phenolic PTFE liner screw caps. 
 
 
Therefore, research of appropriate material focused on screw top vials of sufficient size (4ml). It was 
known that our Fire Investigation group used this type of vials (but with a smaller volume) for their CS2 
desorption procedure – these vials and caps are therefore especially adapted for very volatile solvents 
and to withstand heat. The same sort of vials and caps could be found with sufficient volume size and 
were tested – caps are shown in Fig 27 on the right. The results were much more satisfying and these 
vials and corresponding caps were chosen for further work.  
 
Care was taken when closing the vials before putting them in the oven and the fixation between two racks 
assured their stability during heating. Now that the more technical problems were fixed, the extraction 
procedure had to be standardized in view of quantitative application. The hexane phase containing the 
FAME consisted in more than 1ml and would have to be completely removed and evaporated under 
nitrogen. The remaining FAMEs were recovered with 200µl of hexane also containing an internal 
standard. 
 
No further problems have been observed when applying the procedure after the modifications, and 
besides the good yield, additional peaks of fatty acids could be detected (myristic and arachidic acid). 
 
 
Sample amount  
 
Like for the liquid/liquid extraction procedure the necessary sample amount was verified, particularly in 
view of the smaller peaks detected. Linearity of results had already been observed with the first tests 
applying the bortrifluoride procedure, but it was checked again after some modifications. Analyses have 
been performed with sample amounts of 10, 20, 30, 40 and 50 mg of ecstasy powder. For a better 
representation of the results, peak areas have been normalized to the sum of areas of all detected fatty 
acids. And the ratios of myristic and arachidic acid have been multiplied by 100 because their peaks are 
much smaller than those of palmitic and stearic acid. 
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Fig 28 – Responses of myristic (C14), palmitic (C16), stearic (C18) and arachidic (C20) acids in function of the sample 
amount analyzed. 
 
 
All four peaks have been detected from a sample amount of 10mg. However, linearity is not as good as 
expected especially for palmitic and stearic acid – the higher peaks. Surprisingly the responses of the 
smaller peaks were more linear. On the other side, it can be seen on the graph (Fig 28) that it is the 
response for 10mg which has a negative influence on the linearity (excepted for arachidic acid). Indeed, 
when removing these responses linearity is improved (Fig 28). 
 
Considering these results a sample amount below 20mg does not seem appropriate. It has to be pointed 
out as well that with an amount of 30mg margaric acid started to be detected and with 50mg even traces 
of oleic acids have been observed. However, the aim was to avoid high sample amounts such as 50mg. 
But to have these peaks being significant, even higher weigh-ins would be necessary. Thus, it was 
decided to keep the sample amount low and to assure the detection of the four detected acids. A sample 
amount of 25mg would be applied for the continuation. 
 
 
3.3.3.4 Comparison of the two resulting methods 
 
Both types of procedure gave surprisingly good results with the test sample, but only one would be applied 
on a greater selection of ecstasy samples. To have an additional element for comparison, the procedures 
were carried out with a small selection of ecstasy tablets. The same seizures than for carbohydrates were 
used, plus two more which did not contain any sugars. 
 
 
Logo Internal No Sample Size  Active Substance (%) Diluent 
Superman L1310A 18 MDMA (29%), MDEA (3%)  
Elephant L985B 19 MDMA (26%)  
Peace and Love L1635 19 MDMA (44%) Lactose 
Flying Bird, Peace L989 17 MDMA (38%) Lactose 
"S" L995B 18 MDMA (35%) Lactose (B) 
Rolling Stone's L985C 18 MDMA (29%) Sorbitol 
Tasmanian Devil L985A 19 MDMA (21%) Sorbitol 
Sparrow Z9 15 Amphetamine (7%) Lactose 
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One last modification was realized before starting the experiments – the internal standard, heneicosane, 
was replaced by eicosane. The problem was that with the bortrifluoride method heneicosane used to elute 
right before stearic acid. Thus, it was aimed to find an alcane eluting between palmitic and stearic acid, 
but at a certain distance. And eicosane was found to fulfill this purpose for both preparation methods, 
except that with the dichloromethane extraction it was detected before and not between the two peaks. 
 
Similarly to carbohydrates five tablets have been crushed and homogenized, and two weigh-ins were 
taken per tablet. After having completed all analyses, results were compared considering the number of 
fatty acids detected with each method and by evaluating the relative standard deviation for relevant peaks. 
They were regarded as such when appearing in the major part of the ten analyses. In Table 9 are listed 
the RSD values of all detected peaks for both methods. 
 
 
 Dichloromethane Bortrifluoride 
 C12 C14 C15 C16 C17 C18 C20 C12 C14 C15 C16 C17 C18 C20 
L1310A       1.11   0.71   41.33 11.39   5.15 21.97 5.76 3.72 
L985B     3.36  4.90   22.99 6.21  5.50 22.95 5.47 8.08 
L1635 6.76 5.06  0.87 11.77 0.72   7.86 4.63  1.16 3.14 1.30 6.83 
L989   9.04  5.42  5.59    2.89  7.11  6.73   
L995B   11.14  5.75  5.95    5.19 4.44 1.72 0.99 0.81 1.64 
L985C   6.67  1.36 7.22 1.90    1.74 5.08 0.81 2.27 0.60 3.69 
L985A   7.09  0.76 4.09 0.30   16.32 3.54 4.51 3.09 8.03 1.72 2.56 
Z9   12.86   2.59   1.56   11.35 3.68 9.28 3.08 15.99 1.09 1.92 
Table 9 – RSD values (%) for all detected peaks after dichloromethane and bortrifluoride preparation. 
 
 
The first observation which can be made is that the number of peaks detected with the bortrifluoride 
preparation is much higher. Indeed, when comparing the chromatograms of the same sample prepared by 
the two methods, bortrifluoride appears to result in a better response. 
 
Additionally, after dichloromethane extraction traces of impurities are visible on the chromatogram and 
might be mistaken for fatty acids since retention times are sometimes close. This can be seen on Fig 29 
where the analysis of the first weigh-in of ecstasy sample L985A for both methods is represented. 
 
On the other side, it has to be pointed out that the RSD values for some peaks (C12 and C17) are rather 
high so that the usefulness of these peaks has to be questioned. The error seems to depend strongly on 
the sample character. This is particularly visible in the case of margaric acid (C17), where for some 
samples the RSD value is very low and for others very high. 
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Fig 29 – Chromatograms of the same sample (L985A) after dichloromethane and bortrifluoride preparation. 
 
 
Comparison of the RSD between the two methods can only be done by considering peaks which are 
present in both cases. Hence, the fatty acids C14, C16 and C18 have been selected and the means of 
their RSD values are represented in Fig 30.  
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Fig 30 – RSD values (%) for myristic (C14), palmitic (C16) and stearic (C18) acid after dichloromethane and 
bortrifluoride preparation. 
 
 
Comparing these RSD values, none of the two methods is clearly better than the other – the values for the 
bortrifluoride preparation are all below 5% and seem more homogenous, whereas the values for the 
dichloromethane method are more irregular and that for C14 is much higher than that for bortrifluoride. 
However, dichloromethane gives slightly better RSD values for palmitic and stearic acid. 
 
Not mentioned until now, it becomes however important to emphasize technical considerations, because 
these were significant in the determination of the final method to apply. Both procedures are comparable 
in terms of complexity and duration. In both cases, problems have been met during preparation. But where 
bortrifluoride showed robustness, dichloromethane appeared to be much more problematic. 
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The organic phase is removed in the dichloromethane procedure by turning over the vial and piercing the 
septa of the crimp seal with a syringe. This, in itself, is not practical but can be handled. But it has 
sometimes been observed that derivatisation did not work, which could only be noticed after GC analysis. 
The reason for this problem is supposed to be the removal of traces of aqueous phase next to the organic 
phase. 
 
The dichloromethane phase tends to form bubbles, which impedes this particular preparation step. This 
tendency could partly be avoided by centrifugation, but for some ecstasy samples it was impossible to get 
one organic phase instead of bubbles. The result is that out of eighty preparations realized with the 
dichloromethane method, fourteen could not be used because derivatisation did not work.  
 
 
3.3.4 Conclusion 
 
Therefore, summarizing the advantages and disadvantages of each method (Table 10) it was decided to 
continue with the bortrifluoride preparation. 
 
Method Advantages Disadvantages 
Dichloromethane 
- RSD slightly better for C16 and C18 
- works without evaporation step 
- organic phase is under aqueous phase 
and has tendency of forming bubbles  
derivatisation problem 
- slightly leaks from syringe 
- traces of impurities 
Bortrifluoride 
- very good separation of the two phases 
- robustness 
- high yield 
- more fatty acids detected 
- extracts exclusively fatty acids 
- higher RSD (though in acceptable limits) 
Table 10 – Advantages and drawbacks of dichloromethane and bortrifluoride preparations. 
 
The variation of the RSD depending on the peak and ecstasy sample would have to be taken into account. 
It certainly influences the procedure to adopt and the following exploitation of obtained data. But 
altogether, the bortrifluoride method for fatty acid derivatisation appears to be an appropriate preparation 
method for ecstasy analysis.  
 
 
 
 
 
 
4 PRACTICAL PART 
 
 
The optimisation of the analytical method for carbohydrate and fatty acid analysis was an important part of 
this research. Both methods have to be applied to a greater number of ecstasy tablets. The first reason is 
the verification of the functionality and suitability of both methods and if the quality of the results remains 
constant independently of the sample character. 
 
Applied to a larger sample will allow checking of variability between ecstasy tablets (inter-variability) and, 
because every tablet will be analysed more than once, also the intra-variability. Thus, the resulting 
observations should allow the assessment of the quality of the analytical method and the characterisation 
of the ecstasy samples. 
 
A new gas chromatograph was acquired by our laboratory and thus resulted in a change of the quality of 
the chromatograms, which means, for instance, a more sensitive response for routine ecstasy analysis. 
Ecstasy tablets analysed on the new GC instrument using the same method than before showed more 
and higher peaks than on the old GC instrument. Therefore, the situation changed with regard to the 
beginning of the research – fatty acid peaks were not necessarily so small anymore and new peaks of 
synthetic impurities were detected. This means that the routine method had to be investigated as well. It 
was important to find out if the increased sensitivity also resulted in useful information suitable for drug 
profiling. 
 
Therefore it was decided to apply the routine ecstasy method next to the methods developed for 
carbohydrate and fatty acid analysis. After having analysed the selected ecstasy samples by all three 
methods, the obtained data would be grouped in data obtained from the ecstasy method and data 
obtained from the developed methods. The resulting two groups were then compared in terms of quality of 
information relevant for ecstasy classification. 
 
 
4.1 SAMPLING 
 
At least a hundred ecstasy seizures – with the eight seizures already used for the method development, 
were taken for a final selection of 109 seizures. This selection was made considering several criteria 
which will be explained hereafter.   
 
The most important factor was certainly that the tablets were representative for the illicit drug market, 
particularly in Switzerland. Representative tablets were first determined by the visual appearance, such as 
size, colour and logo. This first consideration resulted in the exclusion of all Thai tablets (Fig 31), known to 
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be particular as they always present the same small size, characteristic colour (orange and green) and 
contain methamphetamine adulterated with caffeine and ethyl vanillin (Zingg, 2005).  
 
            
Fig 31 – Three examples for Thai pills – the two on the left present the very frequent "wy" logo, whereas the one on 
the right, also making part of this group, presents a "Y", but is for all other characteristics similar. 
 
The regular statistics obtained from the ecstasy database gives a good idea of how a typical ecstasy tablet 
looks like : 
 
- it is round and the diameter is principally situated around 8mm (Fig 32), and weighs between 200 
and 300mg (Fig 32), 
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Fig 32 – Statistical evaluation of diameter and weight from ecstasy seizures between 1998 and 2005. 
 
- the colour is variable, but it is not as frequent to observe bright colours as would be expected, a 
great part of the tablets being white or cream (Fig 33), 
 
Fig 33 – Colour distribution in ecstasy seizures between 1998 and 2005 – colours correspond to the evaluated 
categories. 
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- the logo is very variable as well, but there are a few very popular logos, 
- the principal illicit substance is MDMA and the principal diluent is lactose – adulterants are either 
observed with amphetamine or methamphetamine, but seldom with MDMA. (Fig 34 and Fig 35) 
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Fig 34 – Graphical representation of the occurrence of illicit substance observed in ecstasy tablets – Ecstasy 
database (IPS-WD). 
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Fig 35 – Graphical representation of the occurrence of diluents in ecstasy tablets – Ecstasy database (IPS-WD). 
 
 
Thus, it appears that the major part of ecstasy tablets have a diameter of ~8mm, are composed of MDMA 
and lactose, which is reflected in the selection for this research. Additionally, it was aimed at obtaining 
groups of several seizures, but being visually similar. This could consist in collecting seizures making part 
of the same class – a class is composed of tablets having similar physical and chemical characteristics. 
Otherwise, a popular logo has been chosen, such as Mitsubishi or Superman, and a more important 
number of seizures was selected by taking care to have similar and dissimilar tablets. 
 
Finally, the last criterion taken into account, but nonetheless important, was the number of tablets 
available. The possible list was already reduced by the before cited criteria. Additionally, tablets seized 
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before 1998 were excluded because they were often damaged or incomplete, or simply to avoid the factor 
of degradation. Furthermore, it was decided only to consider the seizures being composed of at least four 
tablets. The idea was to use one tablet, but to have fallback possibilities in case problems appeared or 
additional analyses were necessary, and also to leave some for other ongoing studies at the IPS. 
 
The resulting selection of ecstasy seizures is presented with the relevant details in Appendix VII. It has to 
be mentioned that the list has been updated during the project, to correct apparent mistakes in the 
database content. 
 
 
4.2 SAMPLE PREPARATION AND APPLIED METHODS  
 
One tablet per ecstasy seizure is analysed. The reason is that for the major part of selected ecstasy 
seizures only a few tablets were available. Another important factor was the time available for analysis, 
since in average 5 seizures could be analysed per week applying all three methods.  
 
The tablet is ground and homogenised in an agate mortar. Three weigh-ins were taken for each type of 
analysis and each weigh-in was analysed twice. Thus, six measures were obtained per sample and 
method. Analyses were performed on an Agilent 6890 gas chromatograph coupled to an Agilent 5973 
inert mass spectrometer. 
 
 
1) Carbohydrate analysis 
 
Sample preparation 
 
About 2mg of ground and homogenised ecstasy powder are dissolved in 1ml pyridine. Then, 200µl of 
hexamethyldisilazane (HMDS) and 100µl of trimethylchlorosilane (TMCS) are added and the mixture is 
vortexed for 30 seconds. The solution can be analysed after having rested for 5 minutes. 
 
Instrumental method - The method is called Sucmod5 and is described in Table 11.  
 
 
2) Fatty acid analysis 
 
Sample preparation 
 
About 25mg of the ground and homogenized ecstasy sample are mixed with 1.5ml bortrifluoride (14%) in 
methanol and 1.5ml hexane and then quickly flushed with nitrogen. The vials are closed tightly and put 
into the oven for 1h at 100°C. After having taken the samples out of the oven every cap should be 
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tightened again, as the sudden temperature change seems to loosen them slightly and solvent can easily 
evaporate.  
 
The hexane phase is entirely transferred into a 1.5ml vial and evaporated under nitrogen. The remaining 
FAME are recovered with 200µl of hexane containing the internal standard. A 100µl is transferred into a 
vial with an insert and analysed. 
 
Instrumental method - The method is called AcGras and is described in Table 11.  
 
 
3) Routine analysis 
 
About 2mg of ground and homogenised ecstasy powder are dissolved in 500µl of a chloroform / pyridine 
(5 :1) solution. Then, 100µl of N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) are added. The vials 
are sealed and put into the oven for 1h at 85°C. The samples can be analysed after having cooled down 
to room temperature. 
 
Instrumental method - The method is called XTCIB and is described in Table 11.  
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Method Sucmod5 AcGras XTCIB 
Sample introduction  
– Split 
– Volume 
– Total flow 
– Injector T  
 
20 : 1 
1µl 
24ml/min 
275°C 
 
50 : 1 
2µl 
60ml/min 
250°C 
 
20 : 1 
2µl 
24ml/min 
290°C 
Gas saver 15ml/min after 2min 15ml/min after 2min 15ml/min after 2min 
Carrier gas Helium Helium Helium 
Column  
– Type 
 
– Mode 
– Average velocity 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm 
(film) 
Constant flow 
38cm/sec 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm 
(film) 
Constant flow 
40cm/sec 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm 
(film) 
Constant flow 
38cm/sec 
Oven T-program 
175°C (1min), 5°C/min, 180°C (10min), 
10°C/min, 250°C (10min),  
5°C/min, 270°C (2min) 
140°C (2min), 5°C/min, 230°C (2min) 150°C, 8°C/min, 250°C, 6°C/min, 320°C 
GC-MS interface T 275°C 280°C 280°C 
MS information  
– Solvent delay 
– Mass range 
– Sample rate 
– MS quad T 
– MS source T 
 
2.5 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
 
2.5 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
 
2.5 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
Table 11 – Instrumental conditions of the three methods applied to the sample 
 
 
 
 
5 DATA ANALYSIS 
 
 
5.1 INTRODUCTION 
 
The aim of this research project is to evaluate the potential of the two types of excipients in drug profiling 
and to attempt a classification of ecstasy tablets. This could be done by visually comparing the 
chromatograms. However, it would be unsuitable for the comparison of several dozen or hundreds of 
samples. Especially, when the results to compare are of a multivariate nature an oversight is all too easy. 
 
The development of advanced chemical instruments and processes has led to a need for advanced 
methods to analyse the resulting data. (Hopke, 2003) Chemometrics has been developed for this purpose. 
It is the application of statistical and mathematical methods to chemical problems to permit maximal 
collection and extraction of useful information. 
 
Data analysis by means of chemometric methods helps to evaluate large and complex data. It uses a 
characteristic of the samples (e.g. peak heights or areas of the chromatogram) for comparison to other 
samples. The process can be automated by using macros edited on Visual Basic Editor® and/or particular 
software. Additionally, data analysis may allow visualising similarities and differences between samples, 
necessary for sample characterisation and classification. 
 
 
5.1.1 Purpose 
 
Data analysis will not only allow the characterisation of the samples, followed by their classification, but 
also the comparison of the potential of the two excipients with the information resulting from routine 
ecstasy analysis. To do so, comparison procedures were evaluated in function of these two data sets, 
which will be called XTC and FA/sugars. A suitable comparison method was determined for each data set 
and was used to form groups of linked ecstasy seizures. The notion of link would have to be explained at 
that moment according to the information available (cf. Ch - 6). The groups were compared to the already 
existing classes defined by Zingg, and then to each other (XTC versus FA/sugars). 
 
The results of sugar and fatty acid analysis were put together, as this was easier to handle. Considering 
that sugar analysis results mainly in one large peak often accompanied by one very small peak (lactose 
and lactose2, sorbitol and mannitol), this data was considered to be insufficient for appropriate 
interpretation on its own and might give an erroneous characterisation. The use of so few variables was 
estimated to be risky, since, in general, data analysis starts with the maximum of variables which can be 
reduced later. The grouping of the two types of data was judged to be safe as they are situated on the 
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same level of analysis, being qualitative and semi-quantitative and with the resulting information of the 
same nature.  
 
 
5.1.2 Procedure 
 
For each data set an optimal comparison method of samples has been determined, which would allow a 
good characterisation of linked samples and a good separation of linked and non-linked samples. Thus, 
for the determination of the comparison method it was important to define what was considered as linked 
or non-linked. 
 
Linked samples are supposed to have the same origin – ideally this would mean the same compression 
batch. But this could also mean the same producer and not necessarily same compression batch if the 
same excipient blend was used for different compressions. Therefore, linked would in our case signify 
same origin at the level of compression of the tablets. Consequently, non-linked is situated at the same 
level, but does not necessarily mean different producers. The same producer could use different blends 
and produce different tablets. 
 
However, this sort of considerations is too specific when it comes to define data which will be used for the 
determination of the comparison method. The information necessary to make groups of linked samples 
and non-linked samples is simply not available in our case, and generally seldom known when dealing 
with illicit products. The major problem in this research was the absence of large amounts of ecstasy 
tablets whose common origin was proven. Only small seizures were available and their origin was not 
necessarily clear. Therefore, other ways had to be found to define a linked and a non-linked sample 
group. 
 
Finally, similarity was measured between the linked samples and dissimilarity between the non-linked 
samples by various combinations of pre-treatments and comparison methods. These combinations were 
then compared by considering several criteria such as false positives and negatives, overlapping between 
the two groups, etc. In the end, two combinations were determined for the comparison of samples 
analysed by the XTC method, and also two for those analysed by the FA/sugar methods. 
 
 
5.1.2.1 Sampling 
 
For the linked sample group, the ten measures obtained from five tablets for each of the eight seizures 
used for the method development and the six replicas of the remaining 101 seizures (three weigh-ins 
analysed twice) were taken. This was also a way to check the homogeneity of the ecstasy tablets. 
However, it has to be emphasised that although some tablets presented considerable variations, the so 
defined linked group is an ideal case, as the resulting similarity values rather represent homogeneity than 
intra-variability. In reality the variation inside one compression batch would certainly be higher.  
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Criteria had to be defined to decide on non-linked ecstasy samples. The problem was that it was 
impossible to be sure if two samples were really of different origin or not for the same reason expressed 
above (illicit products – absence of control). This could result in an arbitrary choice but the applied logic 
seems to guarantee a reasonable selection of probably non-linked samples. 
 
For data analysis it was necessary to have as much similarity values as possible in order to obtain a good 
representation of the discrimination power of the several comparison methods. A large selection of non-
linked samples is very difficult in our case. The information available for the major part of the samples 
were administrative data, physical and chemical characteristics. All tablets being round, the samples were 
first sorted out in function of the diameter and the logo. Therefore, the diameter certainly was an important 
criterion because it is a variable showing very small variation for one press and small differences can 
already be significant. Concerning the logo it has to be added that in fact the whole visual appearance has 
been considered – picture, defaults, colour, stains, breakline – as these were, when observed all together, 
peculiar to a compression batch. 
 
Another very important criterion was the chemical composition – from previous screening analyses 
(confirmed by the actual XTC method) the active substance and its percentage was known, as well as the 
presence of sugars. This allowed further differentiation in subgroups. Finally, there were cases where the 
thickness made the difference by being particularly great and in other doubtful cases it was the date and 
place of seizure giving helpful information. Considering two seizures made at an interval of 2-3 years in 
two different cities, the chance that they have a common origin is much smaller than for two seizures 
being made in the same year in the same city. This is an added subjective appreciation only taken into 
account after all other criteria.   
 
On the basis of these several characteristics considered together it was possible to select 43 ecstasy 
tablets constituting the non-linked sample group. The sample list containing all details can be found in 
Appendix VIII. 
 
 
5.1.2.2 Data preparation 
 
This task requires some more detailed explanation since it had a strong influence on the determination of 
the comparison method. In the beginning, the whole procedure – from pre-treatment selection until 
evaluation of similarity measures by histogram representation – has been carried out with all sample areas 
such as they were obtained after analysis. But the final visual representation of the results made problems 
appear with regard to the used data (Fig 36).  
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Fig 36 – Histogram representation of the final results before data cleaning (left) and after (right). 
 
 
Histogram representations showed large overlapping of linked and non-linked samples with values for 
linked samples that were unusually high. Curve shapes, such as represented in Fig 36 on the left, were 
often observed. The irregular shape of the red curve is a strong indicator for erroneous data, particularly 
the fact that it crosses twice or more the blue curve. After these observations were made, skimming 
through individual sample values made appear sometimes very high standard deviations. Data cleaning 
was required, as the sample size is not large enough that such variations could be considered as 
representation of a real situation, and most of the variations were due to analytical problems.  
 
Thus, it was decided to have a closer look at all samples and to detect those with high standard deviation. 
If the latter could be explained by some technical reason (instrumental problem, incorrect integration, 
preparation problem, etc.) the concerned measure has been discarded. If no explanation could be found 
for the high variation, then it was attributed to the inhomogeneity and the sample was kept. 
 
To make this data verification a bit easier, the pre-treated variables of the questionable samples have 
been visualised by using the software The Unscrambler©. If observing some irregularities due to a 
particular measure, the observation has been compared to the results obtained after similarity measures, 
and the chromatograms of the six replicas have been checked. The decision about discarding a measure 
or not was taken after having considered all three. An example is given in Fig 37 and Fig 38 with the 
results of sample n° 1668, where it clearly appears that the high variation is caused by the third weigh-in.  
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Fig 37 – Visualisation of the pre-treated data of sample 1668 by The Unscrambler© (left) – extract of the fatty acid 
chromatogram (right). 
 
 
 1668suc1_1 1668suc1_2 1668suc2_1 1668suc2_2 1668suc3_1 1668suc3_2 
1668suc1_1 0 0.00129625 0.0059858 0.00762398 4.6425668 4.70293298 
1668suc1_2 16 0 0.00198779 0.00281249 4.72900353 4.79010334 
1668suc2_1 16 16 0 0.00021559 4.85309284 4.91526105 
1668suc2_2 16 16 16 0 4.87944101 4.94191159 
1668suc3_1 16 16 16 16 0 0.00052426 
1668suc3_2 16 16 16 16 16 0 
Fig 38 – Correlation values obtained with the squared cosine function. 
 
 
Additionally, the number of variables has been reduced in both data sets. For the XTC method five peaks 
(the non-derivatised MDMA, MDEA and MDA, a second unknown peak, and myristic acid) and for the 
FA/sugar method two peaks (two maltose peaks) have been discarded. All these peaks were only present 
in trace levels or in irregular quantities and it appeared that they induced a great variation in the 
intravariability values.  
 
The consequence was that the whole procedure had to be started again with the two cleaned data sets in 
order to obtain coherent results. The drawback is naturally that the latter will represent an ideal situation, 
which can be very different from reality. 
 
 
5.2 DETERMINATION OF A COMPARISON METHOD  
 
All comparisons of data will be realised with the relevant peak areas obtained by the three analytical 
methods. The applied procedure was largely inspired by the work realised in the SMT project about 
amphetamine profiling (SMT, 2003; Lock, 2005), since it gives a good overview of commonly used math 
treatments for the comparison of analytical results. The same pre-treatments and comparison methods 
have been tested. Additionally, profiling methods applied in our laboratory and projects for heroin and 
cocaine sample comparison were considered (INTERREG, 2006; Esseiva and Guéniat, 2005; Esseiva, 
2004).  
 
C16 
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5.2.1 Theoretical introduction to the tested treatments 
 
5.2.1.1 Pre-treatments 
 
Raw data may have a distribution that is not optimal for analysis. Meaningful information might be hidden 
or affected by noise, instrumental influences, preparation variances, and so on. Samples analysed in the 
same sequence can eventually be analysed by using the raw data – but those analysed at different times 
may not, even if preparation is identical and nothing has been changed on the instrumental level.  
 
The pre-treatments are a sort of preparation of the data to make them comparable and reduce noise 
information and external influences (external to the ecstasy sample). The following four pre-treatments 
have been tested. 
 
 
Normalisation 
 
The peak areas were normalised by dividing each one by the sum of areas. For the ecstasy routine 
method this signifies to divide every target peak by the sum of target peaks in the chromatogram. For the 
FA/sugar method this means dividing the target peak by the sum of all fatty acid and sugar peaks for one 
sample. 
 
∑
=
x
i
x
i
N  
 
with  xi = Area of peak i   
 
Normalisation is used to get all data in approximately the same scale and to remove variation due to 
varying sample amounts or instrument detector sensitivity. However, high peaks may reduce influence of 
the smaller peaks. This can be avoided by using an additional pre-treatment, e.g. standardisation before 
or the logarithm or fourth square root after normalisation. (Sauve and Speed, 2004; Lock, 2005) 
 
 
Standardisation 
 
Data standardisation consists in the division of the target peak area by the standard deviation calculated 
for the whole sample set for the same peak.  
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with  xi = area of peak i   
 n  = number of samples 
 SDi = standard deviation of peak i 
 
Great differences in ranges are eliminated through standardisation and variables are put on the same 
scale. Therefore, influence is given to all variables (peaks), supposed that the standard deviation is similar 
for the various peaks. It has to be mentioned that smaller peaks generally produce a higher error in peak 
areas than the higher peaks, which influences the standard deviation as well. 
 
 
Logarithm 
 
The logarithm is applied to every peak area. Care has to be taken with missing peaks, as they might be 
represented by "0" whose logarithm is infinite. 
 
i
x
i
L log=  
 
with  xi = area of peak i  
 
However, the logarithm is a widely used data transformation and is especially useful to make skewed 
variables more symmetrical. It reduces the influence of the larger peaks while giving them a higher 
importance than smaller peaks. 
 
 
Fourth square root 
 
The fourth square root is calculated for every peak area. It serves a similar purpose as the logarithm and 
is appropriate in cases of slight asymmetry. 
 
4
ii xR =  
 
with  xi = area of peak i   
 
It therefore represents a good alternative to the logarithm in case of data containing zeros, although the 
influence of higher peaks is not reduced as much as with the logarithm. However, the reduction of the 
peak's influence might deteriorate the discriminating aspect of the analytical method. 
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5.2.1.2 Methods for data comparison 
 
In the methods available to compare analytical data, we can distinguish two types of comparison – there 
are methods which calculate the correlation between data, and there are others which calculate a distance 
between data. In this research three of each have been tested. The correlation methods used were the 
Pearson correlation, the Squared Cosine function and the Similarity Index. For the distance methods, the 
Euclidean distance, the Canberra Index and the Manhattan distance have been tested. Additionally, it 
appears that the correlation methods highlight the similarities between samples, whereas the distance 
methods rather highlight the differences. 
 
 
Pearson correlation  
 
The Pearson correlation coefficient r, is generally a value between -1 and 1 reflecting the degree of 
correlation between two data sets. A coefficient of 1 would correspond to very strong correlation, a value 
near 0 to absence of correlation and a coefficient of -1 to negative (inverse) correlation. 
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where xkj and xlj are the j
th peak areas of data sets k and l, respectively, and kx  and lx  the means of the 
peaks in data sets k and l. For a better comparison of the different methods, the correlation coefficient has 
been transformed in order to obtain values between 0 and 100, with 0 corresponding to strong correlation, 
around 50 to absence of correlation and 100 to negative correlation. (Lock, 2005) 
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Squared cosine function 
 
The squared cosine function derives from the angle calculation between two vectors determined by the 
variables (peaks) of two data sets. By developing the equation of the scalar product of the two vectors, the 
squared cosine of the angle between them can be determined. The correlation value that derives from 
there is given by the following equation. 
 
 
 Data Analysis 73 
 
( )
( ) ( )





+++×+++
+++
×=
22
2
2
1
22
2
2
1
2
2211
......
...
100
nn
nn
bbbaaa
bababa
C  
 
 
where a1, a2, … an correspond to the values of the variables 1 to n of chromatogram A and b1, b2, … bn to 
those of chromatogram B. The correlation value is a number without dimension and auto-normalising. The 
values obtained are situated between 0 and 100. (Keto, 1989; Esseiva, 2004) 
 
 
Similarity Index  
 
The similarity index (Karkkainen et al, 1994; Eerola and Lehtonen, 1988) is a metric defined by the 
following equation 
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where k, k2, m and w are constants and n the number of peaks. The xi is chosen as the bigger of xi and yi 
which gives xi/yi ≥ 1. The constants were determined by (Eerola and Lehtonen, 1988) and are given the 
values 6, 0.25, 50 and 1, respectively. The resulting equation is  
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The highest value that can be obtained from this formula is 101.67 and is used for the conversion of the 
distances in values between 0 and 100. 
 
0167.1
100
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Euclidean and Manhattan Distance  
 
These two distances are popular similarity measures for vector distances (Tanaka et al, 1994; Smolinski 
et al, 2002; Perkal et al, 1994; Janzen et al, 1992; Avramenko and Kraslawski, 2006). They are special 
cases of the Minkowski distance which is defined as  
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where kjx  and ljx  are the j
th peak areas of the data sets (or vectors) K and L. If q = 2, then kld  represents 
the Euclidean distance, whereas for q = 1, it represents the Manhattan distance. The obtained similarity 
values can range from 0 to infinite. Therefore they are transformed by dividing each value by the highest 
value obtained and then multiplying with 100. 
 
 
Canberra Index  
 
Canberra index is a distance where the difference in each variable is weighed by the sum of the two 
values of the variable. This means that the contribution from each variable / target peak cannot be larger 
than 1/n. The equation is given below 
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where xi and yi are the i
th peak areas of the data sets X and Y, and n is the number of peaks. In order to 
get distances between 0 and 100 the obtained values are multiplied by 100. (Lock, 2005) 
 
 
5.2.2 Selection of pre-treatments 
 
Considering the several pre-treatments and comparison methods presented above, it becomes clear that 
there are numerous possibilities of combinations which could be tested. This, however, would take 
considerable time and it has been decided to realise first tests with a smaller sample group in order to limit 
the number of pre-treatments to use for the whole sample set. 
 
 
5.2.2.1 Sampling 
 
Linked samples 
 
Concerning the XTC method, eight ecstasy tablets with seven to ten replicas were taken which resulted in 
285 similarity values. As for the FA/sugars method, fifteen ecstasy tablets with four to ten replicas were 
chosen which resulted in 250 similarity values. 
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The differences of sample size and number can be explained by the fact that some ecstasy tablets 
presented unacceptable variations. All analytical measures were verified and the data cleaned as 
sometimes variations were due to analytical problems. This could mean that some analyses did not work 
well, or peak areas were not correctly integrated, or baseline problems were observed, etc. Some samples 
showed a high variation that could not be explained by technical problems and was attributed to the 
inhomogeneity of the tablets. These samples were not taken into account for the determination of the 
comparison method. 
 
 
Non-linked samples 
 
The values for the non-linked sample group were calculated by using the means of the replicas of fifteen 
ecstasy samples considered to be different. In this way, 105 values could be obtained. For the FA/sugar 
method the same fifteen ecstasy samples than above were used and for the XTC method the eight 
ecstasies were completed by seven additional tablets so that in the end the same ecstasies were used for 
both methods. 
 
 
5.2.2.2 Missing peaks 
 
Considering the nature of the variables, it was important to find a solution to the problem of the missing 
peaks. The peaks taken into account for the two data sets are presented in Table 12. 
 
XTC method FA/sugar method 
MDMA Mannitol 
MDEA Sorbitol 
Amphetamine Lactose 
MDA Lactose2 
Unknown Peak C12 (Lauric acid) 
Caffeine C14 (Myrsitic acid) 
Mannitol C15 (Pentadecanoic acid) 
Sorbitol C16 (Palmitic acid) 
Lactose C17 (Margaric acid) 
Lactose2 C18_2 (Linoelic acid) 
C16 (Palmitic acid) 1C18_1 (Oleic acid) 
C18 (Stearic acid) 2C18_2 (Oleic acid) 
 C18 (Stearic acid) 
 C20 (Arachidic acid) 
Table 12 – Peaks used for sample comparison. 
 
It appears from Table 12 that in each sample there will necessarily be some missing peaks, because no 
ecstasy tablet contains all of the listed substances, at least in the case of the XTC method. When 
importing the data with an excel macro the missing peaks are simply replaced by 1. In the SMT project 
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replacements of missing peaks by 0 and by 200 were compared. It was regarded as pointless to use 
replacements by 1 and by 0, as both were very low compared to a peak area of five numbers upwards. In 
order to observe influence from missing peaks resulting from replacements, key values from the whole 
scale were chosen – a zero, an intermediate and a high value. The latter was determined in function of the 
minimal area integrated by both analytical methods. Thus, the replacement values tested were : 
 
 
XTC method − 0, 200 and 1E5 
FA/sugars method − 0, 200, 1E4 and 6E4 
 
 
Two high values were used for the FA/sugars method because when this part of data analysis was begun 
the value of 1E4 was considered to be low enough for not mixing with the smallest integrated peaks. Later 
it was discovered that the areas of the latter were much higher and that 1E4 did not at all constitute an 
upper limit of noise signal. Of more than 4500 peak areas about ten were below 1E5. Therefore a higher 
value was added.  
 
 
5.2.2.3 Tested pre-treatements 
 
Six combinations of pre-treatments have been tested (Table 13). Taking into account the replacement of 
the missing peaks this resulted in the application of sixteen pre-treatments to the XTC data set and twenty 
to the FA/sugar data set.  
 
Combination 
Given short  
Name 
Missing peak  
replacement 
Normalisation + Fourth square root N4R All 
Normalisation + Standardisation NS All 
Normalisation + Logarithm NL All, except 0 
Standardisation + Normalisation SN All 
Standardisation + Normalisation + Logarithm SNL All, except 0 
Standardisation + Normalisation + Fourth square root SN4R All 
Table 13 – Tested combinations of pre-treatments. 
 
 
5.2.2.4 Evaluation of the pre-treatments 
 
All six comparison methods have been applied to the various combinations of pre-treatments in order to 
compare them. The considered criterions were the evaluation of the false positive, the estimate of 
discrimination and confirmation by PCA analysis. The idea is the reduction of combinations to test on the 
whole data set and these criteria allow a first selection. They will reveal a tendency of combinations which 
seem to be appropriate for the application on the given data sets.  
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False positive 
 
For each combination of pre-treatment and comparison method the highest distance value in the linked 
sample group has been determined and was set as threshold value. The percentage of false positives has 
been calculated by counting all values in the non-linked sample group that were below this threshold. The 
basis for this calculation is given by the notion that a distance between two non-linked samples which is 
smaller than the distance between two linked samples is a false positive. The results are represented in 
Table 14 and Table 15. Because the majority of the results was very good and it was decided to highlight 
the less good results for better visibility. 
 
 
0   Squared         
  Pearson Cosinus SI Manhattan Canberra  Euclid Dist 
N+4R 2.86 na >10 >10 >10 >10 
N+S >10 na >10 >10 >10 >10 
S+N >10 na >10 >10 >10 >10 
S+N+4R 9.52 na >10 >10 >10 >10 
200             
N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
N+S 5.71 5.71 1.90 15.24 0.00 20.00 
N+L 0.00 0.00 12.38 0.00 na 0.00 
S+N 5.71 5.71 1.90 6.67 0.00 9.52 
S+N+L 0.00 0.00 0.95 0.00 na 0.00 
S+N+4R 0.00 0.00 0.00 0.95 0.00 1.90 
1E5             
N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
N+S 5.71 5.71 1.90 15.24 0.00 20.00 
N+L 0.00 0.00 22.86 0.00 na 0.00 
S+N 5.71 5.71 1.90 6.67 0.00 9.52 
S+N+L 0.00 0.00 7.62 0.00 na 0.00 
S+N+4R 0.00 0.00 0.00 0.00 0.00 0.95 
Table 14 – Percentages of false positives for the XTC data set; na – not available (calculation problems due to the 
value 0). 
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0   Squared         
  Pearson Cosine SI Manhattan Canberra  Euclid Dist 
N+4R 8.57 na >10 >10 7.62 5.71 
N+S >10 na 9.52 >10 9.52 >10 
S+N >10 na 9.52 >10 9.52 >10 
S+N+4R >10 na >10 >10 7.62 9.52 
200             
N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
N+S 0.00 0.00 0.00 0.00 0.00 0.00 
N+L 0.00 0.00 0.00 0.00 na 0.00 
S+N 0.00 0.00 0.00 0.00 0.00 0.00 
S+N+L 0.95 0.00 2.86 0.00 na 0.00 
S+N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
1E4             
N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
N+S 0.95 0.00 0.00 0.00 0.00 0.95 
N+L 0.00 0.00 0.95 0.00 na 0.00 
S+N 0.95 0.00 0.00 0.00 0.00 0.00 
S+N+L 0.00 0.00 0.00 0.00 na 0.00 
S+N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
6E4             
N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
N+S 0.95 0.00 0.00 0.00 0.00 1.90 
N+L nd nd nd nd nd nd 
S+N 0.95 0.00 0.00 0.00 0.00 1.90 
S+N+L nd nd nd nd nd nd 
S+N+4R 0.00 0.00 0.00 0.00 0.00 0.00 
Table 15 – Percentages of false positives for the FA/sugars data set; na – not available (calculation problems due to 
the value 0), nd – not done. 
 
 
Both methods show relatively similar results. A difference between the two data sets appears in the 
number of false positives. There are more with the XTC data set than with the FA/sugars data set. 
However, both show many combinations having a percentage of false positives of 0, which is actually 
perfect. On the other side, the replacement value of 0 gives very bad results and can be discarded in the 
two data sets. The pre-treatment combination of N4R happens to be the only one with no false positive at 
all and therefore represents an interesting choice for further studies. 
 
Finally, the presence of some missing values ("na") has to be explained. The squared cosine function has 
not been applied with the replacement value 0. Problems have appeared during calculations with this 
combination and could not be resolved. Therefore, it was decided not to use this correlation method with 0 
values.  
 
Problems also appeared when calculating the distance values for the Canberra Index with data that had 
been pre-treated by the normalisation followed by logarithm. Just for reminding here the basic principle 
concerning the logarithm : 
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y = log x  ⇔ 10y = x 
 
 
It has already been mentioned that the logarithm cannot be applied for x ≤ 0. It also results from these 
equations that the logarithm of 1 is 0 and that for 0 < x < 1 the logarithm will be negative. Thus, if the 
logarithm is applied to normalised peak areas, generally negative and positive values are obtained. This 
appeared to be a problem when calculating the Canberra Index with data presenting negative and positive 
values for the same peak. It has to be noted that the peak areas do not have to be very different – they 
can be very close, but after normalisation one of them gives a value below and the other above 1, which 
will result for the first in a negative logarithm and for the second in a positive one.  
 
 
∑
= +
−
=
n
i ii
ii
yx
yx
n
dexCanberraIn
1
1  
 
 
That may appear to be a small thing, but considering the equation of the Canberra Index, it makes a great 
difference if x and y are both of the same sign or not. So it happened that for some samples completely 
aberrant distances have been observed. For that reason, it was decided not to use the Canberra Index 
with a pre-treatment including the logarithm. And as the values for the missing peak replacement 6E4 
were calculated later, the logarithm has not been taken into account at all ("nd"). 
 
 
Estimate of the discrimination 
 
To confirm the results from the evaluation of the false positives, an estimate of the discrimination was 
calculated for all combinations except those which were already discarded (replacement by 0). The 
discrimination is calculated with the mean values and the standard deviations of the obtained 
distances/correlations. A high discrimination value signifies good separation between linked and non-
linked samples. (INTERREG, 2006) 
 
 
linkedlinked
linkednonlinkednon
STDEVMean
STDEVMean
D
+
−
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The calculation can be represented graphically as shown in Fig 39. The higher the value D, the better the 
separation between the linked and the non-linked zone.  
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Fig 39 – Graphical representation of the estimate of the discrimination. 
 
 
The results are represented in Table 16 and Table 17 below. 
 
200   Squared         
  Pearson Cosine SI Manhattan Canberra  Euclid Dist 
N+4R 167.77 155.99 112.25 12.07 12.51 12.41 
N+S 11.57 11.50 21.52 2.33 6.57 1.69 
N+L 759.67 570.29 2.59 17.23 na 21.84 
S+N 11.57 11.50 21.52 3.07 6.57 2.24 
S+N+L 825.18 589.78 48.43 17.23 na 21.84 
S+N+4R 69.99 77.84 112.25 8.78 12.51 8.36 
1E5             
N+4R 136.67 121.19 108.49 11.31 10.79 10.98 
N+S 11.55 11.42 21.52 2.33 6.57 1.69 
N+L 229.87 181.84 1.92 12.07 na 12.74 
S+N 11.55 11.42 21.52 3.08 6.57 2.23 
S+N+L 259.84 181.20 5.09 12.07 na 12.74 
S+N+4R 62.15 56.73 108.53 8.68 10.79 7.57 
Table 16 – Discrimination factor for the XTC data set; na – not available (calculation problems due to the value 0). 
 
 
 
 
 
 
 
 
 
 
 
 
 Data Analysis 81 
 
200   Squared          
  Pearson Cosine SI Manhattan Canberra  Euclid Dist 
N+4R 162.88 139.93 17.84 19.35 14.84 17.06 
N+S 45.55 37.55 27.29 8.31 10.12 6.19 
N+L 24.37 42.47 10.74 16.31 na 9.29 
S+N 45.55 37.55 27.29 8.53 10.12 6.35 
S+N+L 14.26 20.66 3.88 16.31 na 9.29 
S+N+4R 38.26 25.96 17.84 16.30 14.84 11.63 
1E4        
N+4R 257.54 219.32 42.34 17.92 14.47 17.85 
N+S 44.76 35.60 26.99 8.31 9.96 6.08 
N+L 53.22 93.18 8.86 15.43 na 11.10 
S+N 44.76 35.60 26.99 8.53 9.96 6.24 
S+N+L 27.12 23.19 10.92 15.43 na 11.10 
S+N+4R 57.28 45.22 42.34 14.27 14.47 10.91 
6E4        
N+4R 303.22 265.50 126.77 16.94 13.44 18.08 
N+S 41.57 31.67 37.71 7.35 9.57 5.30 
N+L nd nd nd nd nd nd 
S+N 41.57 31.67 37.71 7.55 9.57 5.43 
S+N+L  nd nd nd nd nd  nd 
S+N+4R 81.45 64.31 126.77 12.68 13.44 10.50 
Table 17 – Discrimination factor for the FA/sugars data set; na – not available (calculation problems due to the value 
0), nd – not done. 
 
 
All values above 100, which is a very good result, were highlighted and marked in red. In the case of the 
FA/sugar method the results are similar to those obtained with the false positives. For each similarity 
measure the pre-treatment combination N4R always gives the best results, sometimes equalled by SN4R. 
For the XTC method the result is not that clear. Discriminations obtained with N4R and SN4R are certainly 
very good, but the pre-treatments with the logarithm give exceptionally high values for Pearson and 
Squared cosine correlations and slightly higher values for Manhattan and Euclidean distance. 
 
For better comparison of the XTC and FA/sugars data sets, it was aimed at applying the same pre-
treatment to both. The estimate of the discrimination did confirm the results obtained by the false positive 
evaluation in that sense that the pre-treatment N4R gave altogether very good results for both 
calculations. Concerning the logarithm, it was considered that the very high discrimination values for the 
XTC method did not compensate the fact that this pre-treatment could not be applied to one of the 
similarity measures.  
 
Therefore, preference was given to the pre-treatment N4R and it was decided to evaluate the pre-
treatment SN4R with the highest missing peak replacement as well, because it gives very good results for 
the false positives. 
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Evaluation by PCA 
 
Principal Component Analysis (PCA) was applied to verify the distribution of the data in function of the 
pre-treatment and thus to control if the latter gave satisfying results. The principles of PCA are fully 
explained in a following chapter where its use was of higher importance (cf. Additional Studies - NIR). In 
short, PCA is a projection method that helps visualise all the information contained in a data table. Here it 
was applied to the data pre-treated by N4R and SN4R. Results are shown in Fig 40 and Fig 41. 
 
 
 
     
Fig 40 – PCA analysis with the XTC data set pre-treated by N4R_1E5 (left) and SN4R_1E5 (right). 
 
 
 
     
Fig 41 – PCA analysis with the FA/sugars data set pre-treated by N4R_6E4 (left) and SN4R_6E4 (right). 
 
 
Every colour corresponds to one ecstasy tablet and its replicas meaning eight colours for the XTC data set 
and fifteen colours for the FA/sugars data set. Therefore, circles of the same colour should be grouped 
together and be separated of those of a different colour.  
 
The PCA analysis was applied to have visual representation of the good functioning of the chosen pre-
treatments and it can be observed that this is the case in all four figures, as sample separation is almost 
complete. 
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5.2.2.5 Choice of pre-treatment 
 
Therefore, the pre-treatments that would be applied in combination with the six similarity measures on a 
larger sample set are the following : 
 
 
 Pre-treatment Missing peak replacement 
XTC data set 
N4R 
SN4R 
200 and 1E5 
1E5 
FA/sugars data set 
N4R 
SN4R 
200, 1E4 and 6E4 
6E4 
 
 
 
5.2.3 Selection of a comparison method 
 
Now that a selection of pre-treatments has been made, the six available methods for similarity measures 
had to be compared. The similarity values for linked samples should be obtained from the replicas of all 
samples analysed (109) and those for the non-linked samples from a maximum selection of ecstasy 
tablets considered to be of different origin (43).  
 
 
5.2.3.1 Evaluation of the comparison methods 
 
The selected pre-treatments have each been applied together with the six similarity measures to all 
samples in order to obtain similarity values for the linked sample group. They have as well been applied to 
the mean areas of the replicas of the selected non-linked sample group. The number of similarity values 
obtained is shown Table 18. 
 
 Linked Samples Non-linked  
 XTC method FA/sugars method samples 
Number of similarity values 1642 1422 903 
Table 18 – Number of similarity values obtained for each sample set. 
 
The results have been evaluated by representing all values on histograms (Tanaka et al, 1994) and then 
for each combination the following characteristics have been determined:  
 
o Minima value of the non-linked sample group - MinNL 
o Maxima value of the linked sample group - MaxL 
o Standard deviation of the linked sample group 
o False positives and negatives 
o Estimate of the discrimination 
o Percentage of linked samples below the minima value of the non-linked sample group 
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The histograms constitute the basis for the comparison because many of these values are just the 
numerical form of what is represented in the graph. (Fig 42) 
 
 
 
Fig 42 – Schema of a histogram with some comparison criterions. 
 
 
Concerning the false positives and negatives, two slightly different approaches have been found. The first 
one has been taken from the SMT project (SMT, 2003) and is represented in Fig 43 : 
 
 
                 
Fig 43 – Calculation of false positives and negatives according to the SMT project. 
 
 
Considering these graphs the false positives correspond to all non-linked values below the maxima of the 
linked similarity values, and the false negatives to all linked values above the minima of the non-linked 
similarity values. 
 
The second approach has been applied in the INTERREG project (INTERREG, 2006) and is represented 
in Fig 44. 
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Fig 44 - Histogram for FA/sugars data set obtained after N4R (200) and Manhattan distance. 
 
 
In this approach, the moving average curves are drawn for linked and non-linked data sets and the 
similarity value of their intersection is determined. The false positives correspond to all non-linked values 
below the similarity value of the intersection, and the false negatives to all linked values above the 
similarity value of the intersection. 
 
It appears that the first approach takes into account the whole overlapping zone whereas in the second 
approach a cross-value is determined at the intersection of the moving average curves of linked and non-
linked samples. Both approaches have been applied in this research and no significant differences have 
been noticed, except for the false negatives whose level is regularly higher with the first approach. 
 
The final evaluation of the comparison method has been carried out by considering these various 
criterions under numerical form, represented on the two following pages in Table 19 and Table 20, and by 
visually comparing the appearance of the histograms, especially the overlapping zone. The latter should 
be small, not to say absent, and come close to a regular triangular shape. All histograms can be found in 
Appendix IX. 
  
Concerning the evaluation of the other criteria – the maxima value of the linked sample group (MaxL), the 
standard deviation of the linked sample group (STDEVL) and the false positives (%FP) and negatives 
(%FN) should be small. Whereas the minima value of the non-linked sample group (MinNL), the estimate of 
discrimination (D) and the percentage of linked samples below the minima value of the non-linked sample 
group (%L<NL) should be high. 
 
Considering the different nature of the similarity measures it was decided to choose one correlation and 
one distance method per data set. The selected methods are highlighted in the two tables below (Table 19 
and Table 20). 
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Method Pre-treatment MinNL Inter- MaxL STDEV L SMT INTERREG %L<NL D 
      section     % FP % FN % FP % FN     
Pearson N4R 200 0.015 0.400 0.364 0.038 1.883 24.361 2.104 0.000 80.88 122.95 
 N4R 1E5 0.013 0.450 0.443 0.046 1.772 29.233 2.215 0.000 76.31 92.95 
  SN4R 1E5 0.068 0.800 0.950 0.074 1.993 10.840 1.661 0.061 92.45 82.21 
Squared Cosine N4R 200 0.048 0.900 0.845 0.088 1.550 100.000 1.772 0.000 85.93 146.81 
 N4R 1E5 0.092 0.900 0.825 0.086 1.772 13.398 1.772 0.000 92.39 100.86 
  SN4R 1E5 0.218 1.000 1.371 0.099 2.547 3.837 1.772 0.122 96.41 82.58 
Similarity Index N4R 200 0.155 0.300 0.294 0.036 0.554 2.253 0.775 0.000 97.99 151.62 
 N4R 1E5 0.155 0.300 0.294 0.036 0.554 2.253 0.775 0.000 97.99 138.44 
  SN4R 1E5 0.155 0.300 0.294 0.036 0.554 2.253 0.775 0.000 97.99 138.44 
Euclidean Distance N4R 200 1.353 7.500 7.097 1.014 1.883 31.669 2.215 0.000 78.87 14.74 
 N4R 1E5 2.211 8.000 8.010 1.128 1.993 13.642 1.993 0.061 88.86 12.49 
  SN4R 1E5 4.104 8.500 10.804 1.282 2.658 4.324 1.218 0.305 95.74 11.04 
Manhattan N4R 200 0.827 4.000 4.357 0.596 1.661 42.875 1.218 0.061 75.64 15.93 
 N4R 1E5 2.444 4.500 5.168 0.726 1.329 7.125 0.886 0.183 95.86 13.72 
  SN4R 1E5 3.337 5.500 6.531 0.810 1.772 2.862 0.664 0.183 97.81 12.22 
Canberra N4R 200 1.846 3.000 2.623 0.455 0.443 5.055 0.664 0.000 98.17 16.16 
 N4R 1E5 1.846 3.000 2.623 0.454 0.443 5.055 0.664 0.000 98.17 12.99 
  SN4R 1E5 1.846 3.000 2.623 0.454 0.443 5.055 0.664 0.000 98.17 12.99 
Table 19 – Evaluation of the comparison methods applied to the XTC data set. 
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Method Pre-treatment MinNL Inter- MaxL STDEV L SMT INTERREG %L<NL D 
      section     % FP % FN % FP % FN     
Pearson N4R 200 0.007 0.550 0.481 0.065 0.664 94.726 0.775 0.000 69.06 58.12 
 N4R 1E4 0.000 0.350 0.285 0.031 0.554 94.726 0.664 0.000 32.12 105.30 
 N4R 6E4 0.013 0.200 0.208 0.019 0.775 94.726 0.775 0.070 76.72 154.07 
  SN4R 6E4 0.903 1.600 1.525 0.143 0.664 0.633 0.664 0.000 99.37 65.06 
Squared Cosine N4R 200 0.315 1.400 1.275 0.164 0.664 4.641 0.775 0.000 95.36 65.71 
 N4R 1E4 0.313 0.800 0.614 0.067 0.443 2.250 0.443 0.000 98.38 106.93 
 N4R 6E4 0.230 0.400 0.389 0.035 0.332 0.625 0.332 0.000 99.58 140.62 
  SN4R 6E4 0.497 0.900 0.795 0.087 0.443 1.195 0.554 0.000 99.30 59.61 
Similarity Index N4R 200 0.208 10.000 14.396 1.634 7.863 5.556 5.094 0.281 94.59 10.89 
 N4R 1E4 0.208 4.000 5.603 0.511 3.987 5.556 1.993 0.281 94.59 20.89 
 N4R 6E4 0.208 0.600 0.890 0.054 1.440 1.758 0.664 0.070 98.45 64.57 
  SN4R 6E4 0.208 0.600 0.890 0.054 1.440 1.758 0.664 0.070 98.45 64.57 
Euclidean Distance N4R 200 4.304 9.500 8.975 1.411 0.775 4.782 0.886 0.000 95.22 11.80 
 N4R 1E4 4.725 7.500 7.577 1.075 0.776 2.180 0.554 0.070 98.31 13.38 
 N4R 6E4 4.567 6.500 6.756 0.900 0.664 0.555 0.443 0.139 99.51 14.45 
  SN4R 6E4 2.798 6.500 6.620 0.848 1.329 5.485 0.997 0.070 95.85 6.94 
Manhattan N4R 200 2.755 5.000 6.132 0.691 1.772 2.321 0.775 0.281 98.59 13.31 
 N4R 1E4 3.285 4.500 5.805 0.648 1.330 0.985 0.887 0.211 99.23 13.18 
 N4R 6E4 3.453 4.500 5.447 0.637 0.998 1.195 0.443 0.141 99.37 13.21 
  SN4R 6E4 2.119 4.500 5.674 0.620 1.883 4.008 0.997 0.141 96.84 7.43 
Canberra N4R 200 2.296 7.500 11.756 1.243 1.440 6.048 0.886 0.141 94.51 10.88 
 N4R 1E4 2.296 6.000 6.776 0.736 1.661 6.329 0.997 0.141 94.73 11.28 
 N4R 6E4 2.296 4.000 3.979 0.521 0.775 2.461 0.775 0.000 98.45 11.20 
  SN4R 6E4 2.296 4.000 3.979 0.521 0.775 2.461 0.775 0.000 98.45 11.20 
Table 20 – Evaluation of the comparison methods applied to the FA/sugars data set. 
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The choice of the final comparison methods is not necessarily obvious, as there was no method superior 
to all others. The selection is built on a compromise between the numerical values and the appreciation of 
the histograms. A general view of the histograms and a zoom of the overlapping zone are shown for the 
chosen comparison methods in Fig 45 (XTC data set) and Fig 46 (FA/sugar data set).  
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Fig 45 – Histograms of the selected comparison methods for the XTC data set – linked samples are represented in 
red, non-linked in blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 Data Analysis 89 
 
0
10
20
30
40
50
60
70
80
90
100
1 7
1
3
1
9
2
5
3
1
3
7
4
3
4
9
5
5
6
1
6
7
7
3
7
9
8
5
9
1
9
7
Similarity values
O
c
c
u
rr
e
n
c
e
 
0
10
20
30
40
50
60
70
80
90
100
1 7
1
3
1
9
2
5
3
1
3
7
4
3
4
9
5
5
6
1
6
7
7
3
7
9
8
5
9
1
9
7
Similarity values
O
c
c
u
rr
e
n
c
e
 
 
Squared Cosine Function (N4R 6E4)   Euclidean Distance (N4R 6E4) 
 
 
0
1
2
3
4
5
6
7
8
9
10
0
0
.2
0
.4
0
.6
0
.8 1
1
.2
1
.4
1
.6
1
.8 2 >
3
Similarity Values
O
c
c
u
rr
e
n
c
e
 
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10
Similarity values
O
c
c
u
rr
e
n
c
e
 
Fig 46 – Histograms of the selected comparison methods for the FA/sugars data set – linked samples are represented 
in red, non-linked in blue. 
 
 
 
5.3 INTERMEDIATE CONCLUSION 
 
Data analysis has been carried out with a sample set of 109 ecstasy seizures, each seizure having been 
previously analysed by three analytical methods. The routine method – XTC method – was to be 
compared to the new ones – FA and sugar methods, therefore the results of the latter have been put 
together in order to have two groups in total. 
 
During this task several problems had to be dealt with. For reasons explained earlier (Ch – 4) the obtained 
data made intravariability to be calculated mostly by using the replicas of each sample analysed. Analyses 
of larger sample batches would have allowed a more realistic result. Unknown origin was also a problem 
when samples had to be determined for the intervariability analysis. They were chosen on the basis of an 
appreciation of physical and chemical characteristics known for each sample as well as operational data 
coming from investigation. The small sample set size was also problematic because it required careful 
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data cleaning arising from variations that might not even have been noticed in a larger data set, but 
seriously influenced the results here. 
 
However, a comparison method could be determined. It was shown in the selection of the pre-treatment 
that the overall best results were obtained with pre-treatment containing the normalisation and the fourth 
square root. Missing peaks were best replaced by either an intermediary value (200), or a higher value 
near to the noise signal (> 6E4), since the replacement value of 0 not only gave worse results, but also 
caused some problems. After having compared several similarity measures, one correlation and one 
distance method can be proposed for each of the two data sets. 
 
 
 Missing peak Pre-treatment Similarity measure 
XTC method 200 
1E5 
N4R 
Canberra Index 
Similarity Index 
FA/sugars method 6E4 N4R 
Squared Cosine 
Euclidean Distance 
 
 
These combinations were applied on the mean areas of the replicas of all 109 ecstasy samples in order to 
verify if groups can be determined, and if so, to compare the groups obtained from the data set after XTC 
routine analysis with those obtained after fatty acid and sugar analysis. 
 
 
 
 
 
 
6 EVALUATION OF THE ECSTASY DATA ANALYSIS 
 
 
6.1 EVALUATION OF COMPARISON METHODS 
 
One distance and one correlation method have been applied to the pre-treated mean values of all 
selected 109 ecstasy samples. Thus, for each data set – XTC and FA/sugar – two tables were obtained. 
They contain the similarity values of every ecstasy sample compared to all others, the table being thus of 
the size 109 x 109 cells. In this first part, both will be compared in order to verify if results are coherent for 
each data set and to evaluate differences between the similarity measures. 
 
 
6.1.1 Excipient data set – Squared Cosine function vs. Euclidean Distance 
 
6.1.1.1 Graphical representation 
 
The FA/sugar data set has been treated by the Squared cosine function and the Euclidean distance. 
Visual comparison is almost impossible due to the big size of the resulting tables and they can not be 
represented here as such. However, the tables could be imported by The Unscrambler© software, Camo, 
and be visualised as matrix plots. The latter allows getting an overview of the distribution of the similarity 
measures by creating five differently coloured segments according to the listed values. The resulting plots 
are represented in Fig 47 and Fig 48. 
 
 
 
Fig 47 – Matrix plot of the table obtained after application of the Squared cosine function. 
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Fig 48 – Matrix plot of the table obtained after application of the Euclidean distance. 
 
 
Considering the two matrix plots above, immediately two observations can be made. One is the similar 
distribution of colours, or at least a similar tendency, indicating also a similar attribution in distance values. 
This similarity can only be considered as a tendency since there is an obvious difference in coloration 
between the two methods. Indeed, it has been observed during data analysis that the values for distance 
methods are regularly higher than for correlation methods, resulting in less blue and more orange or red 
colours. Knowing this, the distribution for both methods can be regarded as similar. 
 
 
6.1.1.2 Use of threshold values 
 
In order to proceed to further comparison of the two methods, potentially possibly linked samples had to 
be determined. This does not mean a complete evaluation of similarity. Sample pairs were listed 
according to two threshold values. The highlighted ecstasy pairs for the two applied similarity measures 
were then compared in order to verify if differences existed and if so, how they could be explained. 
 
The two threshold values simply corresponded to the MinNL (minima non-linked sample group) and the 
MaxL (maxima linked group) determined in the previous chapter and are shown in Table 21 for reminder. 
The resulting list contained in the first column all ecstasy pairs presenting a similarity value below MinNL, 
and in the second all ecstasy pairs with a similarity value between MinNL and MaxL. 
 
 
Similarity measure MinNL MaxL 
Squared cosine function 0.23 0.39 
Euclidean distance 4.57 6.76 
Table 21 – Threshold values for both applied similarity measures. 
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The two similarity measures resulted in an almost equal number of pairs for the values below MinNL (Fig 
49). Additionally, the pairs were found to be the same. The one additional pair found with the Euclidean 
distance was attributed to the second group with the Squared cosine function.  
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Fig 49 – Number of ecstasy pairs below MinNL (Threshold1) and between MinNL and MaxL (Threshold2). 
 
 
A greater difference was observed when considering the values between MinNL and MaxL (Threshold2 in 
Fig 49). These values represent the overlapping zone between linked and non-linked samples in the 
histogram representation used in the previous chapter. Thus, a higher number of them indicates a greater 
overlapping. The Euclidean distance method resulted in almost twice as much pairs (67) than the Squared 
cosine function (35). All of the observed pairs resulting from the Squared cosine method are also found in 
those resulting from the Euclidean distance method. The overlapping zone should be small, if possible 
even inexistent, therefore the correlation method can be considered to be more appropriate.  
 
 
6.1.1.3 Conclusion 
 
From the previous considerations it can be concluded that both methods present similar results without 
contradiction. The observed differences could be explained and did not represent any incoherence, but 
rather a logical consequence of the type of calculation. Therefore, it was not regarded necessary to use 
both methods for the ongoing evaluation of data analysis. Only the results obtained with the Squared 
cosine function would be used for the evaluation of similarity between ecstasy tablets. 
 
 
6.1.2 XTC data set – Similarity Index vs. Canberra Index 
 
6.1.2.1 Graphical representation 
 
The XTC data set has been treated with the Similarity index and Canberra index. The obtained tables 
were also imported by The Unscrambler© in order to visualise them in form of matrix plots which are 
represented in Fig 50 and Fig 51. 
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The same observations as for the FA/sugar data set can be made. Again, a similar distribution of colours 
can be observed and the difference between correlation and distance method can be seen. However, the 
latter is not marked as much as for the precedent data set. No significant difference can be detected for 
the two methods applied to the XTC data set. 
 
 
 
Fig 50 – Matrix plot of the table obtained after application of the Similarity index. 
 
 
 
 
Fig 51 – Matrix plot of the table obtained after application of the Canberra index. 
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6.1.2.2 Use of threshold values 
 
The lists of similar ecstasy pairs have been established considering the MinNL and MaxL values for the 
two selected methods, which are reminded in Table 22.  
 
Similarity measure MinNL MaxL 
Similarity Index 0.16 0.29 
Canberra Index 1.85 2.62 
Table 22 – Threshold values for both applied similarity measures. 
 
 
The resulting lists give a similar picture to the one obtained with the FA/sugar data set (Fig 52). The 
difference here is that the distance method seems to be more appropriate, and not the correlation method. 
When applying the same reasoning than above, the overlapping zone should be smaller with the Canberra 
Index than with the Similarity Index.  
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Fig 52 – Number of ecstasy pairs below MinNL (Threshold1) and between MinNL and MaxL (Threshold2). 
 
 
6.1.2.3 Conclusion 
 
The same conclusion can be drawn here compared to that for the FA/sugar data set – the results of the 
two methods seem to be similar and no inexplicable differences were observed. Therefore, only the 
Canberra Index was chosen for further data analysis. 
 
 
6.2 EVALUATION OF THE ECSTASY TABLET COMPARISON 
 
Similarity values are calculated in order to express the closeness of two samples. More specifically, it is 
used as a means for the search of eventual links. Is the value small ? The presence of a link becomes 
very probable – is it high ? The absence of a link is more likely. However, depending on the sample type 
the meaning of a link has to be defined. 
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In illicit tablet production links can be found at the following levels: 
 
o Synthesis 
o Tablet producer 
o Blending 
o Compression 
 
The first considers the active substance and how it could be characterised, generally through trace 
analysis of by-products, precursors, etc. It will not be considered here. 
 
The level of producer has been introduced because a tablet producer may have a personal recipe 
differentiating him from others. Additionally, he may possess more than one press resulting in visually 
different tablets, but being made of the same blend. The level of the producer is simply less specific with 
regard to the excipients content than the level of the blend. A link at this level would signify that the same 
active substance and the same excipients in very similar proportions can be observed in two tablets. 
 
The link at the level of the blending would be very specific as it considers two tablets originating from the 
same mixture prepared at a certain moment and probably being compressed in the same run. They do not 
necessarily present the same physical characteristics (except the diameter) if they were for example 
produced on a rotary machine with various pairs of punches. However, their chemical composition would 
be identical. 
 
The tablets presenting the same physical characteristics are considered as linked through compression: 
they are supposed to come from the same press. Therefore, they do not necessarily have the same 
chemical composition. However, this definition of link requires specific knowledge about physical 
characteristics which are not available in this project.  
 
It results from these considerations that information obtained by the excipients particularly deals with the 
second and third level – tablet producer or blend. The following chapter will evaluate how much 
information is obtained from excipient analysis and what type of links can be expected. 
 
 
6.2.1 Results obtained with fatty acid and sugar analysis 
 
6.2.1.1 Evaluation of the excipient distribution 
 
One of the aims of this research was to show the variety in excipients used by different illicit producers 
and furthermore to classify ecstasy tablets with regard to their excipient content. These two aims are 
necessarily strongly correlated because the classification presupposes presence of variety in excipient 
composition. Therefore, by showing that ecstasy samples can indeed be grouped according to their 
excipients both hypotheses will be confirmed. 
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The number of different sugars detected in all 109 ecstasy samples is limited to four, which are lactose 
monohydrate, anhydrous lactose, sorbitol and mannitol, the latter having been observed only in traces. 
For the differentiation of lactose monohydrate and anhydrous lactose, the reader is referred to Chapter 7 
(Additional studies). Mixtures of two sugars were rare and they were not blended in equal proportions. 
Actually, they seemed to have been mixed rather accidentally since the second sugar was always present 
in very low quantities. Concerning the stearate, up to ten different fatty acids could be observed, with 
palmitic (C16) and stearic (C18) acid being the principal ones.  
 
In order to get an idea of the importance of each of the variables, statistics were run on the data (peak 
areas) obtained for the whole data set. The data was mean normalised beforehand because of great 
range differences. Fig 53 shows the distribution of peak areas in form of box plots for each variable and it 
appears clearly that lactose, palmitic (C16) and stearic acid (C18) would be the main factors in ecstasy 
comparison. 
 
 
 
Fig 53 – Distribution of peak areas of all ecstasy samples for each excipient variable. 
 
 
This seemed to be few factors for sample grouping and it was decided to have a closer look at their 
variation inside the sample set. A histogram in Fig 54 shows a more detailed view of the peak area 
distribution for these three variables. It appears that all three variables present a large distribution in the 
sample set and might therefore result in useful variety between tablets, especially since the other peaks 
would also be taken into account.  
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Fig 54 – Peak Area distribution for lactose (peak1), palmitic (C16) and stearic acid (C18). 
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6.2.1.2 Sample grouping 
 
In order to evaluate the signification of the obtained correlation values after excipient analysis, it was 
necessary to investigate how far the ecstasy tablets could be differentiated by only using the excipient 
peak areas. It was therefore decided to compare the data of all samples visually according to the following 
three criteria, going from the general to the more specific ones : 
 
1) The first one is the qualitative criterion. Samples were grouped according to their active substance. It 
was decided to use this additional information for a quite obvious reason. An analyst would never start 
with the analysis of excipients before at least making a screening test to verify if and what illicit 
substance is present. The identity of the latter is necessarily known because it is inherent to the 
chemical composition and as such to the blending to be compressed. Therefore, it was taken into 
account. However, no quantitative data was used. 
 
Samples were furthermore grouped according to the type of sugar. A semi-qualitative criterion could 
be defined for the fatty acids. There appeared to be three distinct types of palmitic and stearic acid 
proportions, which could be clearly differentiated : C16 < C18, C16 ≈ C18 and C16 > C18 (Fig 55). 
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Fig 55 – The three different types of C16/C18 distribution. 
 
2) The second criterion took into account the proportions of the two or three main peaks which were the 
principal sugar peak and the palmitic and stearic acid. If substantial differences in the relevant peak 
areas appeared which would result in further differentiation, this was taken into consideration. Small 
differences were not taken into account as no quantitative analysis has been performed. 
 
3) Finally, the distribution of the small peaks was observed concerning particularly the eight other 
possible fatty acids apart from palmitic and stearic acid. It can be seen in the example shown in Fig 56 
that the profile does not change for the six replicas of the same ecstasy sample. To demonstrate the 
variation that can be observed, the distribution of the eight fatty acids in two different samples is 
shown in Fig 56 as well. 
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Fig 56 – Fatty acid distribution for six replica of ecstasy sample 1301 on the left – for sample 1301 and 1507A on the 
right. 
 
 
Physical properties of the tablets have not been taken into account for the sample grouping as they were 
not directly related to the blending. The colour might have been considered but it appeared as not reliable, 
since about 75% of the tablet were attributed the colours beige, white or dirty white. Additionally, the visual 
attribution of colour being very subjective and the photographs being taken in varying conditions, the 
information is not necessarily trustworthy.  
 
The examined data set could be divided into 67 groups, with 43 of them containing only one sample. Eight 
groups included samples that had to be separated into subgroups. This means that the concerned 
samples could not be separated according to the above criteria, but they appeared to present slight 
differences, generally quantitatively. The groups are listed in Appendix X together with physical 
characteristics and quantitative data. 
 
 
6.2.1.3 Examination of the groups 
 
The correlation values obtained by the Squared cosine function were noted for all groups in order to verify 
if the groups, formed in a sort of manual way, were confirmed by the calculated similarity values, or in 
other words, if the similarity measure resulted in the same groups. Additionally, it would be seen if the 
threshold value determined in the previous chapter (MinNL) was reliable. Fig 57 shows the distribution of 
the values obtained with the cosine function and which were below "1". Although the overlapping zone for 
the squared cosine function was determined as being situated between 0.23 (MinNL) and 0.39 (MaxL), it 
was decided to extend it up to 1 in order to insure the collection of all similar sample pairs. 
 
It has to be specified that the values for the subgroups are also present in those for a group and were 
simply taken apart to have a view of the values for the smallest entities determined. It is true that in this 
representation the term subgroup is somehow fallacious because this term grouped values with all 
samples that could not be differentiated further. Therefore, it also contains the values of groups with 
identical samples. Obviously, it does not make much sense to call them subgroup, as there is none. 
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Fig 57 – Correlation values below 1, with those for samples of a group in green, for samples inside a subgroup in red 
and all others in blue. 
 
 
It appears from Fig 57 that the overlapping zone might indeed be bigger than determined earlier, but this 
was expected since more samples were analysed and some of them were slightly inhomogeneous which 
may have caused some higher values. On the other side, the highest correlation value, and therefore the 
lowest correlation, for a subgroup was 0.43 which is not that far from the initial value (0.39). Additionally, 
the second threshold value, and maybe the more important one, separates the linked from the non-linked 
population and seemed to be appropriate. Nearly 80% from the group similarity values and more than 
90% of the subgroup values were below the MinNL (0.23). However, there were two values below 0.23 
from tablets that were not grouped together, the reason being that they do not contain the same illicit 
substance. These two cases will be considered further. 
 
The lower value of 0.009 was obtained with the two ecstasy samples Z209 and 1494D, the former 
containing a blend of MDMA and MDEA, and the latter just MDMA. The remaining characteristics can be 
found in Table 23 below. 
 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
Z209 23.02.04 8.01 4.22 239.10 "STAR DUST" dirty white Yes MDMA, MDEA   
1494D 19.12.01 8.02 5.22 296.95 Elephant white Yes strong MDMA 29.46  
Table 23 – Summary of the main characteristics of the samples Z209 and 1494D. 
 
 
These two samples present a rather particular case, inasmuch that they do not only contain no sugar, but 
also that only palmitic and stearic acid were present in very small quantities. Consequently, they are 
identical because there is no data to show any variation. It thus appears that when no excipient can be 
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detected, much care has to be taken in the comparison of the results. Consequently, all other available 
information is to be considered when evaluating the similarity. In this case we have to do with very 
common tablets – presenting a frequently observed form (round and flat), the same for the diameter, a 
very common colour and frequent logos. The only particular characteristic is the presence of two active 
substances in seizure Z209 which speaks against a link between the two seizures. Considering the 
interval of almost 2½ years between the two seizures it also tends to indicate a non-link. But altogether 
there is so few significant information available, that no conclusion can be drawn. 
  
On the other side, the absence of excipients can also be considered as a significant characteristic as it is 
rather rare to find nothing except the illicit substance (absence of excipients meaning no excipients 
detected by GC). This was for example the case with ecstasy samples 1303, 1304C, 1305, 1306B and D 
(Table 24). These were the only tablets were no trace of any excipient has been observed. As they appear 
to show no difference, the absence of sugar and fatty acids can be considered significant in confirming 
their linkage. 
 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
1306D 17.05.00 8.10 3.36 219.71 Star dirty white None MDMA 36.84  
1306B 17.05.00 8.09 3.41 221.59 Star dirty white None MDMA 36.28  
1303 17.05.00 8.11 3.44 222.48 Star beige None MDMA 41.83  
1305 17.05.00 8.09 3.45 220.93 Star dirty white None MDMA 37.29  
1304C 17.05.00 8.10 3.48 225.19 Star dirty white None MDMA 40.49  
Table 24 – Summary of the main characteristics of the samples 1303, 1304C, 1305, 1306B and D. 
 
 
However, this is a particular case. It serves to demonstrate the importance of the main variables – one 
sugar and two fatty acid peaks. The loss of one or more of them requires much caution in the evaluation of 
any similarity. It has been observed that in the case of absence of a principal sugar, it was important to 
have some additional fatty acids next to C16 and C18 for the grouping of the samples. These smaller fatty 
acid peaks have always been considered as a whole and never separately, the first reason being certainly 
the very small size of the peak, and then they were expected to be correlated. The correlation of the 
variables has been calculated and is represented in Table 25. 
 
Not surprisingly, correlation can be observed between some fatty acids, the highest value being observed 
with C15 and C17. Being odd-numbered they are rare and considering the nature of fatty acids, it seems 
logical that they are correlated. Even for the more common fatty acids there is no such thing as observing 
one fatty acid on its own. Depending on the substance (animal, plant, or other) a varying number of 
characteristic fatty acids can be detected, but generally more than two. Knowing this, the correlation 
values presented above are actually better than might be expected.  
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  Mtol Stol Lac1 Lac2 C12 C14 C15 C16 C17 C18:2 1C18:1 2C18:1 C18 C20 
Mtol 1                           
Stol 0.16 1                         
Lac1 0.16 -0.28 1                       
Lac2 -0.09 -0.10 -0.06 1                     
C12 -0.03 0.27 -0.04 -0.05 1                   
C14 0.04 0.31 0.03 0.38 0.41 1                 
C15 0.00 0.41 0.02 0.01 0.41 0.78 1               
C16 0.06 0.46 0.17 0.09 0.40 0.53 0.55 1             
C17 0.06 0.36 0.07 0.06 0.33 0.78 0.97 0.49 1           
C18:2 0.40 0.10 0.29 -0.07 0.32 0.12 0.12 0.04 0.16 1         
1C18:1 0.56 -0.06 0.36 -0.10 0.18 -0.05 -0.12 -0.02 -0.05 0.89 1       
2C18:1 -0.04 -0.05 0.34 -0.04 -0.03 -0.06 -0.07 0.01 -0.05 0.57 0.51 1     
C18 0.05 0.34 0.19 0.27 0.47 0.78 0.76 0.83 0.77 0.13 0.01 0.02 1   
C20 0.14 0.17 0.16 0.24 0.31 0.65 0.73 0.50 0.81 0.21 0.10 -0.04 0.82 1 
Table 25 – Correlation of the fourteen variables obtained with the data of 109 ecstasy samples.  
 
 
It results that the number of fatty acids to be used for sample comparison can be reduced and the same 
variation can be observed. This might be examined in future work. However, for this research the 
maximum of information has been taken into account. 
 
A second case has been observed with two ecstasy tablets containing different illicit substances (ecstasy 
seizure 952 and 960), but presenting a high similarity through their excipients. The similarity value being 
this time 0.19, it is situated at the upper limit of the linked population zone. Thus, the simplest reaction 
would be to reduce the threshold value of 0.23 to e.g. 0.18 in order to avoid these bad surprises. 
Observing the distribution of the similarity values in Fig 57, this would not change anything for the 
subgroup values. However, it would be a blind reaction. The two samples in question do indeed present a 
very similar distribution of sugar and fatty acids and it is imperative to consider eventual explanations. This 
brings us to the interpretation of the similarity values, essential especially for cases like this one. 
 
 
6.2.1.4 Signification of the groups 
 
As already mentioned, the similarity value is calculated in order to give information about the presence of 
a link between two seizures of ecstasy tablets. A low value indicates a high correlation and vice versa. 
Such a low value like that observed for the two samples above would intuitively lead to the conclusion that 
the two tablets are the same – they are linked. Nevertheless, they have been classed in two different 
groups, so there is actually some difference. Thus, it has to be evaluated where the high similarity or the 
link comes from. Did the tablets come out of the same press a few minutes one after the other ? Or were 
they produced in the same clandestine laboratory ? Or do they just happen to show identical properties ? 
It is very difficult to answer these questions for one particular reason. 
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No information is available about illicit production, except for the synthesis of the active substances. Better 
knowledge about production habits would be of great use and research should be done in order to answer 
questions with regard to a clandestine laboratory, such as : 
 
- What type of press can be found ? 
- How many presses can be found ?  
- How many different logos are used ? 
- Are there more than one type of excipients ? 
- Are there one or more dyes ? 
- Is there a preference for a particular active substance ? Etc. 
 
The answer to these questions would at least give an idea of how production works, of what can be 
expected, but as the situation stands at the moment only assumptions can be made. And these are based 
on the observations made on ecstasy seizures.  
 
However, when considering the basic production steps presented in Fig 58, it appears that the excipients 
are necessarily related to the blend before compression. It was decided that the term blend included the 
active substance as it is most probable that someone prepares a mixture according to a recipe from A to 
Z. Preparing a bulk quantity of excipient blend and using it for different illicit substances, and thus different 
compression blends, appears to be improbable particularly with regard to the stearates which are added 
just before compression. 
 
 
 
Fig 58 – Basic production steps for ecstasy tablets. 
 
 
The most general assumption which can be made is that a low similarity value indicates that the blends 
used for the two concerned tablets contained the same excipient, except in the previously mentioned case 
where excipients were lacking. With regard to the sugars, this might not be a very selective indication 
since we have seen in ecstasy statistics that there is a clear preference for lactose (cf. Chapter 2). 
However, the realised analyses showed that only half of the tablets contained lactose monohydrate, the 
other half contained no sugar at all, or sorbitol, anhydrous lactose, or combinations. Additionally, 
variations in proportions of the two lactose peaks were observed. This can be an indication for different 
lactose products, particularly in the case of anhydrous lactose. This will be shown in Chapter 7 (Additional 
Studies). Thus, the information obtained from sugars can be more specific than simply its identity. 
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The fatty acids are the ingredients of metallic stearates used as lubricant. Despite the name, stearates 
also contain palmitates and other fatty acid salts. The US pharmacopoeia states that stearate and 
palmitate together should account for not less than 90% of the fatty acid content. This still leaves a 
considerable range of materials to be supplied as stearate and it would be expected to observe variations 
in the fatty acid content. Indeed, this can be confirmed by the various number and proportions of fatty 
acids observed in the analysed ecstasy samples. Additionally, it is recommended to use a single supplier 
for a given formulation because a stearate from a new supplier might have other effects on compaction 
and dissolution.  
 
Another interesting point concerning the presence of stearates is its hydrophobic character. It has been 
shown that it might reduce dissolution rate and bioavailability of several tablet formulations. Even an illicit 
ecstasy producer should be worried about optimal effects of the illicit substance to take place. In order to 
minimise this behaviour, the stearates should be the last excipient added to the blend and only be mixed 
for a short time before compression. (Davies, 2001) The fatty acid content thus appears to be 
characteristic for a blend. 
 
A low similarity index would therefore not only imply the use of the same excipients, but even indicate a 
link towards the same producer. That two producers use the same excipients is absolutely conceivable. 
However, the likelihood that two producers use excipients with identical chemical properties (coming from 
the same supplier) in identical proportions is much smaller. Considering the variety observed during 
sample grouping it might even be conceived that a low similarity value signifies a link to the same blend. 
There are indeed groups with one or two tablets showing very slight differences in quantities but still 
visible enough to distinguish them (Fig 59). Considering the distribution of the peak areas in these groups, 
there simply seems to be a little less/more sugar or fatty acids so that the proportions between the two 
very slightly changes (Fig 60). 
 
 
1345A Heart (Punchmark)  1204A Double lightning  1388 "FF"  1693 Heart 
1130 Heart (Punchmark)  1148 Diamond  1380A "FF"  1683 Heart 
1134A Heart (Punchmark)  1209 Diamond  1473A "FF"  1708 Heart 
1314B Heart (Punchmark)  1112F Diamond       
   1218A Double lightning       
Fig 59 – Groups with one tablet being very slightly different. 
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Fig 60 – Group Diamond/Double lightning – sample 1204A is distinguished by its lactose and fatty acid content. 
 
 
This small change could be explained for example by the fact that they were produced in consecutive 
batches. However, nothing is known about the homogeneity inside one batch which is typically one of the 
problems addressed in pharmaceutical tablet production. And therefore not enough data is available to 
make a statement with regard to a link at the level of a single blend. However, since variation in the 
excipient content has been proven, a low similarity value does rather indicate a link with regard to the 
producer. 
 
Although focussing on the chemical composition of the ecstasy tablets, their physical characteristics need 
to be considered as well, as they are also related to the producer. All determined groups are composed of 
tablets presenting identical physical characteristics. There was only one exception where two different 
logos were observed (Diamond + Double lightning). The concerned tablets are however linked on the 
basis of the physical characteristics (Zingg 2005), presenting a particular tablet shape and a strong colour 
(Fig 61). 
 
      
Fig 61 – Front view of sample 1209 on the very left and of sample 1204A on the very right; side and back view being 
the same for both they are shown once in the middle. 
 
The physical correspondence was therefore confirmed by the excipient composition. Nonetheless, there 
were several tablets showing identical physical properties and as a result were sometimes attributed to the 
same class, but were differentiated by their excipients. In these cases care should be taken before making 
any classes and the significance of the various characteristics should be discussed. 
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In this context it is interesting to notice that a sort of fashion effect has been observed. A large group of 
somehow similar but not identical tablets happen to correspond to very common logos as well (Ferrari, 
Mitsubishi). Additionally, the above mentioned tablets – similar in physical characteristics, different in 
excipient content – also had very popular logos, such as Mitsubishi or Superman. Therefore, when dealing 
with tablets presenting popular logos and no particular colour (white, beige), a low similarity value should 
be considered with caution. The similarity in excipient content does not necessarily prevail over physical 
characteristics and vice versa, but they have to be considered together. It seems that with these 
fashionable imprints, similarities may easily appear at any level which might simply be due to their high 
frequency. There must be an enormous amount of tablets with these imprints on the illicit market, and it 
would be interesting to study the excipient content on a large sample of tablets seized at different places 
to learn more about the variation inside batches and in-between batches. 
 
Finally, something should be said about the colour of the tablets, because intuitively it was attributed to the 
blend as well. The fact is that it was difficult to include it in the criteria for the grouping. The colour is not at 
all reliable when dealing with white, beige or dirty white tablets which concerned however over half of the 
sample set. It was not included in the grouping criteria because dyes are not essential excipients and may 
be added whenever to the blend. Their significance was not clear enough to rely on it for the sample 
grouping. However, when evaluating the groups it sometimes was a very helpful indicator and was in that 
sense also mentioned in the previous paragraphs. 
 
 
6.2.1.5 Conclusion 
 
If we get back to the initial hypotheses, they have been confirmed through the precedent paragraphs. 
Variation in excipient content could be shown and as consequence of this, it was possible to form groups 
as well. The variation observed between these groups was confirmed by the similarity values obtained. 
The evaluation of these values resulted in the conclusion that a high correlation in excipient content 
(therefore a low similarity value) indicates a link towards the tablet producer.  
 
However, it also has been shown that it is important to consider all available information about the 
remaining characteristics of the tablets and particularly be careful with popular logos. This is even 
imperative when dealing with tablets where no excipient has been detected by GC-MS analysis. 
 
 
6.2.2 Results obtained with the routine method – Comparison with FA/sugar 
method 
 
The particular circumstances of the application of this method have to be reminded. The ecstasy sample 
set has been analysed by the routine method usually applied for the screening and quantification of 
ecstasy tablets, because the new GC-MS instruments appeared to be more sensitive than those used 
before. Small peaks after analyses on the old instrument were accentuated on the new one (e.g. palmitic 
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and stearic acid) and new peaks were detected. Therefore, it was considered interesting to evaluate this 
new information and to compare it with the FA/sugar method. No changes or optimisation have been 
applied to the routine method and as such it is an accessory study carried out in parallel with the excipient 
analysis. The same procedure with regard to data analysis has been applied in order to be able to 
compare the results with those obtained from the excipient data set. However, interpretation will be limited 
to this comparison. 
  
 
6.2.2.1 Evaluation of the variables 
 
Similarly to the excipient analysis the applied variables will shortly be evaluated in order to see which ones 
have the strongest influence, how they interact and if variation can be observed. Contrarily to excipient 
analysis, the substances detected by the routine method are of different kinds. They are composed of the 
active substance(s), traces of synthetic impurities, adulterants and excipients (fatty acids and sugars). 
Altogether, twelve peaks have been used for data analysis. The obtained data has been exported to the 
software The Unscrambler© and statistics have been run on the raw peak areas. The result is shown in 
form of box-plots in Fig 62. 
 
 
 
Fig 62 – Distribution of peak areas of all ecstasy samples for each variable. 
 
 
The result is similar to the excipient analysis inasmuch that again three major variables are observed – 
MDMA, and the two lactose peaks. However, when considering the area distribution of the three peaks in 
detail differences appear (Fig 63). It is interesting to observe that the peak areas obtained for MDMA show 
a relatively small distribution indicating a less important variation.  
 
Therefore, the principal source of variation seems to be the sugar content. However, the other variables 
may have a stronger influence than appears first. The variables used in the routine analysis are, by their 
nature, supposed to be less correlated than were the fatty acids in the excipient analysis. And, indeed, 
much less correlations are observed in Table 26. 
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Fig 63 – Peak area distribution of the three main peaks MDMA, Lac1 and Lac2. 
 
 
 MDMA MDEA Amph MDA Unknown Caffeine Mtol Stol Lac1 Lac2 C16 C18 
MDMA 1            
MDEA -0.11 1           
Amph -0.31 -0.04 1          
MDA -0.50 -0.06 -0.06 1         
Unknown 0.85 -0.10 -0.28 -0.46 1        
Caffeine -0.39 -0.05 0.84 0.22 -0.36 1       
Mtol -0.33 -0.05 -0.04 0.71 -0.31 0.32 1      
Stol 0.17 -0.01 -0.06 -0.10 0.11 -0.08 -0.03 1     
Lac1 -0.08 0.02 0.02 0.25 -0.03 0.10 0.25 -0.32 1    
Lac2 -0.08 -0.05 0.66 -0.07 -0.01 0.55 -0.03 -0.17 0.17 1   
C16 0.09 -0.07 0.15 -0.07 0.15 0.10 -0.02 0.47 0.26 0.19 1  
C18 0.07 -0.08 0.26 -0.06 0.10 0.20 -0.02 0.28 0.31 0.43 0.84 1 
Table 26 - Correlation of the twelve variables obtained with the data of 109 ecstasy samples. 
 
 
The observed correlations next to the fatty acids are not surprising since the unknown peak has only been 
detected when MDMA was present and similarly for caffeine when amphetamine was present.  
 
 
 
6.2.2.2 Sample grouping  
 
The similarity values obtained with the XTC data set were evaluated in the same way than with the 
excipient data set. Samples were visually compared according to similar criteria than for the sugars and 
fatty acids, only that here the quantitative analysis of MDMA, performed after the seizure of the tablets, 
was intended to be taken into account as it is part of the routine analysis. However, a substantial problem 
has been discovered. The MDMA percentages taken from the ecstasy database (IPS-WD) were not 
correlated to the obtained peak areas in this research. When plotting the raw peak areas against the 
percentages no tendency can be observed (Fig 64). 
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Fig 64 – Raw peak areas plotted against the MDMA percentages. 
 
 
The quantitative analyses have been made over more than five years and on another instrument 
(Capillary Electrophoresis). This explains to some extent the absence of correlation. Consequently, the 
quantitative data was not taken into account for the sample grouping. 
 
Therefore, the criteria used for the sample grouping were the following : 
 
1) The first was again the qualitative composition. The samples were sorted according to their active 
substance, type of sugar, adulterant and fatty acids. It appears that for the fatty acids the same 
criterion could be used than for the excipient sample grouping, inasmuch as the same kind of 
relationship between palmitic and stearic acid could be observed. 
 
2) Secondly the relationship between the major peaks have been considered and difference in 
proportions resulted in differentiation.  
 
3) Finally, differences in quantity were considered and if significant lead to differentiation. 
 
The sample grouping appeared to be rather difficult. Variation was not as great as expected and 
differences were often small. A particular problem was that differences in proportions were not always 
very obvious and reliable. When comparing with the similarity values, samples could be observed that 
were separated because of variation in proportions, but have been given a very good similarity value. 
Another problem was that differences in fatty acid proportions were visible as such but have not been 
taken into account by automatic comparison. Finally, a great number of samples looked very similar, 
presenting MDMA and sugar content in similar ranges, and were therefore difficult to differentiate. 
 
In the beginning this was thought to be caused by the use of the raw peak areas and the grouping has 
been repeated with the normalised peak areas (values after the applied pre-treatment). It appeared not to 
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be much easier and the obtained results were even worse in terms of similarity value distribution, because 
more not-grouped sample pairs below the MinNL limit were observed. Altogether, the sample grouping 
seemed to be rather coincidental and it would not be surprising if a slightly different grouping would be 
found when carried out another day.  
 
This observation is very different from the sample grouping with the excipients. For the latter, the 
analytical methods have been adapted to sugar and fatty acid detection and their peaks were therefore 
considered as reliable. This cannot be assured for the routine analysis which is a screening method and it 
was difficult to appreciate as how reliable the peaks could be considered, and consequently how reliable 
the similarity values were.  
 
 
6.2.2.3 Evaluation of the groups 
 
For further comparison with the excipient method, the sample groups obtained with the raw peak areas 
have been used. As mentioned above, the similarity values obtained with the Canberra Index have been 
attributed to the determined sample groups and their distribution was compared with that of the values 
below the upper limit fixed at three which could not be attributed. The result is presented in Fig 65. 
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Fig 65 – Correlation values below 3, with those for samples of a group in green, for samples inside a subgroup in red 
and all others in blue. 
 
 
The first remark to make with regard to Fig 65 is that the overlapping zone appears to be much bigger 
than previously determined. The highest value for non-differentiated samples is 7.6, much higher than the 
MaxL value – 2.6 – determined in the previous chapter (Data analysis). And as can be seen in the above 
graph, the values for sample pairs which were not grouped together goes down to 1.  
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Against what was said for the FA/sugar grouping, an adaptation of the threshold value (MinNL) seems to 
be appropriate here. But this would not resolve the problems in making groups and a more thorough study 
of the screening method in the context of ecstasy comparison would be advisable. 
 
However, groups have been made in order to compare them to those obtained with the excipient analysis. 
A number of 72 groups have been determined, of which 46 were composed of a single sample and 7 
contained subgroups.  
 
The kind of information that should be obtained with the global ecstasy analysis is similar to that obtained 
with the excipient. Additional knowledge is gained in the form of the peak area of the active substance and 
potentially present adulterants. On the other side, some specificity is lost with regard to the excipients, 
since only two fatty acids are detected. Nonetheless, both data sets are related to the blend before 
compression and give information about the chemical composition of the whole tablet mixture. 
 
The ecstasy screening method appears to be more general because it deals with qualitative and semi-
quantitative aspects. In other words, samples are differentiated because of the present substances and 
their relative quantities. However, this combined information results in enough variation to form groups. In 
the excipient analysis, the detected lactose and much more the stearate is characterised by its peak 
proportion for the first and its fatty acid content for the second, which appears to distinguish different types 
of lactose or stearates. Therefore, the qualitative criteria go further than that obtained with the screening 
method. This might be the reason why the sample grouping appeared easier because greater variation 
seemed to have been observed. 
 
The groups determined by the two methods are not contradictory, but slightly different. A first general 
remark is that there are four groups in the XTC data set composed of samples which do not correspond in 
all physical characteristics. It has been explained in the evaluation of the excipient groups that it is 
conceivable to have tablets with identical composition and different physical characteristics. However, the 
correspondence in chemical composition should be certain, something which cannot be assured in this 
case. The four groups were not formed within the excipient data set. The concerned samples were 
differentiated either because of proportional differences in sugar and fatty acid peaks, or because of 
substantial quantitative differences. This rather speaks against a link based on chemical composition. 
 
Concerning the other differences observed, in ten cases, samples which have been grouped in the 
excipient data set were separated in the XTC data set. Possibly, the active substance content made the 
difference. However, this is considered as a loss of information since the links highlighted by the 
excipients were not seen anymore.  
 
One case remains where samples separated by the excipients were found to be grouped in the XTC data 
set. This is due to the greater specificity of the excipient analysis. The samples were separated because 
of small proportional differences in the fatty acid content, something which would not be detected by the 
ecstasy screening analysis. Additionally, they do correspond in physical appearance, except for the colour 
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(Fig 66). Thus, they might be considered as linked, but being made at different moments, which would 
explain the difference in fatty acids and colour. 
 
 
   
Fig 66 – Front view of the samples 1451A on the left and 1451B on the right. 
 
All groups are listed in Appendix XI and the samples being differently grouped with regard to the excipient 
data set (Appendix X) are highlighted in red. 
 
 
6.2.2.4 Conclusion 
 
The screening method for ecstasy analysis is an interesting alternative as it gives information about the 
several substances possibly present in an ecstasy tablet and detectable by GC-MS in one time. However, 
problems have been encountered. First of all, the quantification of the active substance should be verified 
in order to get reliable results which could be used in sample comparison. Then, it has been seen that 
variation seemed to be less obvious than with the excipient analysis which appeared to be more specific. 
Groups formed by both methods were to a great deal similar, but several differences were observed which 
in many cases signified a loss of interesting information, because samples considered as linked by the 
excipient method were separated by the routine method. 
 
Altogether, the screening method does not appear to be an appropriate method for ecstasy sample 
comparison because similarity values seemed to be less reliable than for the excipient method and 
incoherencies have been detected between calculated similarity and observed variation. 
 
 
 
 
 
 
 
 
 
 
7 ADDITIONAL STUDIES 
 
 
7.1 THE PARTICULAR CASE OF LACTOSE 
 
 
7.1.1 Introduction 
 
It has soon appeared from statistical evaluation of our ecstasy database and from research in relevant 
literature that lactose is one of the most, if not the most, frequently used excipients in ecstasy tablets. 
Since the seized tablets have been analysed by GC-MS, lactose is easily recognised on the 
chromatogram with its two peaks – one big and one small – at the end of the analysis.  
 
The reason for our further interest in this substance is that sometimes the second, normally smaller peak 
happens to be bigger or equal to the first one, and that this is not the result of an instrumental error, 
preparation or degradation. With the method developed for sugar analysis, this inversion of size seemed 
to be even accentuated. Just as for the "normal" case the smaller peak is even more reduced in size.  
 
It is known that lactose exists under two anomer forms – α- and β-lactose. The standard usually applied 
for test analyses and during the method development for sugar analysis was α-lactose monohydrate, 
because this is the most common form. Thus, faced with this phenomenon of inversed peaks, it was 
decided to analyse a standard of β-lactose. And indeed, the standard happened to produce two peaks 
with the second one being higher.  
 
 
 
 
Fig 67 – NIR spectra of a β-lactose standard with samples of anhydrous (Kerry) and α- (Meggle) lactose. 
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The answer seemed to have been found. However, it remained unclear why β-lactose has never been 
mentioned in any publication read for this research. It is not rare to observe this form of lactose. In the 
ecstasy tablets analysed in our laboratory the β-lactose form appears to be as frequent as sorbitol.  
 
Things became clearer when another project using NIR spectroscopy required the collection of a high 
number of cellulose and lactose samples. Another common excipient next to α-lactose monohydrate is 
anhydrous lactose and was therefore also obtained for the NIR project. During this project it was observed 
that β-lactose is the principal component of anhydrous lactose. And although the latter can contain α-
lactose to a minor extent, the spectra of an anhydrous lactose sample and the β-lactose standard were 
almost identical (Fig 67). 
 
 
7.1.2 Lactose blends 
 
The origin of this second high lactose peak could now be explained and some further investigations 
appeared worthwhile. According to the pharmacopoeia and other publications about excipients (Ph.Helv., 
1997; Kibbe, 2000; DMV, 2005), anhydrous lactose is seldom composed of pure β-lactose, but generally 
blended to some extent with α-lactose. 
 
Thus, four 100mg blends were made from α- and β-lactose standards at different proportions (20/80, 
40/60, 60/40 and 80/20) to be analysed on the GC-MS by the routine ecstasy method and the developed 
sugar method. The purpose was first, to compare both methods with regard to linearity between the two 
lactose peaks and the α- and β-lactose content, and second, to characterise the anhydrous lactose 
samples in function of this content. 
 
 
7.1.2.1 Linearity  
 
All data were represented on graphs by plotting the respective quantity of α- and β-lactose against the 
area of the first peak (Peak1) and of the second peak (Peak2). The data obtained for the areas were 
either used untreated, or normalised. It appears that normalisation of the areas has no influence on 
linearity. Regression coefficients are the same in both cases. Therefore, only one graph per method is 
represented below in Fig 68. 
 
Considering Fig 68 it can be seen that less points were used for the ecstasy routine method. This is due to 
analytical problems, a part of the analyses showing secondary peaks next to the two principal ones whose 
peak areas were strongly influenced by this presence. The problematic measures were therefore 
discarded. These secondary peaks are supposed to be caused by degradation, although exact reasons 
are unknown. 
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Fig 68 - α- and β-lactose content in function of the normalised areas of peak1 and 2, respectively, analysed by the 
routine ecstasy method (left) and the sugar method (right). 
 
 
Although both methods gave good linearity, regression shows that the sugar method gave significantly 
better results. These graphs (Fig 68) were realised with data obtained in Scan mode, which means that a 
pre-determined scan range of mass/charge ratios is used for the detection and the peak observed in the 
chromatogram corresponds to all mass ratios detected at that moment.  
 
Another possibility of detection is the SIM mode, which integrates only the area of selected target ions – in 
our case these would be the characteristic ions for α- and β-lactose (Fig 69). This mode of detection is 
generally much more sensitive and has therefore been tried on the lactose blends. Considering the mass 
spectra below it is obvious that they are very close. The difference lies in the abundance of the ions 191, 
217 and 361. 
 
 
 
Fig 69 – Mass spectra of lactose peak1 and 2 after analysis of α- and β-lactose standards by the sugar method. 
 
 
The results are shown in Fig 70. Like above normalisation was not necessary in the case of the sugar 
method. The results of the ecstasy routine method, however, were slightly improved by normalisation. For 
the sugar method it resulted in a nearly perfect correlation between sample amount and peak area. 
However, concerning the sugar method the scan mode gave already very good results and might be 
sufficient when the SIM mode is not available. 
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Fig 70 - α- and β-lactose content in function of the normalised areas (XTC method - left) / untreated areas (sugar 
method - right) of peak1 and 2, respectively – data analysis in SIM mode. 
 
 
7.1.2.2 Anhydrous lactose 
 
The five anhydrous lactose samples which have been analysed together with a β-lactose standard are of 
three different origins. It has to be mentioned that the β-lactose standard is not pure and has an α-lactose 
content of about thirty percent.  
 
In continuation of what was shown above, the purpose of these analyses was to estimate the proportions 
of α- and β-lactose content and then to see if differences between the samples appeared as this might 
indicate a possible differentiation of origin. Since the peak areas have been proven to be proportional to 
the respective lactose anomer content, the analysed samples are represented by their normalised peak1 
and peak2 areas, corresponding to α- and β-lactose, respectively (Fig 71).  
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Fig 71 – Normalised peak areas for anhydrous lactose samples analysed by the ecstasy method (on the left) and the 
sugar method (on the right). 
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First of all, it can be seen that the results obtained with the sugar method are more regular than those 
obtained with the ecstasy method. Additionally, or rather as a consequence of it, the three origins can be 
detected – Kerry, DCL (DMV International) and BD (Borculo Domo) – on the graph on the right. 
 
Using the regression equations from the first graphs it was tried to evaluate the β-lactose content for the 
DCL 21, 22 (DMV) and standard (b-lac – Sigma) samples as these were the only ones where the content 
was known. Even though this was not the usual procedure – normally the calibration samples should be 
analysed in the same sequence than the unknown samples – the results were rather good and near the 
real amount (Table 27). 
 
 Real β-lactose Measured β-lactose content 
Sample content Ecstasy routine method Sugar method 
DCL21 ~84% 89% 84% 
DCL22 ~80% 100% 85% 
β-lactose Sigma ~70% 72% 72% 
Table 27 – Comparison of real β-lactose content with measured values for both methods. 
 
 
7.1.3 Conclusions 
 
Both methods give linear results for both peaks in function of the α- and β-lactose content and are 
therefore suitable for quantitative evaluation of lactose. However, considering the results above, the sugar 
method appears to result in better linearity than the routine ecstasy method. Since the method has been 
developed for sugar analysis, the results therefore confirm an improvement of performance due to 
analytical optimisation. Thus, this observation is not something negative, but just a logical consequence of 
the efforts realised. Therefore, these results indicate that if quantitative evaluation of lactose or its 
anomers is required, the sugar method is certainly more appropriate. 
 
The sugar method also seemed to be more appropriate for the analysis of anhydrous lactose samples; the 
results appeared to be more regular and quantitative evaluation of the β-lactose content was better as 
well. Although, only a few samples could be analysed, these first observations were interesting. They 
seemed to indicate that there are differences in the α- and β-lactose content between the three producers. 
To determine if this could be used for origin characterisation, analysis of a bigger sample is however 
necessary.  
 
On the other hand, this approach could also be used in the case of α-lactose monohydrate. However, the 
problem here is that the second peak is particularly small and its use could result in erroneous amounts. It 
appears that further investigations are needed in order to obtain a significant conclusion with regard to the 
origin of lactose samples. This, however, is beyond the scope of this research project. 
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7.2 NEAR INFRARED SPECTROSCOPY 
 
 
7.2.1 Introduction 
 
Near Infrared Spectroscopy (NIR) has gained great importance in pharmaceutical technology. Its 
applications are wide ranging over on-line measurement in pharmaceutical manufacturing (Herkert et al, 
2001; Rantanen et al, 2000), moisture measurement (Gupta et al, 2005; Rantanen et al, 2000), verification 
of quality and identity of products (Yoon et al, 2004; Clarke et al, 2001), measuring of polymorphism or 
degree of crystallinity (Gombas et al, 2003; Buckton et al, 1998), study of physical properties due to 
manufacturing (e.g. particle size) (Roggo et al, 2005), identification and comparison of excipients (Krämer 
and Ebel, 2000; Yoon et al, 1998; Langkilde and Svantesson, 1995), and many more (Chalus et al, 2005; 
Reich, 2005; Bakeev, 2003). The great advantage of this technique is that it doesn't require any sample 
preparation and the analysis is done in less than a minute.  
 
In this project NIR was applied for the study of lactose and cellulose – the aim being the determination of 
the different chemical forms of these two substances, as well as the differentiation of their origin 
(producer). Cellulose could not be analysed before and it was suspected to be present in ecstasy tablets 
where no or only a little amount of sugars was detected. Therefore the technique was to be applied to real 
ecstasy tablets as well. Additionally, mixtures of amphetamine and chosen cellulose and lactose 
standards were prepared in order to test quantification.  
 
 
7.2.2 Basic Principles27  
 
7.2.2.1 Absorption 
 
On the electromagnetic spectra the infrared region is situated between the microwaves and visible light. It 
is divided in three zones : the near infrared (NIR) from 800 to 2500nm, the middle infrared (MIR) from 
2500nm to 40µm and the far infrared (FIR) from 40 to 1000µm. (Fig 72) 
 
A molecule hit by energy in form of electromagnetic radiation whose frequency of radiation matches the 
vibrational frequency of the molecule will show radiation absorption and the energy of the radiation will 
change. After the absorption of energy two types of vibrations can be observed – stretching (symmetric 
and asymmetric) and bending (scissoring, rocking, wagging and twisting). The result in the NIR spectra 
will be bands of different orders of overtones (harmonics) and combinations (with decreasing intensity) of 
the fundamental vibrations, which are visible in the MIR region. Fig 73 gives an overview of the absorption 
bands of the most common functional groups. 
 
                                                     
27 (Reich, 2005; Schneider, 2002; Röseler, 2004) 
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Fig 72 – Infrared wavelength region in the electromagnetic spectrum (taken from www.mvh.sr.unh.edu). 
 
 
 
Fig 73 – Position of the absorption bands of the most common functional groups in the NIR region (taken from Clairet 
Scientific Ltd). 
 
 
Near infrared spectra are characterised by broad and badly separated bands and a raising baseline.  
Assignment of bands to specific vibration is not possible because of overlapping between overtones and 
combinations. Distinct bands correspond principally to molecules of low atomic masses with strong 
chemical bonds, such as C-H, O-H, N-H or S-H. Since these functional groups can be found in almost all 
organic substances, NIR can be universally used.  Although the single bands are not specific for structural 
elements, the spectra as a whole is characteristic for the compound analysed. And the low intensity of the 
oscillation has also its advantage, because the sample can be analysed without further preparation, e.g. in 
form of dilution or extraction etc. 
 
NIR spectra do not only describe the chemical composition of a sample, but also its physical parameters. 
The spectra can be quite complex because they represent a multitude of information. Therefore, it is 
necessary to treat the spectra with chemometric methods in order to obtain a proper characterisation of a 
sample. 
 
 
7.2.2.2 Instrumental details 
 
The NIR system composed of a light source, a monochromator, a detector and a computer for the 
mathematical treatments of the spectra. The light source is in general a tungsten halogen lamp, which 
shows high intensity in the NIR region. Semi-conductive photo-electronic elements made off Ge, Si, PbS, 
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InSb or InGaAs (increasing sensitivity) are used for the detection. The detectors are chosen according to 
the wavelength region to scan, and their sensitivity. The reference signal is made on ceramic standard.  
The measurement can be done in reflection or transmission mode.  
 
Only the reflection mode has been used in this project, and transmission will not be further detailed. In the 
diffuse reflection mode the detectors are placed at an angle of 45° towards the sample surface in order to 
detect exclusively diffuse reflected radiation, so called remission, because only this one interacts with the 
sample material and therefore contains substantial information. In diffuse reflection the incident 
wavelength is supposed to be much smaller than the sample thickness and no transmission should take 
place. Depending on the particle size and the compactness of the sample it is estimated that light 
penetrates up to a depth of 5mm. Common materials analysed in the reflection mode are solid 
substances, such as powders or tablets. 
 
 
7.2.2.3 Data treatment 
 
Interfering spectral parameters, such as light scattering, path length variation and random noise, resulting 
from physical sample properties (particle size, inhomogeneous distribution, etc) or instrumental effects, 
require treatment of the spectra. In the beginning it was tried to add correcting factors, but during practice 
it became clear that classification and prediction models worked better after reduction or even elimination 
of negative influences. For that reason usual software products offer a range of possible data treatments 
for the extraction of relevant information. In most cases, meaningful multivariate analysis of NIR 
measurements becomes only possible after having transformed the data by the means of math-
treatments. Some of these will be presented hereafter. 
 
 
Raw Spectra  
 
Reflectance spectra are transformed by a logarithmic function (log 1/R) based on the Lambert-Beer law. 
The so-called absorbance spectra are preferred to the reflectance spectra and also recommended by the 
European Pharmacopeia. It also allows the establishment of a nearly linear relationship between the 
concentration of the analyte and absorption. After having taken the measure of a sample, the 
transformation is directly carried out by the software and spectra are displayed as absorbance spectra.  
 
 
1/X Transformation 
 
An spectra can be displayed as function of the wavelength (λ , nm) or the wave number (ν , cm-1).  This 
depends on the monochromator used in the spectrometer. In NIR spectroscopy the use of the wavelength 
has been established and is standard now. However, it is the wave number which is directly proportional 
to the absorption energy. The 1/x transformation consists in a conversion of all data points in wavelength 
 Additional Studies 121 
 
spectra into data points in wave number spectra, which is a more realistic presentation. In the λ  
presentation longer wavelengths have more statistical weight, which influences the interpretation of the 
data. In ν  presentation all data points have the same weight according to their energy.  
 
 
Standard Normal Variate (SNV) 
 
The method has been developed to compensate scatter-induced baseline offsets. It consists in a 
standardisation of the spectra according to the following equation : 
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with  Ai  absorbance at point i 
 A  mean value of the spectra 
 n number of data points in the spectra 
 
Each spectrum is mean centred and then divided at every data point by the standard deviation of the 
absorbance values of the entire spectrum. Every spectrum is treated separately and does not require 
normal distribution such as is necessary for MSC (see below). However, SNV and MSC give similar 
results.  
 
 
Multiplicative Scatter Correction (MSC) 
 
The method was developed for the same purpose than SNV, but here the treatment is based on a data-
set and not on an individual spectrum. This is to eliminate scatter-induced effects on the spectra by 
linearization on an "ideal" spectrum. This "ideal" spectrum is in fact the mean spectrum calculated from all 
the spectra in the set. The mean spectrum is used to calculate two correcting factors, offset and slope, 
which are established through a Least Squares Regression. The offset value is subtracted from every data 
point in the spectrum and then divided by the slope value. 
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with  Ai absorbance at point i 
 bi offset value 
 mi slope value 
 
MSC requires a large data-set, more likely to produce a true mean spectrum.   
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Derivatives 
 
Derivatives can be applied to improve the resolution and to reduce baseline offsets. The most commonly 
used derivatives in NIR are the 1st and the 2nd derivative. The first corrects baseline offsets and the 
second describes the parabolic curvature of the spectrum. The principle change of the spectrum is shown 
in Fig 74. 
 
 
 
Fig 74 – Curve change by derivation from left to right – original curve, first and second derivative. 
 
 
Since derivation also amplifies spectral noise, it is often combined with a Savitzky-Golay algorithm which 
is both a smoothing and derivative algorithm. It relies on the least squares fit of a polynomial to a specified 
segment. Each segment is derived by also considering the adjacent segments. Therefore the amplification 
of spectral noise provoked by the derivation is reduced by the smoothing through the adjacent segments. 
The difficulty in derivation is the choice of the spectral segment size. If the segment is too small the 
smoothing will have nearly no effect. If it is too big smoothing will be too strong and spectral information 
gets lost and artefacts are created. 
 
 
7.2.2.4 Multivariate Analysis
28
 
 
Principal Component Analysis - PCA  
 
Principal Component Analysis is a descriptive method which permits to model a single data set, so as to 
find the underlying structure of the data, study the correlation between variables, describe the objects 
according to summary variables, detect outliers or extreme observations, etc. Sample patterns, such as 
particular groupings, can be observed and useful information identified – as opposed to noise or 
meaningless variation. 
 
Every sample in a data set defined by n variables can be represented as a point in a n-dimensional space. 
Thus, the data set is a swarm of data-points in this space and presents a general shape (Fig 75, ). The 
idea of PCA is to reduce the n variables to a few number of principal components (PC) containing the 
maximum variation (which is information) characterising the data set. First, the origin of the variable space 
is translated to the centre of the swarm of points (the average of each variable Xi is subtracted from the 
value of Xi for each observation). The first PC is then chosen by drawing a line through the cloud of data-
                                                     
28 (Reich, 2005; Schneider, 2002; Röseler, 2004; CAMO, 2001; Massart, 1988) 
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points in such a way that variation is maximum along the line and minimum around it (Fig 75, ). This 
means that the line is directed more or less the maximal elongation of the cloud of points.  
 
 
     
 
Fig 75 – Data set described by three variables and determination of the first PC. (CAMO, 2005) 
 
 
The second PC is chosen in the same way, by considering the plane orthogonal to PC1 and choosing the 
direction with maximum spread around it (Fig 76, ).  
 
Every new PC is representing the maximum variance of the residual information (not taken into account by 
the previous PCs – Fig 76, ). This can go on until as many PCs have been computed as there are 
variables in the data table. It is important to find a compromise in the number of PCs since only the first 
ones contain useful information and the latter ones most likely describe noise. A model with a high number 
of PCs is often more complex and less robust. 
 
 
      
 
Fig 76 – Determination of the second and third PC. (CAMO, 2005) 
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Each component of a PCA model is characterised by three complementary sets of attributes : 
 
- Scores show how the samples are distributed, any specific patterns in the data, and which 
objects are close to each other. 
- Loadings reflect how the original variables are taken into account on each projection (PC). 
The loading plot shows which variables are important and how variables are correlated. 
- Variances are error measures and show how much of the information contained in the data 
set is actually taken into account by the model. 
 
 
Partial Least Squares - PLS 
 
PLS is a regression method, a term for all methods attempting to fit a model to observed data in order to 
quantify the relationship between two groups of variables. The purpose of the method is  
 
1) to describe the relationship between a set of predictors (X-matrix) and a set of responses (Y-
matrix). The mathematical form of this relationship is called a model. 
 
 
 
2) to predict new values, for which only the X-values are known.  
 
 
 
 
Just like PCA the PLS regression is based on projection principles. Partial Least Squares – or Projection 
of Latent Structures – models both the X- and Y-matrix simultaneously to find the latent variables in X that 
will predict the latent variables in Y the best. The objective is to maximise the covariance between X and 
Y. The PLS components are similar to principal components and are therefore referred to as PCs. 
 
There are two versions of PLS algorithms – PLS1 only deals with one response variable at a time, 
whereas in PLS 2 several response variables are modelled together. The PLS2 is a bit like a double PCA, 
with the additional constraint that the t- and u-scores – summarising sample differences in X and Y spaces 
– should be as correlated as possible. Since the PLS has to handle two matrices scores, loadings and 
variances will be in double. There are two additional attributes to consider : 
 
X-DATA + Y-DATA MODEL 
X-DATA + Y-DATA MODEL 
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- Loading weights show how much each X-variable contributes to explain the Y-variations, and 
therefore exists only for the X-variables. 
- B-coefficients are specific to regression methods and are also called regression coefficients. 
The PLS model can be written in an equation that summarises how each response variable is 
related to the set of predictors. 
 
 
 
 
 
7.2.3 Practical Work 
 
7.2.3.1 Instrumentation 
 
Analyses were realized on a FOSS SmartProbe™ Analyzer 6500, equipped with a monochromator for 400 
- 2500nm coverage and a SmartProbe module with integrated detector and a 3 meter optic interactance 
fibre bundle. The spectra were recorded in diffuse reflection mode in the full range coverage (400 – 
2500nm) and at 2nm intervals. Individual spectra were determined as averages of 32 scans. A ceramic 
standard served as reference. 
 
 
7.2.3.2 Procedure 
 
a) Cellulose/lactose standards – Free samples could be obtained from 22 suppliers. The 25 cellulose and 
23 lactose samples are listed below (Table 28 and Table 29). In the beginning all samples were analysed 
as powders directly in their containers. Then some samples were selected for compression in order to 
verify if there would be a great difference in the NIR spectra. As this turned out to be the case, all samples 
were compressed and then measured partly as whole tablet (10 measures on every side), partly as 
crushed powder (10 measures). 
 
 
 
 
 
 
 
 
 
 
 
Y = B0 + B1X1 + B2X2 + … +BNXN 
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Supplier Product name Composition 
Acros 
 
Carboxymethyl cellulose Sodium salt 
Ethyl cellulose 
Hydroxypropyl cellulose 
Methyl cellulose 
Asahi Kasei Ceolus Microcrystalline cellulose 
Blanver Microcel MC-101 Microcrystalline cellulose 
CFF Sanacel Pharma 90 
Qualicel 90 
powdered cellulose  
Cellulose 
Colorcon Methocel E-50 
Methocel A15 
Hydroxypropylmethylcellulose 
Methyl cellulose 
DMV Primellose Na cross-linked carboxymethyl cellulose 
FMC Avicel 102 Microcrystalline cellulose 
Fluka Avicel 101 Microcrystalline cellulose 
Merck*  Microcrystalline cellulose 
JRS Pharma Vivapur101 Microcrystalline cellulose 
Nisso Nisso-HPC Hydroxypropyl celllulose 
Noviant ZSB 16 
Nymcel ZSX 
Sodium Carboxymethylcellulose 
Crosslinked Sodium Carboxymethylcellulose 
NP Pharm Ethispheres 250 Microcrystalline cellulose 
Shin-Etsu LHPC11 
LHPCb1 
Metolose60SH 
MetoloseSM 
Pharmacoat 
Low-Substituted Hydroxypropyl Cellulose 
Low-Substituted Hydroxypropyl Cellulose 
Hydroxypropylmethylcellulose 
Methyl cellulose 
Hydroxypropylmethylcellulose 
Wolff Cellulosics Walocel CRT 15000 PPA Sodium Carboxymethylcellulose 
*the sample was not sent by Merck but obtained in a local drugstore 
Table 28 – List of obtained cellulose samples with their commercial and chemical name. 
 
 
Beforehand, measuring conditions had to be tuned in order to get reproducible results. Test measures 
included varying pressure, amount of powder, as well as measures on whole tablets and crushed tablets. 
Pressure did not have much influence, but so did quantity and stability of the probe. Thus, stable 
conditions were fixed for the continuation of the project. 
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Supplier Product Name Composition 
Acros  Lactose monohydrate 
BASF Ludipress 
Ludipress LCE 
Lactose Mh (93%), povidone (3.5%), crospovidone (3.5%) 
Lactose Mh (96.5%) and povidone (3.5%) 
Borculo Domo Lactopress Spray-Dried 
Lactopress Anhydrous 
Lactochem 
Lactochem Crystals 
Lactose Monohydrate + 15% amorphous lactose 
Anhydrous lactose  
Lactose Monohydrate 
Lactose Monohydrate 
DMV Pharmatose DCL 14 
Pharmatose DCL 21 
Pharmatose DCL 22 
Lactose Monohydrate spray-dried 
Anhydrous lactose  
Anhydrous lactose  
Fisher  Lactose monohydrate 
JT Baker - Mallinkrodt 
Baker 
Lactose Lactose monohydrate 
Lactose New Zealand Super-Tab Spray-Dried Lactose Monohydrate 
Meggle GranuLac 70 
Tablettose 80 
FlowLac 100 
Cellactose 80 
MicroceLac 100 
 
StarLac 
Lactose monohydrate 
Lactose monohydrate 
Lactose monohydrate 
75% lactose monohydrate + 25% cellulose 
75% lactose monohydrate + 25% microcrystalline 
cellulose 
85% lactose monohydrate + 15% maize starch 
Kerry Bio-Science Impalpable Lactose 
Anhydrous 60M Lactose 
Lactose, Anhyd, DT NF 
Lactose monohydrate 
Anhydrous lactose 
Anhydrous lactose  
Sigma   Beta-lactose 
Table 29 – List of obtained lactose samples with their commercial and chemical name. 
 
 
 
b) Amphetamine blends – In order to study the possibilities of NIR technique to analyse substances such 
as found in illicit tablets, six cellulose and seven lactose standards were chosen to make mixtures with 
amphetamine at three purities (5, 10 and 15%). Amphetamine has been chosen as it was available in 
large quantity. The selected standards are listed in Table 30. 
 
All the mixtures were homogenised in an agate mortar before analysis. Four mixtures were taken for 
compression – 3, 6, 10 and 11 – and analysed as solid form and crushed. 
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1 - CFF Sanacel 90 7 - Borculo Domo Lactopress Anhydrous 
2 - Colorcon Methylcellulose 8 - Borculo Domo Lactopress Spray-Dried 
3 - FMC Avicel 102 9 - DMV Pharmatose DCL 14 
4 - Blanver Microcel MC-101 10 - DMV Pharmatose DCL 21 
5 - Shin-Etsu Metolose SM 11 - Meggle FlowLac 100 
6 - JRS Vivapur 101 12 - Kerry Anhydrous Lactose Direct Compression 
 13 - Lactose New Zealand 
Table 30 – Selected cellulose (1-6) and lactose (7-13) samples for amphetamine blends. 
 
 
 
c) Ecstasy – 39 ecstasy tablets from 35 seizures were analysed with the aim to determine the excipient 
and to check them against each other. The configuration of the instrument did not allow analysing them in 
their solid form, the surface of the tablets being smaller than the surface of the probe. Thus, they were 
homogenised in agate mortar before analysis. Five measures were taken for every tablet and care was 
taken that the powder was regularly shaken in order to vary particle disposition. 
 
 
 
7.2.3.3 Software 
 
Vision© 
 
Vision© is a software package specifically designed for use with the FOSS NIRSystems and is delivered 
with the NIR instrument. It was developed for NIR spectral acquisition, method development and routine 
analysis for the pharmaceutical and chemical application. Thus, it controls the instrument and allows 
further treatment of the spectra. Several math treatments have been included for the construction of a 
database and characterization / identification of analysed substances. It was used for the acquisition of the 
spectra and first observations after having applied pre-treatments, such as SNV and derivations.  
 
 
The Unscrambler© 
 
The Unscrambler© is a software developed by Camo, Norway, and is designed for multivariate analysis.  
It offers a selection of common pre-treatments, which can be followed by explorative analysis (PCA, 
Descriptive statistics). Quantitative models can be built by different types of regression analysis (PLS1, 
PLS2, PCR, MLR) and used for prediction of responses of new samples. Furthermore, it proposes 
methods for classification (SIMCA) and experimental design (ANOVA, Response surface analysis). Data 
could be directly imported from Vision software by using NSAS files. All treatments of spectra have been 
realised with The Unscrambler©.  
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7.2.4 Results  
 
It has to be kept in mind that this project was an additional research, completing the main work about 
sugar and fatty acids, and therefore data analysis has not gone that far as it would have in a more 
consequent study. What will be presented hereafter is not only the answer to the exposed questions, but 
is also meant to give an idea of what can be done in the given context. 
 
 
a) Cellulose / Lactose standards 
 
Differentiation of chemical form 
 
In the case of cellulose, seven different forms have been analysed by NIR. The raw spectra are shown in 
Fig 77. Since the names of the different types are rather long, abbreviations have been used and will also 
be applied here in this report. The abbreviations used were the following : 
 
Cell = Microcrystalline cellulose LHPC = Low-Substituted Hydroxypropyl Cellulose 
CMC = Carboxylmethylcellulose HPMC = Hydroxypropylmethylcellulose 
EC = Ethylcellulose MC = Methylcellulose 
HPC = Hydroxypropylcellulose  
 
 
They can be visually differentiated, but show in some cases a similar shape. The spectra of HPMC and 
MC, for example, are very close and it would be impossible to determine the type when seeing the 
spectrum of each alone. 
 
 
 
Fig 77 – Chemical forms of cellulose – Blue (1)=microcrystalline cellulose, Red (2) = Carboxylmethylcellulose, Dark  
Green (3) = Ethylcellulose, Orange (4) = Hydroxypropylcellulose, Brown (5) = Hydroxypropylmethylcellulose, Clear 
Green (6) = Low-Substituted Hydroxypropyl Cellulose, Pink (7) = Methylcellulose. 
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However, it has to be evaluated to what extent variations observed on NIR spectra are significant. Visually 
this can be done by considering in the beginning the variation for one standard. For that purpose thirty 
measures per sample have been taken and it can be seen on the two pictures below (Fig 78) that the 
variation can be very different depending on the sample.  
 
 
  
Fig 78 – 30 measures of standard FMC microcrystalline cellulose (on the left) and Acros CMC (on the right). 
 
 
But it has to be said that the example on the right (Acros) was more an exception, and generally the 
spectra for one standard were very close already on the raw spectra. Additionally, when considering the 
spectra as such, it is recommended to apply a noice-reducing pre-processing method, such as SNV. The 
importance of the treatments of spectra has been explained earlier in this chapter, but it was realised 
during the observation of these standards that a variation detected after e.g. SNV may indicate a real 
difference between samples. Fig 79 is showing an example of the SNV treated thirty spectra of 
microcrystalline cellulose produced by FMC and one originating from NPPharm – the difference is well 
visible. 
 
 
 
Fig 79 – FMC cellulose standard (30 measures) with one measure of the NPPharm cellulose (dark blue). 
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Later, we will see that the differentiation between producers is not that easy. One of the reasons is that 
what appears here as a visible difference is principally due to varying intensities – the general curve shape 
(minima, maximum, slopes) is very similar.  
 
Altogether, the visual comparison of the spectra is good and necessary in the beginning, but very tiresome 
when the mass of data is getting larger. And as the Vision© software was also designed to create 
databases, which would then be applied in routine to quickly identify the analysed substance, it was 
decided to test the automatic recognition of our samples. The work was started on Vision©, but due to 
software problems, all data treatments have been done with The Unscrambler©. 
 
The first aim was to determine a data pre-processing method and appropriate wavelength selection that 
produces a PCA model separating the seven types of cellulose. The mean spectra of all powdered and 
compressed standards have been imported to The Unscrambler© and various pre-processing methods 
(Yoon et al, 2004; Schneider, 2002; Röseler, 2004; Roggo et al, 2005; Krämer and Ebel, 2000; Chalus et 
al, 2005; Brigger et al, 2000) have been tested – they are all listed in Appendix XII. In general, all PCA 
analyses were first applied on the whole spectrum range (1100 to 2300nm), but often a wavelength 
selection was applied as well. The principal reason was to avoid the influence of water which has strong 
overtones in the 1450 and 1930nm region (Yoon et al, 2004; Schneider, 2002; Rantanen et al, 2000; 
Bakeev, 2003). Later it would also be used to select a region that seems particular for a substance. 
 
 
 
Fig 80 – PCA after pre-processing method New2 (Appendix XII) of the seven cellulose groups. 
 
 
It appeared that complete separation was made difficult by two couples – HPMC/MC as expected, but also 
CMC and Cell. It can be seen on the figure above that the respective cellulose types are close (Fig 80). 
But as it seemed to be possible to differentiate the seven groups, the pre-processing method was used to 
create a PLS1 model. The x-variables were the chosen wavelengths of the standard spectra and the y-
variable to predict was a series of numbers standing for the corresponding type of cellulose. Only four of 
the seven cellulose forms were used for this work – Cell, CMC, HPMC and MC – because only a few 
samples were available for the others. The regression plot of the created model is shown in Fig 81. The 
model was tested with 21 randomly chosen spectra which have been all correctly identified. 
EC HPC 
HPMC 
MC 
LHPC 
Cell 
CMC 
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Microcrystalline C. 1 
CMC 2 
HPMC 3 
MC 4 
 
Fig 81 – Predicted vs measured 
regression plot for the prediction of the 
cellulose types. 
 
 
 
 
It has been mentioned sooner that the data analysis has been started on Vision©. Indeed, a database for 
the cellulose standards could be created and several mathematical treatments have been tested. To verify 
the quality of the database, samples were analysed just like in routine in order to see if they were correctly 
identified - most of them were not. The obtained spectra of these 28 samples were taken now to test the 
PLS model and the result is presented in Fig 82. 
 
 
 
Fig 82 – Prediction results for samples non-identified by the Vision© database. 
 
 
All spectra were correctly predicted. For each sample a deviation is given which expresses how similar the 
prediction sample is to the calibration samples used when building the model. The more similar, the 
smaller the deviation. The average deviation for these samples is 0.13. 
 
Concerning the lactose samples, only three types had to be differentiated – lactose monohydrate, 
anhydrous lactose and the blends (Ludipress, LudipressLCE, Cellactose, MicroceLac, StarLac). The raw 
spectra of three standards are shown in Fig 83. The same observations than those for cellulose are valid 
concerning the comparison of the spectra and will not be detailed again.  
 
Abbreviations have also been used for the lactose samples and will be applied here : 
LacMh = lactose monohydrate  AnhLac = anhydrous lactose 
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Fig 83 – Chemical forms of lactose – Red = Lactose monohydrate, Green = Anhydrous lactose and Blue = CelLactose 
(a blend of cellulose and lactose monohydrate). 
 
 
Even though the spectra are not very different they could be easily separated. The spectra have also been 
treated for PCA analysis and lactose monohydrate and anhydrous lactose were already separated by 
using the raw spectra. However, to differentiate the blends from the lactose monohydrate pre-processing 
of the data and wavelength selection was necessary. 
 
 
  
Fig 84 – On the left : PCA after pre-processing method Roggo (Annexe XII) – on the right : prediction results for non-
identified lactose samples applying a PLS1 model after pre-processing method Roggo. 
 
 
It can be seen in Fig 84 that PCA analysis achieves separation of the three groups. The blends are not 
surprisingly a little dispersed and those with the highest lactose monohydrate content are very close to the 
pure standards. The few red spots at one side of the lactose monohydrate group are samples being spray-
dried. Thus, it is the same compound (Lac Mh) but produced differently. Prediction of the non-identified 
samples by Vision© was attempted as well, using the same pre-processing method than for the PCA 
analysis. The result, at the right in the figure above, shows a clear separation between the two types of 
lactose and spectra were also correctly identified with an average deviation of 0.04. 
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Differentiation of producers 
 
This part was carried out with spectra from cellulose, powdered and microcrystalline cellulose 
(Abbreviation - Cell), because this is the chemical form the most often used as excipient and the most 
likely to be found in ecstasy tablets. It can be seen on Fig 85 that the samples can not be distinguished 
visually apart from the two powdered cellulose standards (CFFSan and CFFQual). 
 
 
 
Fig 85 – SNV treated spectra of the ten cellulose standards. 
 
 
For each standard, compressed and powdered, fifteen spectra were imported to the software in order to 
test PCA analysis preceded by the various pre-processing methods (Annexe XII). The result appeared to 
be rather complex – the spectra being almost identical very small differences would make out the grouping 
by PCA. Thus, the first observation was that each standard formed little subgroups and the reason for that 
was not clear. One factor having certainly a great influence was the compression. For the same standard 
the measures after compression were differentiated from those before compression. 
 
 
  
Fig 86 – PCA of Cell standards after pre-processing method New2. 
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The two pictures above (Fig 86) show the same PCA – on the left samples have been coloured in function 
of compressed / non-compressed, on the right side the sample identity is highlighted. It was then decided 
to consider the compressed and non-compressed spectra separately and it appeared that different 
producers could indeed be differentiated, but only using the measures of the powdered samples (Fig 87, 
right). 
 
 
  
Fig 87 – PCA of Cell Standards after pre-processing method Roggo – on the left PCA of compressed standards, on 
the right PCA of non-compressed standards. 
 
 
Since this is a sort of exploratory research in the context of ecstasy analysis, differentiation after 
compression was much more important. Considering the PCA of the measures taken from tablets (Fig 87, 
left), the situation is similar to the beginning in the sense that again subgroups are present. It appeared 
that these could be explained by the different way of measuring – on the tablet surface or the crushed 
powder. The result is that many small groups of 4-5 measures are formed and superpose. An important 
conclusion that can be drawn is the importance of being coherent in sample measuring and processing. If 
the same PCA would be carried out but with spectra produced in exactly the same conditions the groups 
would separated, as can be seen in Fig 88 . 
 
 
 
  
Fig 88 – Left : PCA of compressed Cell standards after pre-processing method Roggo; Right : PCA of compressed 
LacMh standards after pre-processing method New2. 
 
 
 Additional Studies 136 
 
Only measures of crushed tablets have been taken for this PCA. Spectra could almost all be separated in 
function of their producer, except Ceolus and Vivapur (surrounded by the red circle – Fig 88). The 
samples that still form subgroups are those where measures have been made on two crushed tablets. The 
same kind of observations was made with the lactose monohydrate standards where it was also 
attempted to separate the different origins. Again, a test with measures taken in the same conditions did 
not show such a neat separation than in the case of cellulose, but the different groups are not overlapping 
(Fig 88, on the right). 
 
The data analysis of the cellulose and lactose has been stopped here. It has been shown that 
differentiation of the producers is possible, however under very strict conditions. It has to be reminded that 
the work was carried out with standard samples directly obtained from the producer – a situation far from 
"ecstasy reality". Ecstasies are compressed blends, maybe not very complex blends, but still complex 
enough not to allow such a specific differentiation. For the determination of the chemical form of the 
excipient alone it would be necessary to proceed to an extraction. But the results are still very interesting 
as they show that small differences can be detected. 
 
 
b) Amphetamine blends 
 
Five spectra per concentration have been imported for the evaluation of the amphetamine blends – this 
means fifteen spectra per excipient resulting in 255 spectra altogether. Before starting any data analysis 
spectra have been compared in order to see if the change in concentration could be detected, if it was 
regular and in what wavelength region it could be observed. In Fig 89 the three blends of CFFSanacel are 
shown in the wavelength section where the changes were the most obvious. The three groups can be 
easily distinguished. Changes due to the concentration could also be observed in other wavelength 
regions, such as around 1140nm and 2200nm, but were less visible. 
 
 
 
Fig 89 – Amphetamine blends with CFFSanacel in the region between 1400 and 1800nm (after SNV treatment). 
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Considering these encouraging observations it was decided to test PCA analysis and even PLS 
prediction. The question of prediction of illicit substance content in ecstasy has been thoroughly studied by 
Sondermann (1999) and (Schneider, 2002), who have shown that good prediction is possible. It was 
therefore tested on our amphetamine blends. Additionally, the identification of the excipient was attempted 
as well. 
 
The various pre-processing methods were tested for PCA classification to insure good separation of the 
four types of excipients used and simultaneously of the three concentrations prepared. This was achieved 
after wavelength selection of the three interesting regions and the results are shown in Fig 90. The four 
different types of excipients – microcrystalline cellulose, methylcellulose, lactose monohydrate and 
anhydrous lactose – are very well separated. And inside of each group the three prepared concentrations 
can be distinguished.  
 
 
  
Fig 90 – PCA of amphetamine blends after pre-processing method New2 – highlighting the type of excipient on the 
left, and the concentration on the right. 
 
 
The pre-processing method applied for the PCA analyses above and three others giving similar results 
have been tested for the creation of a PLS2 model. Additionally, the sample set was completed by 
remaining spectra not imported in the beginning, so that 390 spectra could be used for this model. Again, 
for the x-variables the selected wavelengths have been chosen (1120-1160, 1458-1740 and 2100-
2300nm), and for the y-variables a series of numbers standing for the corresponding excipient and the 
amphetamine concentrations expressed as percentage. 
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Fig 91 – PLS2 after pre-processing method New2 – Predicted vs measured regression plot for the amphetamine 
concentration on the left and the excipient on the right. 
 
 
In the figure above the predicted values for the amphetamine concentration and the identity of the 
excipient are plotted against the measured values (Fig 91). Slope and correlation should be near 1. As 
they were very high for both y-variables it was decided to test the model on a set of selected spectra 
representing the whole data set used for the construction of the model. The cross-validation mode was 
used for this prediction test. The results are represented in Table 31. 
 
 
 Amphetamine concentration  Excipient 
Sample Predicted Deviation Reference  Predicted Deviation Reference  
BDLactp3_5 15.96 0.78 15.11  3.99 0.12 4.00 Anh Lac 
BDLactp2_3 9.70 0.60 10.01  4.07 0.09 4.00 Anh Lac 
BDLactp1_1 4.89 0.80 5.00  4.14 0.13 4.00 Anh Lac 
BDLactpSD1 5.11 0.72 5.10  2.94 0.11 3.00 Lac Mh 
BDLactpSD3 14.32 0.70 15.00  3.00 0.11 3.00 Lac Mh 
BDLactpSD2 10.28 0.53 10.36  2.96 0.08 3.00 Lac Mh 
CFFSan90_3 12.37 1.43 15.09  1.28 0.22 1.00 Cellulose 
CFFSan90_2 9.92 1.24 10.17  1.19 0.19 1.00 Cellulose 
CFFSan90_1 4.18 1.54 4.91  1.16 0.24 1.00 Cellulose 
ColMC3_2 15.23 1.31 14.93  1.78 0.21 2.00 Methylcell 
ColMC2_3 10.29 0.64 9.87  1.93 0.10 2.00 Methylcell 
ColMC1_8 6.03 0.84 4.92  2.14 0.13 2.00 Methylcell 
DCL21_1_13C 4.03 1.47 4.99  4.19 0.23 4.00 Anh Lac 
DCL21_2_21C 9.28 1.43 10.45  4.11 0.22 4.00 Anh Lac 
DCL21_3_2C 14.66 1.27 14.93  3.91 0.20 4.00 Anh Lac 
FMC1_29C 5.00 0.87 5.14  0.85 0.14 1.00 Cellulose 
FMC2_15C 9.69 0.84 9.90  0.92 0.13 1.00 Cellulose 
FMC3_11C 14.63 0.90 14.92  0.99 0.14 1.00 Cellulose 
FlowLac1_8C 5.04 0.76 5.18  2.86 0.12 3.00 Lac Mh 
FlowLac2_23C 8.81 0.81 9.96  2.87 0.13 3.00 Lac Mh 
FlowLac3_15C 12.97 1.13 15.06  2.90 0.18 3.00 Lac Mh 
Table 31 – Prediction results for the concentration of amphetamine and the type of excipients in amphetamine blends. 
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All data were correctly attributed to the corresponding sample. However, the average deviation for 
amphetamine concentration is 0.98 and higher than for the prediction of the excipient which is 0.15. Thus, 
prediction may not be perfect yet, but rather good for a first attempt and without further optimisation. The 
tests were certainly carried out with simple mixtures – real tablets contain more than the active substance 
and an excipient – but the results are promising. To obtain a more reliable prediction model, blends with 
more components and a wider range of concentrations should used. Additionally, data processing can 
surely be optimised. In conclusion, the results were good enough to show the potential of NIR analysis of 
tablets in combination with an appropriate data processing tool. It is an interesting alternative to routine 
GC analysis considering that the technique does not require any sample preparation and results are 
obtained very quickly. 
 
 
c) Ecstasy 
 
Excipient identification 
 
In the beginning the ecstasy tablets have been analysed by NIR in order to verify if they contain cellulose. 
Therefore only seizures with no or little excipient detected by GC-MS have been used for this work. It 
appeared that the identification of the excipient was not that easy. Considering the principle of NIR 
analysis we know that the spectrum reflects the absorbance in function of the various functional groups 
(Fig 73, schema overtones), which means that substances with similar chemical structures will absorb in 
similar wavelength regions. Blends will therefore present spectra of superposing absorptions and 
compounds might only be recognised if they have a particular functional group. 
 
That explains why MDMA is generally recognised in our tablets, however, no comparison could be made 
to similar substances such as MDE, or MDA. On the other hand, chemical structures of cellulose and 
sugars are the same. In our case we knew beforehand if sugars were present, which was very useful in 
the evaluation of the spectra. The example shown in Fig 92 was an easy case: the shape of the curve was 
very similar to the cellulose standard.  
 
 
 
Fig 92 – SNV treated spectra of ecstasy sample 1002 (red) and a standard of microcrystalline cellulose (FMC – blue). 
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But another example shows a more complicated picture (Fig 93). When considering the spectrum without 
knowing the result of GC-MS analysis, the curve shape would make think of anhydrous lactose rather than 
cellulose.  
 
 
 
 
Fig 93 – SNV treated spectra of ecstasy sample Z60 (green), a standard of anhydrous lactose (KerryDT – red) and a 
standard of microcrystalline cellulose (FMC – blue). 
 
 
Thus, what appeared to be the problem was to decide if there was one excipient or a mixture. And as was 
explained before, curve shapes in mixtures are different from that of a substance alone. And no tests 
could be made to verify how the mixture spectrum changes in function of the excipient content (cellulose 
alone, cellulose/lactose, lactose alone). From the results of GC-MS analysis it appeared that no 
anhydrous lactose was present in that tablet, but lactose monohydrate and therefore the additional 
presence of cellulose was very likely. (Fig 94) 
 
 
 
 
Fig 94 – SNV treated spectra of ecstasy sample Z60 (green), a standard of lactose monohydrate (FlowLac – red) and 
a standard of microcrystalline cellulose (FMC – blue). 
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However, in the cases where anhydrous lactose was detected by GC-MS, nothing could be said about the 
eventual presence of cellulose since the curve does not permit any conclusions. Finally, some cases were 
observed where nothing at all could be said. That means, no excipient could be determined apart from a 
likely presence of talc. (Fig 95) 
 
 
 
Fig 95 – Raw spectra of ecstasy sample 1303 (green), a standard of talc (red) and a standard of MDMA (blue). 
 
 
No good explanation could be found for the absorbance in the section between 1450 and 1650nm. The 
curve shape reminds the blend of lactose monohydrate and cellulose seen before, the presence of sugars 
could however be excluded, and cellulose alone would present another form. Inorganic excipients might 
be present because the absorbance in this region is not high and these do not present notable 
absorbance. Starch could be excluded, due to the curve shape that did not correspond. The MDMA 
content of the concerned tablets is either 40, or 60%. Therefore, another substance must be present next 
to talc, as its absorbance does not seem high enough to explain 40-60% content in each tablet. 
Unfortunately, it was impossible to determine what compound that could be. 
 
The excipient composition determined after GC-MS and NIR analysis are presented in Table 32. In the 
NIR column those substances detected in addition to those noted under GC-MS are mentioned. Lactose 
monohydrate was pointed out in cases such as presented in Fig 94 (Z60). 
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Sample MDMA content GC-MS NIR 
1002 26% Mg Stearate Cellulose 
1003 29% Lac Mh, Mg Stearate Cellulose 
1061 27% Mg Stearate Cellulose 
1079B 29% Mg Stearate Cellulose 
1112G 38% Anh Lac, Mg Stearate Talc 
1207 59% Mg Stearate Talc 
1303 42%  Talc 
1304A 28% Mg Stearate Cellulose 
1304C 41%   Talc 
1305 37%  Talc 
1306B 36%  Talc 
1306C 34% Lac Mh Talc 
1306D 37%  Talc 
1310A 29% Mg Stearate Cellulose 
1327 27% Mg Stearate Cellulose 
1473A 36% Sorbitol, Mg Stearate Sorbitol 
1494D 30% Mg Stearate Cellulose 
1498 41% Lac Mh, Mg Stearate Cellulose, Lac Mh 
1524 37% Mg Stearate Cellulose 
1528 34% Mg Stearate Cellulose 
1619A 43% Lac Mh, Mg Stearate Cellulose, Lac Mh 
1683 31% Mg Stearate Cellulose 
1693 28% Mg Stearate Cellulose 
760 32% Anh Lac, Mg Stearate  
788 36% Anh Lac, Mg Stearate  
814 32% Mg Stearate Cellulose 
831 32% Mg Stearate  
834 41% Sorbitol Talc 
949A  Lac Mh, Mg Stearate Cellulose 
949B   Cellulose 
954  Lac Mh, Mg Stearate  
985B 26% Mg Stearate Cellulose 
985C 29% Sorbitol, Mg Stearate  
Z14B 34% Anh Lac, Mg Stearate  
Z197  Mg Stearate Cellulose 
Z209  Mg Stearate Cellulose 
Z30 30% Mg Stearate Cellulose 
Z44 34% Mg Stearate Cellulose 
Z4A 36% Mg Stearate Cellulose 
Z60 27% Lac Mh, Mg Stearate Cellulose, Lac Mh 
Table 32 – Identification of excipients after GC-MS and NIR analysis. 
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Comparison of ecstasy samples 
 
The spectra of the different tablets were also compared simultaneously with each other in order to check 
out similarities. The spectra have been observed after SNV treatment and those that were identical or very 
similar were noted. They were grouped together and can be seen in Annexe XIII. An example is shown in 
Fig 96 of two tablets presenting different logos, but an identical spectrum.  
 
 
 
Fig 96 – SNV treated spectra of ecstasy sample 949B (blue) and Z30 (red). 
 
 
However, this visual comparison is tedious and difficult, since there is too much information to compare. 
Additional mathematical treatments are necessary to extract latent information. Therefore, the data has 
been imported to The Unscrambler© in order to test PCA analysis and to verify the groups formed after 
having applied pre-processing methods. 
 
 
 
Fig 97 – Extract of raw spectra of ecstasy sample 1494D – in blue the first measure and in red the second, two 
months later. 
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A particular mention has to be made for the wavelength selection. During spectra comparison a maximum 
has been observed at 2010nm in about 75% of the ecstasy tablets. Not only this maximum could not be 
explained by any of the standards, but additionally in two tablets, which were analysed twice in an interval 
of 2 months, it happened to appear only after the second analysis (Fig 97). This was not due to measuring 
conditions which were the same for all tablets and no apparent link existed with the date of analysis. 
 
Contacts at Bayer Healthcare suggested appearance of polymorphism often observed in excipients. 
However, in this case it was certainly not due to the excipients since the maximum was observed in 
tablets having different compositions. The only apparent common denominator for all concerned tablets 
was that they contained MDMA. Unfortunately, nothing is known about potential polymorphism of MDMA. 
However, substances show polymorphism under particular circumstances and the polymorphic forms are 
often not stable. Additionally, it does not seem to explain the sudden emergence in the two tablets 
analysed twice.  
 
Another suggestion was made by Prof Tony Moffat from the School of Pharmacy (University of London). 
He proposed either oxidation or hydrolysis of one of the compounds contained in the tablets to give a new 
compound that absorbs around 2010 which is where amines and amides absorb, or a loss of a solvent 
that reduces the background to give the appearance of an increase at 2010nm. The latter seems unlikely 
since the peak for some tablets was very high, too high in our opinion to be explained by a loss of solvent. 
The first suggestion cannot be verified, but might be possible. In any case, there seems to be a link to the 
concentration of MDMA as tablets with high content also show a very high peak, whereas tablets with 
lesser content present a smaller peak. This relationship is however not linear and only indicates a 
tendency. 
 
In conclusion, it was impossible to find an explanation for this maximum. And as it appeared to vary over 
the time and has therefore to be considered as unreliable for our purpose, the corresponding wavelength 
section has been excluded for the PCA analysis together with those corresponding to moisture. The 
various pre-processing methods applied also resulted in some variations with regard to the formed groups, 
but showed altogether the same tendency. Therefore only one PCA will be shown here in Fig 98. 
 
The groups formed by PCA are similar to those observed by visual comparison (Annexe XIII). However, 
nothing can be said about the significance of these similarities because there is not enough information 
available for a proper interpretation of the group formation. An interesting point is that most of the 
correspondences are observed in samples presenting the same physical and general chemical 
characteristics. Nevertheless no further conclusion about any tendency should be drawn from that, 
because of the very small sample size. 
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Fig 98 – PCA after pre-processing method Schneider, with at the top an overview and than below a zoom of a dense 
area. 
 
 
It was seen in the cellulose and lactose standard evaluation that already small differences might indicate 
difference in origin as well. However, ecstasy tablets are far from being standards. It can be supposed that 
the NIR spectra for tablets coming from one compression batch are rather variable. Nothing is known 
about this intravariability, therefore it is very difficult to judge how much spectral variance may allow 
deciding whether samples are linked or not. When comparing similarities obtained by NIR to the results 
obtained after GC-MS analysis, they were not so different. The problem in this comparison is that the 
three methods consider something different. The XTC method gives us information about the general 
composition, but does not take into account substances such as cellulose. The FA/sugar method focuses 
on two excipients and might therefore be considered as more specific than the XTC method. And finally, 
NIR analysis results in spectra representing the tablet blend as a whole taking into account all absorbing 
compounds. This results in complex spectra but is more representative for the tablet blend. 
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From this point of view NIR analysis seems to be an appropriate method for ecstasy profiling, but at the 
same time it is also the method where the least is known about intra- and intervariability of compression 
batches. Additionally, spectral changes would have to be studied thoroughly when working with blends. 
But it has to be reminded that profiling was not the purpose of this additional project and was therefore 
never considered when planning the work to realise. The possibility of profiling using NIR analysis only 
appeared when comparing the ecstasy spectra and discovering similarities to results obtained by GC-MS 
analysis. And it should therefore be mentioned here that this technique represents an interesting issue in 
the profiling problematic. 
 
 
 
 
 
8 FINAL REMARKS 
 
 
8.1 RESULTS OBTAINED BY EXCIPIENT ANALYSIS 
 
The purpose of this research was to study how the excipients present in ecstasy tablets could be exploited 
and how useful they would be in the establishment of links between seizures. To evaluate if the purpose 
has been fulfilled, the initial hypotheses should be considered. 
 
 
1) Similarities with pharmaceutical production 
 
The verification of this hypothesis was principally carried out by studying the relevant literature and 
evaluating qualitative data collected in the ecstasy database (IPS / WD Zürich). The knowledge acquired 
during this study is reported in Chapter 2 and Appendix I and II. It became obvious that considering the 
manufacture of tablets, even if simple, a minimum number of excipients are required and that 
consequently they should be present in all tablets. Furthermore, it was shown that the substances 
regularly found in illicit tablets correspond to commonly used excipients in pharmaceutical production. 
Finally, the schema, represented in Fig 99, elaborated by Europol after evaluation of data from seized 
clandestine laboratories shows us that illicit production is indeed very similar to pharmaceutical 
production. 
 
 
 
Fig 99 – Detailed procedure of ecstasy production (Europol, 2004). 
 
 
Tablets are solid products, a blend of various substances being compressed to a solid form which will not 
be modified anymore. Therefore, their composition does not change between the time of production and 
the seizure by the police. In the context of illicit tablet comparison, they appeared to present an obvious 
potential. Unfortunately, the study realised by Europol was not as extensive as to give us any information 
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about the use of excipients in illicit tablet production. The absence of this kind of information appeared to 
be problematic for the evaluation of the following hypotheses. 
 
 
2) Variation between producers 
 
It was shown in the theoretical part (cf. Ch – 2) that a recipe for an excipient mixture resulting in tablets of 
good quality is not so easily modified. Thus, producers will probably stick to one once they have found it. 
Consequently, compression batches for one producer should not considerably vary for the same recipe. 
However, we have seen that not very much is known about production habits in illicit tablet manufacture. 
Do different producers collaborate ? Do they exchange recipes ? Does everybody find out for himself ? 
etc. Probably, all of these situations can be observed in reality and it had to be evaluated what a variation 
detected by analytical means signifies and how significant it would be. 
 
It was shown that excipients can be of very different chemical nature and thus research has been 
focussed on two types of excipients, carbohydrates and stearates, which were known to be present in a 
great percentage of ecstasy tablets in our database (IPS-WD). Analytical methods were developed in 
order to obtain optimal information with regard to these two types of substances and applied to 109 
ecstasy samples.  
 
 
 
Fig 100 – Schema of illicit ecstasy production. 
 
 
Considering the schema above Fig 100, already presented in the initial hypotheses (cf. Ch - 1), we can 
observe three levels of possible variation between illicit tablet producers by using information provided by 
excipients: the nature of excipients (qualitative – a, b, x, y), their quantity (x1, y1, x2, y2) and their origin (a, 
x). Similarly to these three levels, the obtained data has been evaluated according to qualitative and semi-
quantitative criteria. Variation could be obtained with regard to the first two levels (the third not being 
intentionally considered), and the formation of groups of similar ecstasy samples was achieved. The 
variation obtained by excipient analysis was such that differentiation of illicit producers appeared to be 
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possible. However, some research about clandestine laboratories, as was specified in Chapter 6.2.1.4., 
and verification of homogeneity inside large compression batches should be carried out.  
 
Furthermore, the confirmation of variation between producers requires a larger sample set, if possible 
originating from large batches coming from known producers. This would be particularly interesting in 
producer countries such as the Netherlands. If such research was undertaken, a particular interest should 
be given to very frequent logos, such as Mitsubishi, Superman, Ferrari, etc. Data comparison showed that 
tablets with these logos often seem to generate a sort of standard composition profile showing little 
variation. This means that they often presented a similar composition, but still showed differences, big 
enough to differentiate them, but not so small to definitely group them. That might be due to the frequency 
of the logo. Being very popular it might be conceivable to find a common production procedure going 
around among producers. For a better appreciation of this kind of possibilities, knowledge about the 
variability inside a production batch and between different batches of these popular imprints would be very 
useful. 
 
Concerning the third level, the origin, fatty acid analysis resulted in such specific information that 
characteristic profiles could be observed; indicating that differentiation of stearate origin might be possible. 
However, this information is based on analysis of seized ecstasy tablets – it would be very interesting to 
investigate the fatty acid composition of stearates provided by different suppliers, and also that of other 
ecstasy batches.  
 
 
3) Possibility of classification by the use of excipients 
 
The hypothesis is not that much different from the second one – it goes a step further. The observed 
variation is used to form classes / or groups. It will be expressed by calculated intra- and inter-variability – 
the former meaning the variation inside a sample batch, and the latter that between sample batches. 
Classification will be achieved through similarity measures. In other words, the manual sample to sample 
comparison is replaced by automated comparison of every analysed sample with all others in the 
database. According to the result of the similarity measure, a sample will be attributed / or not to a class. 
 
This procedure implies the use of mathematical treatments and comparison methods. Several 
combinations have been tested in order to determine a comparison method giving a good separation 
between linked sample populations and non-linked sample populations. When this was achieved, the 
method has been applied to the whole data set and correlation values were obtained for all possible 
sample pairs. These values were evaluated by comparison to the groups determined as explained under 
the previous hypothesis and could be confirmed. This means that the same similarities were observed, 
and thus similar groups were formed. Consequently, the determined comparison method is applicable in 
this context with this type of data.  
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However, a great limitation to the result has to be mentioned inasmuch that this study was rather 
exploratory and the determined comparison method is only indicative, the sample set not being 
representative in terms of sample size. In no way it represents a final result, but can be strengthened or 
modified with extensive sample. Larger ecstasy batches should be analysed which would give a more 
realistic view of the intra- and inter-variability. 
 
Despite these limitations interesting information could be obtained. The samples being grouped together 
were evaluated according to their chemical similarities and the additional data from the database (physical 
characteristics and data coming from police investigations). The tablets grouped by the excipient content 
appeared to be very similar with regard to the physical characteristics as well. Thus, similar physical 
properties are indeed a first indicator of a possible relationship between two tablets. However, there also 
have been cases of physically similar tablets, but differentiated by their excipients. Therefore, no classes 
should be created on the basis of physical characteristics only, except when having the means to find a 
relationship towards the used press. Indeed, there is a type of comparison allowing the possible 
establishment of a link between an illicit tablet and the press used for its compression. The required visual 
comparison between the tablet surface and the suspected punches is at present exclusively carried out at 
the Bundeskriminalamt in Germany. (Dahlenburg, 2002b) It therefore represents an exception and this 
kind of information is normally not available (Fig 101). 
 
 
 
Fig 101 – Comparison of external tablet characteristics (picture taken from (Dahlenburg, 2002a)). 
 
 
Furthermore, it has been shown that particular care should be taken when grouping samples containing 
no detectable excipients (by GC). The absence of any data to compare makes them consequently 
identical from a chemical point of view. Thus, any other available information has to be taken into account 
before declaring them linked. 
 
Altogether, samples were considered as linked when they could not be differentiated by their excipient 
content and after verification that all other available information did not present any unexplainable 
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difference. Concerning the signification of this kind of link, theoretically it could be attributed to the blend 
before compression, as that is the moment when the chemical composition does not change anymore and 
according to Fig 100 slight variations between batches may subsist even for the same producer. Although 
the presence of some results supporting this theory, the lack of quantitative data and of information about 
homogeneity inside a blend makes such a specific link impossible.  
 
Alternatively, a link of this specificity might actually not be that interesting. Our evaluation of similarities 
has shown that sample groups formed by their excipient content rather indicate a link with regard to the 
producer. This is significant inasmuch that it relates tablets to the same clandestine laboratory. When 
considering Fig 100 from another point of view, a producer might make several tablet batches with similar 
excipient content (x1 ≈ x2 and y1 ≈ y2) and could thereby be characterised. And therefore, a link at this level 
is of high strategic interest.  
 
 
8.2 ADDITIONAL RESULTS 
 
It was explained earlier that the same samples were also analysed by the routine method, generally used 
for the screening of ecstasy tablets, as consequence of improvements in analytical sensitivity. The results 
of the ecstasy screening method appeared to show less variation than expected and should not be applied 
for sample comparison as such. The method was not modified or optimised; it was therefore difficult to 
estimate how reliable peak proportions and therefore similarities / differences were. The formed groups 
were for a good part similar to those formed by excipient analysis, but in many cases samples that were 
grouped by the excipients have been separated by the screening method which was considered as a loss 
of useful information. It might be advisable to investigate optimisation of the analytical method for the 
simultaneous detection of active substance and sugar content giving reliable and reproducible results. 
Detection of fatty acids might be included in this optimisation, but no such detailed information as obtained 
with the newly developed method could be obtained for the simple reason of great differences in quantity. 
For the moment, this can only be achieved through extraction or concentration of the stearates. 
 
 
Finally, the additional study on a NIR spectroscopy instrument gave very interesting results. It was shown 
that it was potentially possible to distinguish microcrystalline cellulose and lactose monohydrate standards 
from different suppliers. Although this was a very important observation, it could not be applied to ecstasy 
tablets as such, the differences used for the differentiation being so small, that they would probably not be 
detected after the extraction of the relevant substance. And it was seen that compression alone resulted in 
separate groups so that other actions such as extraction might result in a slightly different spectrum as 
well. 
 
In the context of ecstasy comparison, the problem had to be approached differently. The potential of the 
technique was obvious since already small differences could be detected. Its drawback, however, is the 
interpretation of spectra made of blends, as could be observed with the analyses of ecstasy tablets. NIR 
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might not be the most appropriate technique to determine chemical composition, but it could be very 
useful in comparison of illicit tablets, since it considers the ecstasy blend as a whole just as it comes out of 
the press. 
 
 
8.3 FURTHER RESEARCH 
 
The evaluation of the results of the two techniques applied in this project made appear that the obtained 
information is very complementary. It would be interesting to combine GC-MS and NIR by studying blends 
of MDMA, being the most frequent illicit substance, and common excipients – such as lactose, cellulose 
and Mg stearate – provided by different suppliers. The blends would be prepared by varying supplier and 
concentration of the different compounds. Then, they would be compressed and analysed by GC-MS and 
NIR. A first interesting point would be to verify if the same information is obtained by the two techniques in 
terms of similarity between samples and attribution of original supplier. Another approach would be like 
the one applied for the amphetamine blends analysed by NIR – to use the information from both 
techniques in order to predict the composition and origin. 
 
Another context which is not so far from the ecstasy problematic here presented is the investigation of 
counterfeit drugs and illicit trafficking of licensed drugs. The NIR technique is particularly appropriate for 
this sort of research and has already been applied in that sense. Several publications (Herkert et al, 2001; 
Yoon et al, 2004; Röseler, 2004; Rodionova et al, 2005; Westenberger et al, 2005) and presentations at 
the recent IAFS2005 (Moffat, 2005) confirm this interest.  
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8.4 CONCLUSION 
 
The aim of this research was to investigate how far information obtained by the analysis of the excipients 
in ecstasy tablets could be useful in the establishment of links between seizures. Two analytical methods 
have been developed in that sense and give detailed and reproducible results about the sugar and fatty 
acid content in tablets. It has been shown that variation in excipient content could be obtained, leading to 
the classification of the samples into groups. The variation observed between the groups was confirmed 
by the similarity values we obtained. The evaluation of these data gave rise to the conclusion that a high 
correlation in excipient content (corresponding to a low similarity value) indicates a link towards the tablet 
producer. However, we furthermore showed that it is important to consider all available information about 
the remaining characteristics of the tablets. This is even imperative when dealing with tablets where no 
excipient has been detected by GC-MS analysis. 
 
It has been shown that a link towards a producer can be of strategic importance as it might cover 
similarities between several compression batches represented by a high number of tablets distributed on 
the illicit market and all being related to the same production site. However, confirmation of these 
observations is required by realising further studies with a larger sample set including large seizures, if 
possible from known production sites. 
 
Furthermore, analysis of fatty acids appeared to give specific profiles which were useful for sample 
characterisation. It could even be imagined to use these profiles for the determination of suppliers / 
sources of stearates, after having studied possible differentiation with known products.  
 
Finally, the application of NIR spectroscopy on cellulose and lactose standards resulted in possible 
differentiation of suppliers for the cellulose standards, however not yet being applicable to ecstasy tablets 
as such. Then, prediction of amphetamine concentration and excipient type was demonstrated which 
might be very useful in routine ecstasy analysis. The possibility of illicit drug profiling using NIR analysis 
appeared during the comparison of ecstasy spectra and the detection of similarities to results obtained by 
GC-MS analysis. The two techniques being complementary, NIR represents an interesting issue in the 
profiling problematic. 
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APPENDIX I – TABLET MANUFACTURE 
 
 
PHARMACEUTICAL PRODUCTION16 
 
"Tablets are solid preparations. Each tablet contains one dosage of one or more active substances and is 
obtained by agglomerating through compression a constant volume of particles." (Le Hir, 1997) 
 
The tablet has gained much importance since its launching on the pharmaceutical market and is now the 
most used pharmaceutical dosage form. This can easily be explained by its advantages which are 
enumerated hereafter : 
 
- simple use : tablets have a small volume and are solid that makes them easy to handle in conditioning 
and transport manipulations, 
- easy and practical taking, 
- precise dosage per taking, 
- good conservation by dry and condensed environment, 
- particularly interesting dosage form for insoluble active substances, 
- low cost price thanks to large industrial production possibility, 
- the release of the active substance can largely be regulated or modified with the corresponding 
production / formulation techniques. 
 
There are few drawbacks, the most important being the tablet perfection. Indeed, if the production is not 
perfectly studied the tablets risk easy damage or bad disintegration in the alimentary canal.  
 
Tablet production can be divided into two principal phases : 
  
- the first consists in preparing the blend of the various substances which means the active substance/s 
and part of the excipients, 
- in the second the blend is compressed in order to obtain tablets. 
 
The quality of the tablets depends on both phases, but principally on the first one. In galenic two types of 
blend preparations are known – granulation and direct compression. Generally, granulation is the more 
widespread preparation. (Kummer, 1998) 
 
 
 
                                                     
16 (Bauer et al, 1999; Le Hir, 1997; Davies, 2001) 
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Blend preparation  
 
Granulation  
 
The purpose of this procedure is to modify the texture of the blend in order to increase its density so that it 
presents good flow properties and reduces presence of air between particles. Important presence of air 
might hamper the compression. Additionally, granulation helps to optimise surface properties, porosity, 
solubility and disintegration time with regard to bioavailability. The two granulation modes mostly used are 
wet granulation and dry granulation. 
 
The principal advantages of granulation over a simple powder blend are : 
 
- a better conservation of homogeneity in the powder blend, 
- a higher density, 
- a better fluidity, 
- and a better aptitude for compression. 
 
 
Direct compression 
 
It is possible to avoid the granulation step by proceeding to direct compression of powder blends thanks to 
excipients presenting the required characteristics which are the following : 
 
- a good compressibility, 
- a good fluidity, 
- disintegration properties, 
- lubricant properties, 
- reproducibility between batches, 
- high dissolving capacities, 
- and moderate cost. 
 
Thus, the concerned compounds are at the same time binder, diluent and even disintegrator. The blend 
has to fulfil three conditions – good plasticity, good flowability and absence of agglomerate formation. 
Some common excipients used for direct compression are : crystallised lactose (coarse), spray-dried 
lactose, anhydrous lactose, dextrates, microcrystalline cellulose, powdered cellulose, dicalcium 
phosphate, pre-gelatinised starch. (Kummer, 1998; Marquis, 2000) 
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Comparison 
 
The easier and more economic production mode of tablets is the direct compression as it does not require 
the additional step of granulation. However, manufacture conditions and excipient requirements as 
described above are difficult to handle. It only needs a small deviation in particle size / form of one of the 
blend compounds for the final tablets to be mechanically not resistant enough. For this reason, tablet 
production including granulation is often preferred, and more particularly including wet granulation as it is 
less problematic than the dry mode. 
 
 
Compression 
 
In the beginning compression took place on single punch machines. Later, almost exclusively rotary tablet 
machines were used.  
 
SINGLE PUNCH MACHINES – the most important parts of this machine are : 
 
- the die : generally with a vertical cylindrical hole (simplest case) – this part is immovable, 
- two mobile punches : the movements of the lower and upper punch are adjustable by an eccentric 
cam in order to determine amplitude and compression strength, 
- hopper and feed shoe : required for the die filling and the ejection of the tablet. The hopper is the 
powder reservoir. It is attached to the feed shoe which oscillates horizontally.  
 
Compression can be summarized in four principal phases (Fig 1): 
 
I. the feed shoe oscillates above the die, filling it with powder and moves away, 
II. the upper punch enters the die and compresses the powder, 
III. the upper punch is removed, and the lower punch rises in the die to eject the tablet, 
IV. ejection of the tablet by the feed shoe and filling of the die. 
 
 
 
Fig 1 – Compression steps on a single punch machine (Bauer et al, 1999). 
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For a single punch machine the output per hour is between 1500 to 6000 tablets depending on the 
machine. For rotary machines the number of tablets is increased per number of punch pairs. Simple rotary 
machine already reach an output per hour of 20000 to 50000 tablets which can still be increased. 
 
ROTARY TABLET MACHINES – on this machine the hopper and feed system is fixed and the rotating turret, 
corresponding to the die but with more than one hole and punch pair, is turning horizontally around its 
axis. The powder hopper is positioned above a feed frame that retains a powder bed above the dies when 
the lower punch is in the filling position. As the lower punches pass below the feed frame, they descend 
within the die into their lowest possible position. The powder is filled into the dies by the suction effect 
caused by their descent and gravity from the feed frame above. Then, the lower punches pass over a 
weight control cam which causes the punch to rise, ejecting some of the powder which is scraped off by 
the edge of the feed frame. Compression takes place when the upper and the lower punches pass 
between compression rollers. During compression the punches move together, in contrast to the single 
punch machine. Following compression, the upper punches are removed by the upper punch cam track 
and the lower punches pass over an ejection cam. Tablets are removed from the punch tip by a scraper 
blade positioned in the edge of the feed frame. The rotary tablet machine is represented schematically in 
Fig 2. 
 
 
Fig 2 – Tablet compression in a rotary machine (Le Hir, 1997). 
 
 
Commercial manufacture of tablets is performed almost exclusively on rotary tablet machines due to their 
higher output. Single punch machines are rarely seen, but might be used for small batches. They are less 
expensive, have a simpler mechanism and require only small amounts of material to produce tablets. 
 Appendix I 169 
 
Appearance 
 
The obtained tablets can be of various shapes, sizes and colours. The size is generally governed by the 
dosage. As for the shape, the most common is round, but can also be oval, squared, etc. Depending on 
the punches tablets are flat-faced, flat bevel-edged or concave. They might be given unique identity by 
marking the surface with a code. This can be achieved by printing or by compressing powder with 
punches that are embossed with the code, producing tablets with intagliations/logos. Colouring of tablets 
can be obtained either by incorporating a dye or pigment into the powder prior to compression or by 
applying a coloured coat to the tablet following compression. 
 
 
ILLICIT TABLET MANUFACTURE17 
 
An illicit tablet is first characterised by its mode of manufacture. The most common method is the one 
used in pharmaceutical industry – the compression of a powder or granules in a die between two punches. 
Similarly to licit production, compression can take place on a single punch machine with one pair of 
punches, or on a rotary machine with several pairs of punches. However, other modes of manufacture 
exist such as moulding which is an interesting alternative for a clandestine producer as it does not require 
expensive and heavy machinery. 
 
 
Moulded Tablets 
 
Moulded tablets are all produced in the same simple way. A blend of the active substance, an appropriate 
diluent and a small quantity of binder, sufficient to keep the tablet together, is prepared. The required 
material consists in an upper perforated metal plate and a lower plate with projecting pegs. The blend is 
moistened and pressed in the holes of the upper plate so that it is flush with the surface of the plate on 
both sides. The upper plate is then placed on the lower plate and the content of the holes is forced out by 
the pegs and let to dry. Although variation between moulded tablets is much higher than with machine-
compressed tablets, it is possible to produce tablets of identical diameter and thickness by using this 
technique. The drawback is its low production yield. Moulded tablets are principally used for LSD. 
 
 
Compressed Tablets 
 
Compressed tablets are not exclusively produced on machines. Simpler manual methods exist requiring 
little material. The simplest production mode encountered in illicit tablet manufacture is similar to the 
process used in the very beginning of tablet production. The material consists in a brass plate containing 
holes 10mm in diameter which is placed on an aluminium base plate. The holes are filled up with the 
                                                     
17(Gomm and Hughes, 1991) 
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blend to compress. The powder is tamped down with a steel punch and finally compressed by a hammer 
blow to the punch.  
 
Another example for hand compression of tablets uses a press that looks a bit like a corkscrew of 23cm 
length. The production is very slow as compression is obtained via a screw thread, resulting in the press 
to be dismantled each time to remove the tablet. However, illicit amphetamine and ephedrine tablet have 
both been produced in this way. 
 
Finally, illicit tablets are also produced with machines which might be of old design, originating from 
second-hand suppliers. However, a collection made by (Europol, 2004) concerning material found in 
clandestine laboratories showed that recent powerful machines were found as well. An example of a 
seized press is shown in Fig 3. 
 
 
 
 
Fig 3 – Rotary machine seized in a clandestine laboratory (Europol, 2004). 
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APPENDIX II – DESCRIPTION OF SOME COMMON EXCIPIENTS18 
 
Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Calcium 
carbonate 
Carbonic acid, calcium 
salt 
[471-34-1] 
CaCO3 100.09 
Tablet and 
capsule diluent, 
Therapeutic 
agent  
 
pH = 9.0 
(10% w/v 
aqueous 
dispersion) 
Decomposition at 
825°C 
Nearly insoluble in ethanol (95%) 
and water; solubility increases in 
presence of ammonium salts or 
CO2 , the presence of alkali 
hydroxides decreases solubility. 
Calcium 
phosphate, 
dibasic 
hydrate 
Dibasic calcium 
phosphate dihydrate 
[7789-77-7] 
CaHPO4•2H2O 172.09 
Tablet and 
capsule diluent 
Requires 
presence of a 
lubricant; coarse 
powder is used 
for direct 
compression 
pH = 7.4 ; 
(20% slurry 
of DI-TAB) 
Decomposition 
below 100°C with 
water loss 
Nearly insoluble in ethanol, ether 
and water; soluble in diluted 
acids 
Calcium 
phosphate, 
tribasic 
Is not a clearly defined 
chemical entity, but a 
blend of Ca phosphates; 
Calcium hydroxide 
phosphate 
[12167-74-7] 
Tricalcium 
orthophosphate 
[7758-87-4] 
Ca3(PO4)2 
Ca5(OH)(PO4)3 
310.20 
502.32 
Anticaking 
agent, glidant, 
tablet and 
capsule diluent 
Requires the 
presence of a 
lubricant and a 
disintegrator 
pH = 6.8 ; 
(20% slurry 
of TRI-TAB) 
1670°C 
Nearly insoluble in acetic acid 
and alcohols; slightly soluble in 
water; soluble in diluted mineral 
acids  
                                                     
18 (USP25, 2001; Rhodes and Thornton, 1979; Kibbe, 2000) 
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Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Calcium 
sulphate 
Calcium sulphate 
[7778-18-9] 
Calcium sulphate 
dihydrate 
[10101-41-4] 
CaSO4 
CaSO4•2H2O 
136.14 
172.17 
Tablet and 
capsule diluent; 
anhydrous form 
is used as 
drying agent 
 
pH = 7.3 
(10% slurry) 
dihydrate 
form; 
pH = 10.4 
(10% slurry) 
anhydrous 
form 
1450°C 
anhydrous form 
For the dihydrate at 20°C : nearly 
insoluble ethanol (95%) ; 1 in 
375 in water ; 1 in 485 in water at 
100°C 
Calcium 
stearate 
Octadecanoic acid 
calcium salt 
[1592-23-0] 
C36H70CaO4 
USP : Ca 
compound 
composed of a 
blend of solid org. 
acids obtained 
from fats; consists 
in variable 
proportions of Ca 
stearate and Ca 
palmitate 
607.03 
(pure 
subst.) 
Tablet and 
capsule 
lubricant 
 
Acid value : 
191-203 
149 – 160°C 
Nearly insoluble ethanol (95%), 
ether and water 
Dextrin 
Dextrin  
[9004-53-9] 
(C6H10O5)n•xH2O (162.14)n 
Suspension 
agent, tablet 
binder, tablet 
and capsule 
diluent 
Dextrin is 
partially 
hydrolysed maize 
or potato starch 
  
Nearly insoluble in chloroform, 
ethanol (95%); ether and 2-
propanol; slowly soluble in cold 
water, very soluble in boiling 
water forming a mucilaginous 
solution. 
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Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Dextrose 
D-(+)-Glucose 
monohydrate 
[5996-10-1] 
C6H12O6•H2O 
198.17 
(for 
monohydr
ate) 
Tablet and 
capsule diluent, 
therapeutic 
agent, tonicity 
agent, 
sweetening 
agent 
Used as binder 
and diluent in 
direct 
compression, 
requires more 
lubricant than 
other diluents 
pH = 3.5-5.5 
(20% w/v 
aqueous 
solution) 
83°C 
20°C : nearly insoluble in 
chloroform and ether, 1 in 60 for 
ethanol (95%), 1 in 1 for water, 
soluble in glycerine 
Ethyl 
vanillin 
3-ethoxy-4-
hydroxybenzaldehyde 
[121-32-4] 
C9H10O3 166.18 
Aromatizing 
agent 
  
bp : 285°C 
mp : 76 - 78°C 
20°C : 1 in 2 for ethanol (95%); 1 
in 250 for water, 1 in 100 for 
water at 50°C; soluble in alkali 
hydroxyde solutions, chloroform, 
ether, glycerine et propylene 
glycol 
Glucose, 
liquid 
D-(+)-Glucose 
monohydrate 
[5996-10-1] 
Liquid glucose is a 
mixture of various 
compounds, 
principally of 
dextrose, dextrin 
and maltose. 
 
Coating agent, 
sweetening 
agent, tablet 
binder 
   
Miscible with water; partially 
miscible with ethanol (90%) 
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Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Lactose 
O-β-D-galactopyranosyl-
(14)-α-D-
glucopyranose 
anhydrous 
[63-42-3] 
O-β-D-galactopyranosyl-
(14)-α-D-
glucopyranose 
monohydrate 
[64044-51-5] 
C12H22O11 
C12H22O11•H2O 
342.30 
360.31 
Tablet and 
capsule diluent 
Lactose (spray-
dried) is used for 
direct 
compression.  
Can be combined 
with 
microcrystalline 
cellulose or 
starch and 
requires the 
presence of a 
lubricant. 
Incompatible with 
amphetamines. 
 
201-202°C for α-
lactose 
monohydrate 
 
223°C for 
anhydrous α-
lactose 
 
252.2°C for 
anhydrous β-
lactose  
25°C : nearly insoluble in 
chloroform, ethanol and ether; 1 
in 4.63 for water, 1 in 3.14 for 
water at 40°C, 1 in 2.04 for water 
at 50°C, 1 in 1.68 for water at 
60°C, 1 in 1.07 for water at 80°C 
Magnesium 
stearate 
Octadecanoic acid 
magnesium salt 
[557-04-0] 
C36H70MgO4 
USP : Mg 
compound 
composed of a 
blend of solid org. 
acids obtained 
from fats; consists 
in variable 
proportions of Mg 
stearate and Mg 
palmitate 
591.34 
Tablet and 
capsule 
lubricant 
Physical 
characteristics 
can vary between 
different 
suppliers, as they 
are influenced by 
manufacturing 
conditions. 
 
117-150°C 
(commercial 
samples) 
 
126-130°C (very 
pure Mg stearate) 
Nearly insoluble in ethanol 
(95%), ether and water; slightly 
soluble in benzene and warm 
ethanol (95%)  
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Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Maltose 
4-O-β-D-
galactopyranosyl-β-D-
glucopyranose 
anhydrous 
[69-79-4] 
4-O-β-D-
galactopyranosyl-β-D-
glucopyranose 
monohydrate 
[6363-53-7] 
C12H22O11 
C12H22O11•H2O 
342.31 
360.31 
Sweetening 
agent, tablet 
diluent 
Crystalline 
maltose is used 
in direct 
compression of 
tablets. 
pH = 4.5 – 
6.5 for an 
aqueous 
solution of 
10% 
102 - 103°C with 
decomposition 
Nearly insoluble in ether; very 
slightly soluble in cold ethanol 
(95%); very soluble in water 
Mannitol 
D-Mannitol 
[69-65-8] 
C6H14O6 182.17 
Sweetening 
agent, tablet 
and capsule 
diluent, tonicity 
agent, vehicle 
for lyophilised 
preparations 
Mannitol can be 
used in direct 
compression. 
Isomer of 
sorbitol. 
 166 - 168°C 
20°C : nearly insoluble in ether; 1 
in 100 for 2-propanol; 1 in 83 for 
ethanol (95%); 1 in 18 for 
glycerine; 1 in 5.5 for water; 
soluble in alkalis 
Sodium 
bicarbonate 
Carbonic acid 
monosodium salt 
[144-55-8] 
NaHCO3 84.01 
Alkalising 
agent, 
therapeutic 
agent  
 
pH = 8.3 for a 
freshly 
prepared 
aqueous 
solution 0.1M 
at 25°C 
270°C (with 
decomposition) 
20°C : nearly insoluble in ethanol 
(95%) and ether; 1 in 11 for 
water, 1 in 12 for water at 18°C, 
1 in 10 for water at 10°C, 1 in 4 
for water at 100°C 
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Name 
Chemical name, 
CAS 
Chemical 
Formula 
MW Application Particularities 
Acidity / 
Alkalinity 
Melting Point Solubility 
Sorbitol 
D-Glucitol 
[50-70-4] 
C6H14O6 182.17 
Humectant, 
plasticizer, 
sweetening 
agent, tablet 
and capsule 
diluent 
Sorbitol is used 
as diluent in 
tablet 
preparations after 
wet granulation 
or for direct 
compression. 
pH = 4.5 – 7 
for an 
aqueous 
solution 10% 
w/v 
110 – 112°C for 
the anhydrous 
form 
 
97.7°C for the 
polymorph V 
25°C : nearly insoluble in 
chloroform and ether; slightly 
soluble methanol; 1 in 25 for 
ethanol (95%), 1 in 8.3 for 
ethanol (82%), 1 in 2.1 for 
ethanol (62%), 1 in 1.4 for 
ethanol (41%), 1 in 1.2 for 
ethanol (20%), 1 in 1.14 for 
ethanol (11%) ; 1 in 0.5 for water 
Sucrose 
β-D-fructofyranosyl-α-D-
glucopyranoside 
[57-50-1] 
C12H22O11 342.30 
Base for 
medicated 
confectionery, 
granulating 
agent, sugar 
coating adjunct, 
suspending 
agent, 
sweetening 
agent, tablet 
and capsule 
diluent, 
viscosity-
increasing 
agent 
  
160 – 186°C (with 
decomposition) 
20°C : nearly insoluble in 
chloroform; 1 in 400for ethanol; 1 
in 170 for ethanol (95%); 1 in 
400 for 2-propanol; 1 in 0.5 for 
water and 1 in 0.2 for water at 
100°C 
Zinc 
stearate 
Octadecanoic acid zinc 
salt 
[557-05-1] 
C36H70O4Zn 
USP : Zn 
compound 
composed of a 
blend of solid org. 
acids obtained 
from fats; consists 
in variable 
proportions of Zn 
stearate and Zn 
palmitate 
632.33 
(pure 
subst.) 
Tablet and 
capsule 
lubricant 
  120 – 122°C 
Nearly insoluble in ethanol 
(95%), ether and water; soluble 
in benzene 
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Name Melting range Analytical method 
Caffeine 235° - 239°C LC-UV (ou HPLC) 
Mannitol 164° - 169°C LC-RI (ou HPLC) 
Lactose Monohydrate  TLC 
Magnesium stearate  Stearic and palmitic acid content : GC-FID 
Sorbitol  LC-RI (ou HPLC) 
Stearic acid  GC-FID 
 
 
Name Binder Lubricant Disintegrator Diluent 
Calcium carbonate   X X 
Calcium phosphate dibasic   X X 
Calcium phosphate tribasic   X X 
Calcium sulphate    X 
Dextrin X   X 
Dextrose X   X 
Glucose liquid X    
Lactose    X 
Maltose    X 
Mannitol    X 
Mineral salts X X   
Sorbitol X   X 
Stearates X X   
Sucrose X   X 
 
 
 
 
 
APPENDIX III – CHEMICAL STRUCTURE OF SOME 
CARBOHYDRATES 
 
MONOSACCHARIDES 
 
 
OHH
HOH
OHH
CH2OH
OHH
CHO
O
CH2OH
OH
H
H OH
OH
H
H
OHH
HOH
HOH
CH2OH
OHH
CHO
O
CH2OH
H
OH
H OH
OH
H
H
HOH
HOH
OHH
CH2OH
OHH
CHO
O
CH2OH
OH
H
H H
OH
H
OH
O
HOH
OHH
CH2OH
OHH
CH2OH
O
H
OH
H
OH H
H
H
OH
O
CH2OH
HOH
H OHH
d-Glucose (Hexose)
H,OH
d-Galactose (Hexose)
H,OH
d-Mannose (Hexose)
H,OH
d-Fructose (Hexose)
OH,CH2OH
OH,CH2OH
pyranose (6) furanose (5)
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DISACCHARIDES (OLIGOSACCHARIDES) 
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CH2OH
OH H
H OH
CH2OH
H
Lactose
β−D-galactopyranosyl-(1-4)-α−D-glucose
Maltose
H,OH (1-4)α-D-glucopyranosyl-D-glucose
Sucrose (Saccharose)
α−D-glucopyranosyl-(1-2)-β−D-fructofuranose
Raffinose (Oligosaccharide)
α-D-galactopyranosyl-(1-2)-α-D-glucopyranosyl-(1-2)-β-D-fructofuranose
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POLYOLS 
 
 
CH2OH
CH2OH
OH H
HOH
OHH
H OH
CH2OH
H OH
CH2OH
H OH
HOH
CH2OH
CH2OH
H OH
HOH
OHH
H OH
OH
OH
OH
OH
OH
OH
d-Mannitol
(D)
Xylitol
d-Sorbitol
(D)
Inositol
 
 
 
 
 
 
 
APPENDIX IV – FATTY ACID CLASSIFICATION19 
 
 
NOMENCLATURE 
 
Fatty acids are classified in function of the alkyl chain length and of the number, position and configuration 
of the double bonds. There are three possible ways to designate them – the IUPAC nomenclature (seldom 
used for fatty acids), the historical name (common) and the symbolic name (practical, simple, 
unequivocal). The latter, however, requires a short explanation. The symbolic name contains the number 
of carbons followed by a double point and the number of double bonds. 
 
Example of a saturated fatty acid :  palmitic acid – 16 : 0  
 
 
 
 
 
In the case of unsaturated fatty acids the formula is completed by the indication of the positions and 
configurations of the double bonds. The numbering of the double bonds starts at the methyl end (CH3–) of 
the chain (position n). 
 
Example of an unsaturated fatty acid : [α-] linolenic acid – 18 : 3 cis, cis, cis, n-3, n-6, n-9 
 
 
 
 
 
However, this nomenclature is generally simplified by considering the natural cis configuration and the 
nonconjugated nature of the fatty acids. 
 
Therefore the same fatty acid than above would result in : 18 : 3 (n-3) [USA: 18 : 3 ω3] 
 
It appears that only the position of the first double bond is added to the formula. 
 
 
 
                                                     
19
 (Christie, 1982; Belitz et al, 2004) 
OH
O
OH
O
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Saturated fatty acids 
 
Generally, they are separated in short-chain fatty acids (≤ 12 carbons) and long-chain fatty acids (≥ 14 
carbons), whose principal representatives are palmitic (16 : 0) and stearic acid (18 : 0). The most common 
are listed in Table 1. 
 
IUPAC name Historical name Symbolic name 
Butanoic Butyric 4 : 0 
Hexanoic Caproic 6 : 0 
Octanoic Caprylic 8 : 0 
Decanoic Capric 10 : 0 
Dodecanoic Lauric 12 : 0 
Tetradecanoic Myristic 14 : 0 
Hexadecanoic Palmitic 16 : 0 
Octadecanoic Stearic 18 : 0 
Eicosanoic Arachidic 20 : 0 
Dodocosanoic Behenic 22 : 0 
Tetracosanoic Lignoceric 24 : 0 
   
Pentanoic Valeric 5 : 0 
Heptanoic Enanthic 7 : 0 
Nonanoic Pelargonic 9 : 0 
Pentadecanoic  15 : 0 
Heptadecanoic Margaric 17 : 0 
Table 1 – Saturated fatty acids – formula CH3(CH2)nCOOH. 
 
Unbranched, straight-chain molecules with an even number of carbon atoms are dominant among the 
saturated fatty acids. They are normally of animal origin and solid at room temperature like for example 
margarine, butter or lard. However, there are some vegetables and oleaginous plants which contain high 
amounts saturated fatty acids as well. These are for example palm fat, coconut, avocado or peanut. 
 
Fatty acids with odd numbers of carbon atoms are present in food only in traces. Some of these are 
important as food aroma constituents. 
 
 
Unsaturated fatty acids 
 
Unsaturated fatty acids are the predominant form in lipids and those with 18 carbons are the most 
important. The five most common are listed below in Table 2. 
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Historical name Symbolic name 
Oleic acid 18 : 1, cis, n-9 (ω9) 
Linoleic acid 18 : 2, cis, cis, n-6, n-9 (ω6) 
[α-] Linolenic acid 18 : 3, cis, cis, cis, n-3, n-6, n-9 (ω3) 
Arachidonic acid 20 : 4, cis, cis, cis, cis, n-6, n-9, n-12, n-15 (ω6) 
Erucic acid 22 : 1, cis, n-9 (ω9) 
Table 2 – Some unsaturated fatty acids. 
 
Unsaturated fatty acids are generally of plant origin, but can also be found in animal products like fish. 
They are characteristically fluid because they are oils. 
 
Melting point and crystalline structure are strongly correlated in the case of fatty acids. The unsaturated 
fatty acids, because of their double bonds, are not free to rotate and hence have rigid kinks along the 
carbon chain. A molecule is less bent by a trans than by a cis double bond, this one causing a bending of 
40°. Hence, the molecular crumpling is increased by an increase of cis double bonds. 
 
Odd-numbered and unsaturated fatty acids can not be uniformly packed into a crystalline lattice as can the 
saturated and even-numbered acids. The consequence of less symmetry within the crystal is that the 
melting points of even-numbered acids exceeds the melting points of the next higher odd-numbered fatty 
acids. 
 
 
 
 
 
 
APPENDIX V – SUGAR ANALYSIS BY CAPILLARY 
ELECTROPHORESIS 
 
 
CAPILLARY ELECTROPHORESIS20  
 
Capillary electrophoresis has often been cited as the new revolutionary technique for sugar analysis and 
several publications can be found presenting various methods. So it was only natural to test this technique 
for this research.  Eleven sugar standards – glucose, galactose, fructose, mannose, sorbitol, mannitol, 
inositol, xylitol, lactose, sucrose and maltose - have been used to be analysed on a Agilent 3D CE.  
 
The principal of the analysis has been taken from Hofstetter-Kuhn et al (1991) who had achieved a good 
analysis of carbohydrates by applying borate complexation (in situ complex formation with borate ions). 
However their method conditions could not be used on the machine available in our laboratory. Thus, 
variations of methods presented in other publications using borate complexation have been tested (Soga, 
1995; Bennani and Fabre, 2001; Altria et al, 1999).  
 
To determine an optimal method to separate the eleven selected sugars, various parameters have been 
studied : concentration of tetraborate (including variations of running and sample buffer concentrations), 
pH, voltage and preconditioning. 
 
 
Buffer & pH 
 
Because the procedure applied here uses borate complexation the buffer used is a borate buffer. It is 
important to notice that it is the tetrahydroxyborate ion that undergoes complexation, rather than boric 
acid. At constant sugar concentration the amount of complex increases with the borate concentration as 
well as with pH due to a higher amount of borate ions. Control of pH is one of the most important means to 
influence separation of compounds in electrophoresis since the pH enters directly in the equation of the 
effective electrophoretic mobility. Furthermore, it influences the complex formation between carbohydrates 
and borate ions with a basic pH being optimal.  
 
Carbohydrates have a very low UV absorbance, but their detection in the low UV region can be 
significantly enhanced by using borate complexation and alkaline pH.  
 
                                                     
20 (Paulus and Klockow, 1996; Hoffstetter-Kuhn et al, 1991; El Rassi and Nashabeh, 1995; Andersson and Hagglund, 
2002; Altria et al, 1997) 
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Voltage 
 
Voltage is determining for the duration of analysis and its quality as well. It should not be too high as that 
could cause negative side-effects such as incomplete separation and Joule heat. Low voltages however 
could result in long analysis times. The voltages tested here were between 15 and 19kV. 
 
 
Preconditioning 
 
In order to obtain consistent results it is important to keep the capillary in a good state. Consequently, 
three points have to be taken care of when working with CE and particularly when analysing 
carbohydrates. First of all, a new capillary has to be pre-conditioned before being used for any analysis. 
This is done by rinsing it for ~20 min with 0.1M NaOH, deionised water and running buffer. 
 
Once it is in use, the inside of the capillary must be allowed to stabilise by applying pre-conditioning before 
every analysis and by realising blanks at regular intervals. For the former, normally the same solutions are 
used then cited above, but for a shorter time. The blanks are generally realised with the sample buffer and 
it has to be tested at whatever interval they have to be performed.  
 
 
The following parameters were fixed in the beginning and kept unchanged for all tests realised : 
 
Capillary Length: 56 cm BF3 (extended path), I.D: 50 µm 
Temperature 60°C 
Injection 50 mbar, 3s 
Detection UV-DAD, 195nm (10nm)/450nm 
 
Run-time varied between 15-18 minutes depending on the voltage applied. 
 
The capillary was chosen because of relatively short length and the presence of the bubble cell BF3, 
which means that the detection path length is increased by a factor of three and will therefore improve 
sensitivity.  
 
Temperature has been determined according to references using the same principle for carbohydrate 
analysis. Generally, high temperatures in CE result in an increase of band widths. For carbohydrates, 
however, the opposite has been observed. An increase of temperature means that the equation 
equilibrium of complexation is reached faster, thus resulting in narrower peak shapes. Additionally, the 
content of the open-chain form of sugars in increased which is better for complexation, and injection 
volume is increased as well due to a decreased viscosity of the sample. 
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The detection wavelength is the same than used by Hofstetter-Kuhn (1991) for the reasons mentioned 
under Buffer & pH. The injection mode has been taken from Altria et al (1999), his method being based 
on the study of Hofstetter-Kuhn but applied on a similar machine than the one used in our laboratory. 
 
 
Results 
 
First results were very promising – all sugars could be detected, but separation was not good enough yet. 
Unfortunately, during the time when optimisation of the parameters was attempted, problems started to 
appear. 
 
− Optimisation of all three groups together (monosaccharides, disaccharides and polyols) was 
not possible – if an improvement for one group could be achieved, the result for the other 
groups would be worse than before. And it appeared impossible to obtain an acceptable 
compromise.  
For example, disaccharides, monosaccharides and polyols would complex differently for a 
given borate concentration, the first ones needing a higher amount of borate to form 
complexes. But a high borate concentration would also result in longer migration times. (Altria 
et al, 1999) 
− Over the time a variation of migration times has been observed. For a same sugar and same 
conditions they would be different if analysed alone or in a mixture, for different concentrations 
and before and after maintenance of the machine. These variations were sometimes very 
important, but even slight differences could not be accepted because the migrations times 
were very close for certain sugars. 
− Furthermore it appeared that there were great differences of peak size between the three 
types of sugars for the same concentration. Monosaccharides often presented large but not 
very high peaks, the opposite was observed for polyols (high but not large) and disaccharides 
showed very small peaks in both ways. This wouldn’t be a problem if the migration times were 
not as close as they were in our case. Additionally, lactose would suddenly present split peaks 
(probably the α- and β-form) for conditions thought to give better results than before.  
− Finally, it was observed that although preconditioning was applied before every analysis the 
baseline was often irregular. Various attempts to improve its quality were made by changing 
conditions of preconditioning, filtering the buffer (0.45µm, then 0.2µm) and regular washing of 
the capillary, without very much success.  
 
As it appeared to be impossible to get satisfying, reproducible separation of the tested sugars, it was 
decided to abandon this technique for gas chromatography which after only a few tests gave already 
better results than CE. 
 
 
 
 
 
 
APPENDIX VI – INSTRUMENTAL CONDITIONS OF THE 
COCAINE GC-MS METHOD 
 
 
Method COC 
Sample introduction  
Split 
Volume 
Total flow 
Injector T  
 
20 : 1 
2µl 
23 ml/min 
230°C 
Gas saver 15ml/min after 2min 
Carrier gas Helium 
Column  
Type 
Mode 
Average velocity 
 
DB1MS, 30m(L) x 0.25mm (i.d.) x 0.25µm (film) 
Constant flow 
37cm/sec 
Oven T-program 180°C (1min), 4°C/min, 275°C (5.25min) 
GC-MS interface T 250°C 
MS information  
Solvent delay 
Mass range 
Sample rate 
MS quad T 
MS source T 
 
2 min 
50 – 550 a.m.u 
3, A/D samples 8 
150°C 
230°C 
 
 
 
 
 
APPENDIX VII – SAMPLING, ALL SAMPLES 
 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
760 19.7.98 9.03 3.56 250.37 None Rose Yes MDMA 32 Lactose (B) 
788 7.6.98 9.02 3.38 254.31 None Rose Yes MDMA 36 Lactose (B) 
831 26.4.98 9.02 3.58 240.56 None White Yes MDMA 32 Lactose (B) 
Z14B  9.08 4.86 273.24 None White Yes MDMA 34 Lactose (B) 
985C 14.6.99 9.06 4.61 297.08 Rolling Stones Beige None MDMA 29 Sorbitol 
1111B 17.9.00 9.19 3.35 261.11 Ferrari Beige Yes MDMA 34 Lactose 
1319A 8.1.01 7.97 4.70 259.80 Ferrari Yellow Yes MDMA 35 Lactose 
1451A 16.1.01 7.99 4.38 255.46 Ferrari Orange dirty Yes MDMA 33 Lactose 
1451B 16.1.01 7.96 4.68 258.67 Ferrari Yellow Yes MDMA 32 Lactose 
1130 24.7.00 9.18 3.91 315.37 Heart (punchmark) Beige Yes MDMA 14 Lactose 
1134A 12.8.00 9.16 3.92 315.42 Heart (punchmark) Beige Yes MDMA 17 Lactose 
1314B 13.1.01 9.21 3.94 305.77 Heart (punchmark) Beige Yes MDMA 16 Lactose 
1345A 29.6.00 9.14 3.87 311.16 Heart (punchmark) Beige Yes MDMA 20 Lactose 
1324 4.2.01 9.14 3.89 294.37 Heart White Yes MDMA 24 Lactose 
1668 26.12.03 8.07 4.57 262.49 Heart Rose Yes MDMA 23 Lactose 
1683 10.6.04 8.17 4.07 248.05 Heart White dirty Yes MDMA 31  
1693 17.2.05 8.20 3.69 216.99 Heart White dirty Yes MDMA, MA 28  
1708 8.4.05 8.20 3.69 220.35 Heart White dirty Yes MDMA, MA 24  
520 21.1.98 9.13 3.95 285.52 Crown White None Amphetamine 30 Lactose 
523 12.2.98 9.14 4.01 294.90 Crown White None MDMA 29 Lactose (B) 
524 12.2.98 9.14 4.04 300.27 Crown White None MDMA 29 Lactose (B) 
1444B 26.12.01 6.06 4.23 139.09 Dolphin Blue None MDMA 68 Lactose 
1445 30.12.01 6.06 4.06 131.09 Dolphin Blue None MDMA 68 Lactose 
1500 3.2.02 6.05 3.97 128.35 Dolphin Blue None MDMA 63 Lactose 
1519  6.02 3.96 128.73 Dolphin Blue None MDMA 75 Lactose 
1507A 10.2.02 9.04 4.84 298.25 Tasmanian Devil Beige None MDEA 25 
Sorbitol,  
Lactose 
985A 14.6.99 9.08 4.63 294.72 Tasmanian Devil White dirty None MDMA 21 Sorbitol 
922 18.9.99 8.30 4.33 243.17 Diamond Violet None MDA 28 Lactose 
952 22.10.99 8.07 3.49 214.02 Diamond Violet None MDA 28 Lactose 
1091 19.6.00 8.18 3.35 213.55 Diamond Violet None MDA 27 Lactose 
1118 19.6.00 8.17 3.30 208.65 Diamond Violet None MDA 26 Lactose 
1148 13.8.00 8.21 3.54 224.76 Diamond Violet None MDA 23 
Lactose,  
Mannitol (tr) 
1209 24.9.00 8.22 3.58 226.53 Diamond Violet None MDA 24 
Lactose,  
Mannitol (tr) 
1112F 17.9.00 8.21 3.52 222.63 Diamond Violet None MDA 24 
Lactose,  
Mannitol (tr) 
Z197 2.4.04 8.07 2.79 160.60 Diamond Violet None MDA   
1204A 10.9.00 8.23 4.15 274.46 Double lightning Violet None MDA 22 
Lactose,  
Mannitol (tr) 
1218A 31.8.00 8.20 4.16 275.14 Double lightning Violet None MDA 25 
Lactose,  
Mannitol (tr) 
1112G 17.9.00 7.04 4.37 218.40  "007" Orange None MDMA 38 Lactose (B) 
1388 30.7.01 7.04 4.98 240.08  "FF" Yellow None MDMA 32 Sorbitol 
1380A 15.7.01 7.04 4.94 240.81  "FF" Yellow None MDMA 35 Sorbitol 
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Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
1473A 29.6.01 7.07 5.04 242.37  "FF" Yellow None MDMA 36 Sorbitol 
995B 20.12.99 8.06 5.39 361.41  "S" Green Yes MDMA 35 Lactose (B) 
Z60 2.1.99 8.03 4.65 278.66  "STAR DUST" White Yes MDMA 27 Lactose 
949A 31.1.99 8.01 4.85 294.38  "STAR DUST" White Yes MDMA  Lactose 
949B 31.1.99 8.03 4.93 296.41  "STAR DUST" Beige Yes MDMA   
1002 2.1.00 8.04 5.47 335.88  "STAR DUST" White dirty Yes MDMA 26  
1061 3.4.00 8.11 5.69 345.95  "STAR DUST" Beige Yes MDMA 27  
1304A 17.5.00 8.07 5.52 336.74  "STAR DUST" Beige Yes MDMA 28  
Z209 23.2.04 8.01 4.22 239.10  "STAR DUST" White dirty Yes MDMA, MDEA   
1207 16.9.00 7.09 3.80 173.88  "Xhi" White dirty Yes MDMA 59  
1498 2.2.02 7.06 4.89 230.79  "Xhi" Rose Yes strong MDMA 41 Lactose 
1619A 13.2.02 7.05 4.86 227.01  "Xhi" Rose Yes strong MDMA 43 Lactose 
1301 2.5.00 9.18 3.91 308.16 Ferrari (framed) White None MDMA 31 Lactose 
1309 9.6.00 9.15 3.89 307.71 Ferrari (framed) White None MDMA 32 Lactose 
942 5.12.99 9.09 3.67 292.18 Ferrari (framed) White None MDMA 25 Lactose 
970A 4.2.00 9.09 3.77 292.35 Ferrari (framed) White None MDMA 26 Lactose 
970B 4.2.00 9.11 3.74 300.29 Ferrari (framed) White None MDMA 29 Lactose 
970C 4.2.00 9.10 3.72 296.43 Ferrari (framed) White None MDMA 28 Lactose 
Z2A 22.7.98 8.29 4.80 288.73 Elephant Beige Yes MDMA 25 Sorbitol 
Z30 3.10.98 8.06 4.71 291.89 Elephant Beige Yes MDMA 30  
985B 14.6.99 8.03 4.93 303.49 Elephant White Yes MDMA 26  
1494D 19.12.01 8.02 5.22 296.95 Elephant White Yes MDMA 29  
737 2.7.98 11.14 4.92 393.75 Star Rose Yes 4-MTA  Lactose 
743 15.4.98 11.15 4.94 399.08 Star Rose Yes 4-MTA  Lactose 
1303 17.5.00 8.11 3.44 222.48 Star White dirty None MDMA 42  
1305 17.5.00 8.09 3.45 220.93 Star White dirty None MDMA 37  
1304B 17.5.00 8.10 4.75 255.17 Star White dirty None MDMA 37 Lactose 
1304C 17.5.00 8.10 3.48 225.19 Star White dirty None MDMA 40  
1306A 17.5.00 8.11 4.75 253.18 Star White dirty None MDMA 35 Lactose 
1306B 17.5.00 8.09 3.41 221.59 Star White dirty None MDMA 36  
1306C 17.5.00 8.12 4.74 254.54 Star White dirty None MDMA 34 Lactose 
1306D 17.5.00 8.10 3.36 219.71 Star White dirty None MDMA 37  
1317 5.1.01 9.06 3.90 298.11 Star White Yes MDMA 40 Lactose 
1460 6.4.01 8.09 3.84 297.35 Star White Yes MDMA 36 Lactose 
1405 7.9.01 8.02 3.25 201.53 Euro Orange None MDMA 60 Lactose 
1416B 1.8.01 8.01 3.24 200.23 Euro Orange None MDMA 58 Lactose 
832 29.5.98 9.04 4.76 309.58 Twins Beige Yes MDMA 27 Sorbitol 
1380B 15.7.01 9.08 4.40 314.77 Twins Beige Yes MDMA 32 Sorbitol 
1473B 29.6.01 9.11 4.41 308.05 Twins Brown Yes MDMA 34 Sorbitol 
1524 14.4.02 8.15 4.81 287.90 Marlboro Blue Yes MDMA 37  
1528 4.5.02 8.14 4.86 299.65 Marlboro Rose Yes MDMA 34  
Z44 30.8.98 8.05 4.85 291.04 Mitsubishi Beige Yes strong MDMA 34  
Z4A 8.8.98 8.06 5.05 317.67 Mitsubishi Beige Yes MDMA 36  
834 8.8.98 8.13 5.21 299.51 Mitsubishi Beige Yes MDMA 41 Sorbitol 
814 23.8.98 8.16 5.19 300.74 Mitsubishi Beige Yes MDMA 32  
1003 2.1.00 8.65 4.56 320.02 Mitsubishi White dirty Yes MDMA 29 Lactose 
1300 28.3.00 9.04 3.83 297.00 Mitsubishi White Yes MDMA 29 Lactose 
Z84 14.6.99 9.07 4.65 348.30 Mitsubishi White Yes MDMA 20 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
954 12.8.99 9.08 5.53 390.31 Mitsubishi White None MDMA  Lactose 
978A 18.2.00 9.09 3.82 296.44 Mitsubishi White None MDMA 35 Lactose 
960 5.12.99 9.09 3.84 295.44 Mitsubishi White None MDMA  Lactose 
1223 15.10.00 9.12 4.04 294.13 Mitsubishi White dirty Yes MDMA 26 Lactose 
1312 31.7.00 9.14 3.87 302.96 Mitsubishi Beige Yes MDMA 37 Lactose 
557A  9.08 3.63 286.42 Sparrow White Yes Amphetamine 5 Lactose 
557B  9.09 3.54 287.90 Sparrow White Yes Amphetamine  Lactose 
Z9  9.07 3.54 286.42 Sparrow White Yes Amphetamine 7 Lactose 
989 21.6.99 8.63 3.40 226.96 Flying bird Beige Yes MDMA 38 Lactose 
1635 19.11.02 7.60 4.67 261.15 Peace and love Violet Yes MDMA 44 Lactose 
1265 14.12.00 8.05 4.09 255.97 Superman White Yes Amphetamine 24 Lactose (B) 
1116A 4.7.00 8.00 4.06 243.02 Superman White Yes Amphetamine 23 Lactose (B) 
1345B 29.6.00 8.01 4.01 249.22 Superman White Yes Amphetamine 19 Lactose (B) 
1327 17.2.01 8.14 5.06 287.00 Superman White Yes MDMA 27  
842E 2.6.99 9.12 4.25 317.45 Superman Beige Yes strong MDMA 27 Lactose 
894A 16.8.99 9.19 4.35 321.66 Superman White dirty Yes strong MDMA 23 Lactose 
1208 21.10.00 8.06 3.64 237.26 Superman White Yes MDMA, MDA 35 Lactose 
1079B 16.4.00 8.04 5.05 296.82 Superman White dirty Yes MDMA, MDEA 29  
1310A 19.6.00 8.07 5.01 292.45 Superman Beige Yes MDMA, MDEA 29  
836A 6.10.98 9.01 3.19 258.75 Superman Beige Yes MDMA, MDEA 12 Lactose 
Z34 4.10.98 9.07 3.22 264.50 Superman Beige Yes MDMA, MDEA 12 Lactose 
 
 
 
 
APPENDIX VIII – SAMPLING, NON-LINKED SAMPLES 
 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Illicit Qty Diluent 
 seizure [mm] [mm] [mg]    Substance [%]  
1112G 17.9.00 7.04 4.37 218.40  "007" Orange None MDMA 38 Lactose (B) 
1473A 29.6.01 7.07 5.04 242.37  "FF" Yellow None MDMA 36 Sorbitol 
995B 20.12.99 8.06 5.39 361.41  "S" Green Yes MDMA 35 Lactose (B) 
1061 3.4.00 8.11 5.69 345.95  "STAR DUST" Beige Yes MDMA 27  
949A 31.1.99 8.01 4.85 294.38  "STAR DUST" White Yes MDMA  Lactose 
Z60 2.1.99 8.03 4.65 278.66  "STAR DUST" White Yes MDMA 27 Lactose 
1207 16.9.00 7.09 3.80 173.88  "Xhi" White dirty Yes MDMA 59  
1619A 13.2.02 7.05 4.86 227.01  "Xhi" Rose Yes strong MDMA 43 Lactose 
523 12.2.98 9.14 4.01 294.90 Crown White None MDMA 29 Lactose (B) 
922 18.9.99 8.30 4.33 243.17 Diamond Violet None MDA 28 Lactose 
1091 19.6.00 8.18 3.35 213.55 Diamond Violet None MDA 27 Lactose 
1112F 17.9.00 8.21 3.52 222.63 Diamond Violet None MDA 24 
Lactose,  
Mannitol (tr) 
Z197 2.4.04 8.07 2.79 160.60 Diamond Violet None MDA   
1445 30.12.01 6.06 4.06 131.09 Dolphin Blue None MDMA 68 Lactose 
1494D 19.12.01 8.02 5.22 296.95 Elephant White Yes MDMA 29  
Z2A 22.7.98 8.29 4.80 288.73 Elephant Beige Yes MDMA 25 Sorbitol 
1416B 1.8.01 8.01 3.24 200.23 Euro Orange None MDMA 58 Lactose 
1451A 16.1.01 7.99 4.38 255.46 Ferrari Orange dirty Yes MDMA 33 Lactose 
942 5.12.99 9.09 3.67 292.18 Ferrari (framed) White None MDMA 25 Lactose 
989 21.6.99 8.63 3.40 226.96 Flying bird Beige Yes MDMA 38 Lactose 
1324 4.2.01 9.14 3.89 294.37 Heart White Yes MDMA 24 Lactose 
1708 8.4.05 8.20 3.69 220.35 Heart White dirty Yes MDMA, MA 24  
1134A 12.8.00 9.16 3.92 315.42 Heart (punchmark) Beige Yes MDMA 17 Lactose 
1524 14.4.02 8.15 4.81 287.90 Marlboro Blue Yes MDMA 37  
834 8.8.98 8.13 5.21 299.51 Mitsubishi Beige Yes MDMA 41 Sorbitol 
954 12.8.99 9.08 5.53 390.31 Mitsubishi White None MDMA  Lactose 
1003 2.1.00 8.65 4.56 320.02 Mitsubishi White dirty Yes MDMA 29 Lactose 
1223 15.10.00 9.12 4.04 294.13 Mitsubishi White dirty Yes MDMA 26 Lactose 
Z44 30.8.98 8.05 4.85 291.04 Mitsubishi Beige Yes strong MDMA 34  
760 19.7.98 9.03 3.56 250.37 None Rose Yes MDMA 32 Lactose (B) 
831 26.4.98 9.02 3.58 240.56 None White Yes MDMA 32 Lactose (B) 
985C 14.6.99 9.06 4.61 297.08 Rolling Stone Beige None MDMA 29 Sorbitol 
557A  9.08 3.63 286.42 Sparrow White Yes Amphetamine 5 Lactose 
743 15.4.98 11.15 4.94 399.08 Star Rose Yes 4-MTA  Lactose 
1460 6.4.01 8.09 3.84 297.35 Star White Yes MDMA 36 Lactose 
1306A 17.5.00 8.11 4.75 253.18 Star White dirty None MDMA 35 Lactose 
1306B 17.5.00 8.09 3.41 221.59 Star White dirty None MDMA 36  
1208 21.10.00 8.06 3.64 237.26 Superman White Yes MDMA, MDA 35 Lactose 
1079B 16.4.00 8.04 5.05 296.82 Superman White dirty Yes MDMA, MDEA 29  
1345B 29.6.00 8.01 4.01 249.22 Superman White Yes Amphetamine 19 Lactose (B) 
894A 16.8.99 9.19 4.35 321.66 Superman White dirty Yes strong MDMA 23 Lactose 
Z34 4.10.98 9.07 3.22 264.50 Superman Beige Yes MDMA, MDEA 12 Lactose 
832 29.5.98 9.04 4.76 309.58 Twins Beige Yes MDMA 27 Sorbitol 
 
 
 
 
APPENDIX IX – HISTOGRAMS 
 
HISTOGRAMS FROM THE XTC DATA SET 
 
Pearson correlation 
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Squared Cosine Function 
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Similarity Index 
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Euclidean Distance 
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Manhattan Distance 
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Canberra Index 
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HISTOGRAMS FROM THE FA/SUGAR DATA SET 
 
Pearson correlation 
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Squared Cosine Function 
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Similarity Index 
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Euclidean Distance 
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Manhattan Distance 
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Canberra Index 
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APPENDIX X – SAMPLE GROUPS OBTAINED WITH THE EXCIPIENTS 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
737 02.07.98 11.14 4.92 393.75 Star rose Yes ThioStar 4MTA     Lactose 
743 15.04.98 11.15 4.94 399.08 Star rose Yes ThioStar 4MTA     Lactose 
             
1345B 29.06.00 8.01 4.01 249.22 Superman white Yes   Amphetamine 48.25 18.60 Lactose (B) 
1116A 04.07.00 8.00 4.06 243.02 Superman white Yes  Amphetamine 60.55 23.00 Lactose (B) 
1265 14.12.00 8.05 4.09 255.97 Superman white Yes   Amphetamine 69.18 24.40 Lactose (B) 
             
Z9   9.07 3.54 286.42 Sparrow white Yes Portugal Amphetamine 19.47 6.80 Lactose 
             
557B   9.09 3.54 287.90 Sparrow white Yes Portugal Amphetamine     Lactose 
557A   9.08 3.63 286.42 Sparrow white Yes Portugal Amphetamine 15.19 5.30 Lactose 
             
952 22.10.99 8.07 3.49 214.02 Diamond violet None Diamant-B MDA 58.71 27.50 Lactose 
             
Z197 02.04.04 8.07 2.79 160.60 Diamond violet None Diamant-E MDA       
             
1118 19.06.00 8.17 3.30 208.65 Diamond violet None Diamant-C MDA 55.78 26.10 Lactose 
1091 19.06.00 8.18 3.35 213.55 Diamond violet None Diamant-C MDA 58.45 26.80 Lactose 
             
1204A 10.09.00 8.23 4.15 274.46 Double lightning violet None Diamant-Ecl MDA 61.10 21.70 Lactose, Mannitol (tr) 
1148 13.08.00 8.21 3.54 224.76 Diamond violet None Diamant-D MDA 52.69 23.10 Lactose, Mannitol (tr) 
1209 24.09.00 8.22 3.58 226.53 Diamond violet None Diamant-D MDA 54.16 23.50 Lactose, Mannitol (tr) 
1112F 17.09.00 8.21 3.52 222.63 Diamond violet None Diamant-D MDA 57.08 24.10 Lactose, Mannitol (tr) 
1218A 31.08.00 8.20 4.16 275.14 Double lightning violet None Diamant-Ecl MDA 70.46 25.30 Lactose, Mannitol (tr) 
             
922 18.09.99 8.30 4.33 243.17 Diamond violet None Diamant-A MDA 67.79 28.20 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
1507A 10.02.02 9.04 4.84 298.25 Tasmanian Devil beige None   MDEA 78.13 25.22 Sorbitol, Lactose 
             
1444B 26.12.01 6.06 4.23 139.09 Dolphin blue None   MDMA 95.91 68.00 Lactose 
1445 30.12.01 6.06 4.06 131.09 Dolphin blue None   MDMA 91.81 67.60 Lactose 
             
1500 03.02.02 6.05 3.97 128.35 Dolphin blue None   MDMA 82.80 63.21 Lactose 
1519   6.02 3.96 128.73 Dolphin blue None   MDMA 96.66 75.14 Lactose 
             
1112G 17.09.00 7.04 4.37 218.40 "007" orange None JamesBond MDMA 88.57 38.40 Lactose (B) 
             
1388 30.07.01 7.04 4.98 240.08 "FF" yellow None   MDMA 77.72 31.62 Sorbitol 
1380A 15.07.01 7.04 4.94 240.81 "FF" yellow None  MDMA 86.53 35.41 Sorbitol 
1473A 29.06.01 7.07 5.04 242.37 "FF" yellow None   MDMA 90.84 35.98 Sorbitol 
             
1207 16.09.00 7.09 3.80 173.88 "Xhi" dirty white Yes   MDMA 107.78 58.50   
             
1498 02.02.02 7.06 4.89 230.79 "Xhi" rose Yes strong   MDMA 95.28 40.92 Lactose 
             
1619A 13.02.02 7.05 4.86 227.01 "Xhi" rose Yes strong   MDMA 99.14 42.61 Lactose 
             
1635 19.11.02 7.60 4.67 261.15 Peace and love violet Yes   MDMA 123.23 44.34 Lactose 
             
1319A 08.01.01 7.97 4.70 259.80 Ferrari yellow Yes   MDMA 92.03 34.55 Lactose 
             
1451B 16.01.01 7.96 4.68 258.67 Ferrari yellow Yes   MDMA 87.02 31.57 Lactose 
             
1451A 16.01.01 7.99 4.38 255.46 Ferrari orange Yes   MDMA 85.70 32.71 Lactose 
             
1668 26.12.03 8.07 4.57 262.49 Heart rose Yes   MDMA 61.74 22.97 Lactose 
             
995B 20.12.99 8.06 5.39 361.41 "S" green Yes   MDMA 123.65 34.50 Lactose (B) 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
Z60 02.01.99 8.03 4.65 278.66 "STAR DUST" white Yes Weiss MDMA 78.27 27.00 Lactose 
949A 31.01.99 8.01 4.85 294.38 "STAR DUST" white Yes Weiss MDMA     Lactose 
             
949B 31.01.99 8.03 4.93 296.41 "STAR DUST" white Yes Weiss MDMA       
1002 02.01.00 8.04 5.47 335.88 "STAR DUST" dirty white Yes EP5 MDMA 90.02 26.11   
1304A 17.05.00 8.07 5.52 336.74 "STAR DUST" beige Yes EP5 MDMA 94.57 27.74   
1061 03.04.00 8.11 5.69 345.95 "STAR DUST" beige Yes EP5 MDMA 92.61 26.60   
             
Z30 03.10.98 8.06 4.71 291.89 Elephant beige Yes   MDMA 90.46 30.00   
             
985B 14.06.99 8.03 4.93 303.49 Elephant white Yes   MDMA 77.72 26.30   
             
1494D 19.12.01 8.02 5.22 296.95 Elephant white Yes strong   MDMA 89.36 29.46   
             
1416B 01.08.01 8.01 3.24 200.23 Euro orange None Orange MDMA 120.60 58.40 Lactose 
1405 07.09.01 8.02 3.25 201.53 Euro orange None Orange MDMA 124.60 60.10 Lactose 
             
Z44 30.08.98 8.05 4.85 291.04 Mitsubishi beige Yes strong MitsubishiFIX MDMA 97.23 34.20   
             
Z4A 08.08.98 8.06 5.05 317.67 Mitsubishi beige Yes MitsubishiFIX MDMA 89.49 36.00   
             
1208 21.10.00 8.06 3.64 237.26 Superman white Yes Superman2-D MDMA 83.63 34.80 Lactose 
             
1303 17.05.00 8.11 3.44 222.48 Star beige None   MDMA 99.27 41.83   
1305 17.05.00 8.09 3.45 220.93 Star dirty white None  MDMA 86.39 37.29   
1304C 17.05.00 8.10 3.48 225.19 Star dirty white None  MDMA 99.63 40.49   
1306B 17.05.00 8.09 3.41 221.59 Star dirty white None  MDMA 91.59 36.28   
1306D 17.05.00 8.10 3.36 219.71 Star dirty white None   MDMA 85.83 36.84   
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
1306C 17.05.00 8.12 4.74 254.54 Star dirty white None   MDMA 87.65 34.08 Lactose 
1306A 17.05.00 8.11 4.75 253.18 Star dirty white None  MDMA 89.49 34.60 Lactose 
1304B 17.05.00 8.10 4.75 255.17 Star dirty white None   MDMA 99.05 37.01 Lactose 
             
1460 06.04.01 8.09 3.84 297.35 Star white Yes   MDMA 107.84 36.01 Lactose 
             
1528 04.05.02 8.14 4.86 299.65 Marlboro blue Yes   MDMA 102.75 33.79   
1524 14.04.02 8.15 4.81 287.90 Marlboro rose Yes   MDMA 109.29 37.15   
             
834 08.08.98 8.13 5.21 299.51 Mitsubishi beige Yes MitsubishiFIT MDMA 121.69 40.70 Sorbitol 
             
814 23.08.98 8.16 5.19 300.74 Mitsubishi beige Yes MitsubishiFIX MDMA 98.24 32.00   
             
1327 17.02.01 8.14 5.06 287.00 Superman white Yes   MDMA 80.12 26.81   
             
1693 17.02.05 8.20 3.69 216.99 Heart dirty white Yes   MDMA 19.31 28.15   
1683 10.06.04 8.17 4.07 248.05 Heart dirty white Yes   MDMA 76.28 30.60   
1708 08.04.05 8.20 3.69 220.35 Heart dirty white Yes   MDMA 53.24 24.20   
             
Z2A 22.07.98 8.29 4.80 288.73 Elephant beige Yes   MDMA 71.94 24.80 Sorbitol 
             
1003 02.01.00 8.65 4.56 320.02 Mitsubishi dirty white Yes uu MDMA 94.16 29.10 Lactose (tr) 
             
989 21.06.99 8.63 3.40 226.96 Flying bird beige Yes Paix MDMA 89.39 38.20 Lactose 
             
760 19.07.98 9.03 3.56 250.37 None rose Yes wRoseStrie MDMA 76.84 31.50 Lactose (B) 
788 07.06.98 9.02 3.38 254.31 None rose Yes wRoseStrie MDMA 85.85 35.80 Lactose (B) 
             
831 26.04.98 9.02 3.58 240.56 None white Yes wBlancStrie MDMA 78.80 32.00 Lactose (B) 
Z14B   9.08 4.86 273.24 None white Yes wBlancStrie MDMA 93.03 33.60 Lactose (B) 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
985C 14.06.99 9.06 4.61 297.08 Rolling Stones beige None   MDMA 87.51 28.90 Sorbitol 
             
985A 14.06.99 9.08 4.63 294.72 Tasmanian Devil dirty white None   MDMA 62.43 21.00 Sorbitol 
             
832 29.05.98 9.04 4.76 309.58 Twins beige Yes Jumeaux MDMA 80.80 26.90 Sorbitol 
             
1380B 15.07.01 9.08 4.40 314.77 Twins beige Yes Jumeaux MDMA 101.54 31.58 Sorbitol 
1473B 29.06.01 9.11 4.41 308.05 Twins brown Yes   MDMA 107.45 34.07 Sorbitol 
             
1300 28.03.00 9.04 3.83 297.00 Mitsubishi white Yes MitsubSpots MDMA 87.77 29.07 Lactose 
             
Z84 14.06.99 9.07 4.65 348.30 Mitsubishi white Yes   MDMA 68.95 19.70 Lactose 
             
1111B 17.09.00 9.19 3.35 261.11 Ferrari beige Yes CavFerra MDMA 92.67 34.10 Lactose 
             
1324 04.02.01 9.14 3.89 294.37 Heart white Yes   MDMA 76.67 24.34 Lactose 
             
520 21.01.98 9.13 3.95 285.52 Crown white None   MDMA 85.66 30.00 Lactose 
             
523 12.02.98 9.14 4.01 294.90 Crown white None   MDMA 85.52 29.00 Lactose (B) 
524 12.02.98 9.14 4.04 300.27 Crown white None   MDMA 87.08 29.00 Lactose (B) 
             
960 05.12.99 9.09 3.84 295.44 Mitsubishi white None   MDMA     Lactose 
1309 09.06.00 9.15 3.89 307.71 Ferrari (framed) white None   MDMA 100.60 31.86 Lactose 
1301 02.05.00 9.18 3.91 308.16 Ferrari (framed) white None   MDMA 95.17 30.86 Lactose 
942 05.12.99 9.09 3.67 292.18 Ferrari (framed) white None Ferrari-Red MDMA 72.74 25.00 Lactose 
970A 04.02.00 9.09 3.77 292.35 Ferrari (framed) white None Ferrari-Red MDMA 73.57 25.60 Lactose 
970C 04.02.00 9.10 3.72 296.43 Ferrari (framed) white None Ferrari-Red MDMA 80.91 27.70 Lactose 
970B 04.02.00 9.11 3.74 300.29 Ferrari (framed) white None Ferrari-Red MDMA 87.78 29.20 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]     Substance [mg] [%]   
             
1223 15.10.00 9.12 4.04 294.13 Mitsubishi dirty white Yes   MDMA 80.84 26.30 Lactose 
             
1312 31.07.00 9.14 3.87 302.96 Mitsubishi beige Yes   MDMA 118.60 37.41 Lactose 
             
954 12.08.99 9.08 5.53 390.31 Mitsubishi white None   MDMA     Lactose 
             
978A 18.02.00 9.09 3.82 296.44 Mitsubishi white None   MDMA 102.13 35.40 Lactose 
             
842E 02.06.99 9.12 4.25 317.45 Superman beige Yes strong Superman2-A MDMA 86.37 27.00 Lactose 
894A 16.08.99 9.19 4.35 321.66 Superman dirty white Yes strong Superman2-A MDMA 73.91 22.80 Lactose 
             
1345A 29.06.00 9.14 3.87 311.16 Heart beige Yes Punchmark MDMA 63.42 19.86 Lactose 
1130 24.07.00 9.18 3.91 315.37 Heart beige Yes Punchmark MDMA 44.19 14.10 Lactose 
1134A 12.08.00 9.16 3.92 315.42 Heart beige Yes Punchmark MDMA 54.69 16.60 Lactose 
1314B 13.01.01 9.21 3.94 305.77 Heart beige Yes Punchmark MDMA 51.71 15.66 Lactose 
             
1317 05.01.01 9.06 3.90 298.11 Star white Yes   MDMA 120.77 39.92 Lactose 
             
Z209 23.02.04 8.01 4.22 239.10 "STAR DUST" dirty white Yes MDEA MDMA, MDEA       
             
1310A 19.06.00 8.07 5.01 292.45 Superman beige Yes strong SupermanDef MDMA, MDEA 86.02 28.74   
             
1079B 16.04.00 8.04 5.05 296.82 Superman dirty white Yes strong SupermanDef MDMA, MDEA 86.51 29.00   
             
836A 06.10.98 9.01 3.19 258.75 Superman beige Yes Superman2-B MDMA, MDEA 33.13 11.90 Lactose 
Z34 04.10.98 9.07 3.22 264.50 Superman beige Yes Superman2-B MDMA, MDEA 27.41 11.50 Lactose 
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APPENDIX XI – SAMPLE GROUPS OBTAINED WITH THE ROUTINE METHOD 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
737 02.07.98 11.14 4.92 393.75 Star rose Yes ThioStar 4MTA     Lactose 
743 15.04.98 11.15 4.94 399.08 Star rose Yes ThioStar 4MTA     Lactose 
             
1345B 29.06.00 8.01 4.01 249.22 Superman white Yes   Amphetamine 48.25 18.60 Lactose (B) 
1116A 04.07.00 8.00 4.06 243.02 Superman white Yes  Amphetamine 60.55 23.00 Lactose (B) 
1265 14.12.00 8.05 4.09 255.97 Superman white Yes   Amphetamine 69.18 24.40 Lactose (B) 
             
z9   9.07 3.54 286.42 Sparrow white Yes Portugal Amphetamine 19.47 6.80 Lactose 
             
557A   9.08 3.63 286.42 Sparrow white Yes Portugal Amphetamine 15.19 5.30 Lactose 
             
557B   9.09 3.54 287.90 Sparrow white Yes Portugal Amphetamine     Lactose 
             
z197 02.04.04 8.07 2.79 160.60 Diamond violet None Diamant-E MDA       
             
952 22.10.99 8.07 3.49 214.02 Diamond violet None Diamant-B MDA 58.71 27.50 Lactose 
922 18.09.99 8.30 4.33 243.17 Diamond violet None Diamant-A MDA 67.79 28.20 Lactose 
             
1118 19.06.00 8.17 3.30 208.65 Diamond violet None Diamant-C MDA 55.78 26.10 Lactose 
1091 19.06.00 8.18 3.35 213.55 Diamond violet None Diamant-C MDA 58.45 26.80 Lactose 
             
1112F 17.09.00 8.21 3.52 222.63 Diamond violet None Diamant-D MDA 57.08 24.10 Lactose, Mannitol (tr) 
1209 24.09.00 8.22 3.58 226.53 Diamond violet None Diamant-D MDA 54.16 23.50 Lactose, Mannitol (tr) 
1148 13.08.00 8.21 3.54 224.76 Diamond violet None Diamant-D MDA 52.69 23.10 Lactose, Mannitol (tr) 
             
1218A 31.08.00 8.20 4.16 275.14 Double lightning violet None Diamant-Ecl MDA 70.46 25.30 Lactose, Mannitol (tr) 
1204A 10.09.00 8.23 4.15 274.46 Double lightning violet None Diamant-Ecl MDA 61.10 21.70 Lactose, Mannitol (tr) 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
1507A 10.02.02 9.04 4.84 298.25 Tasmanian Devil beige None   MDEA 78.13 25.22 Sorbitol, Lactose 
             
1500 03.02.02 6.05 3.97 128.35 Dolphin blue None   MDMA 82.80 63.21 Lactose 
1519   6.02 3.96 128.73 Dolphin blue None   MDMA 96.66 75.14 Lactose 
             
1444B 26.12.01 6.06 4.23 139.09 Dolphin blue None   MDMA 95.91 68.00 Lactose 
1445 30.12.01 6.06 4.06 131.09 Dolphin blue None   MDMA 91.81 67.60 Lactose 
             
1112G 17.09.00 7.04 4.37 218.40 "007" orange None JamesBond MDMA 88.57 38.40 Lactose (B) 
             
1388 30.07.01 7.04 4.98 240.08 "FF" yellow None   MDMA 77.72 31.62 Sorbitol 
1380A 15.07.01 7.04 4.94 240.81 "FF" yellow None   MDMA 86.53 35.41 Sorbitol 
             
1473A 29.06.01 7.07 5.04 242.37 "FF" yellow None   MDMA 90.84 35.98 Sorbitol 
             
1207 16.09.00 7.09 3.80 173.88 "Xhi" dirty white Yes   MDMA 107.78 58.50   
             
1498 02.02.02 7.06 4.89 230.79 "Xhi" rose Yes strong   MDMA 95.28 40.92 Lactose 
             
1619A 13.02.02 7.05 4.86 227.01 "Xhi" rose Yes strong   MDMA 99.14 42.61 Lactose 
             
1635 19.11.02 7.60 4.67 261.15 Peace and love violet Yes   MDMA 123.23 44.34 Lactose 
                          
1451A 16.01.01 7.99 4.38 255.46 Ferrari orange Yes   MDMA 85.70 32.71 Lactose 
1451B 16.01.01 7.96 4.68 258.67 Ferrari yellow Yes   MDMA 87.02 31.57 Lactose 
             
1324 04.02.01 9.14 3.89 294.37 Heart white Yes   MDMA 76.67 24.34 Lactose 
1319A 08.01.01 7.97 4.70 259.80 Ferrari yellow Yes   MDMA 92.03 34.55 Lactose 
             
949A 31.01.99 8.01 4.85 294.38 "STAR DUST" white Yes Weiss MDMA     Lactose 
             
z60 02.01.99 8.03 4.65 278.66 "STAR DUST" white Yes Weiss MDMA 78.27 27.00 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
949B 31.01.99 8.03 4.93 296.41 "STAR DUST" white Yes Weiss MDMA       
             
1061 03.04.00 8.11 5.69 345.95 "STAR DUST" beige Yes EP5 MDMA 92.61 26.60   
1304A 17.05.00 8.07 5.52 336.74 "STAR DUST" beige Yes EP5 MDMA 94.57 27.74   
             
1002 02.01.00 8.04 5.47 335.88 "STAR DUST" dirty white Yes EP5 MDMA 90.02 26.11   
z30 03.10.98 8.06 4.71 291.89 Elephant beige Yes  MDMA 90.46 30.00   
z44 30.08.98 8.05 4.85 291.04 Mitsubishi beige Yes strong MitsubishiFIX MDMA 97.23 34.20   
             
Z4A 08.08.98 8.06 5.05 317.67 Mitsubishi beige Yes MitsubishiFIX MDMA 89.49 36.00   
             
1494D 19.12.01 8.02 5.22 296.95 Elephant white Yes strong   MDMA 89.36 29.46   
             
985b 14.06.99 8.03 4.93 303.49 Elephant white Yes   MDMA 77.72 26.30   
             
1416B 01.08.01 8.01 3.24 200.23 Euro orange None Orange MDMA 120.60 58.40 Lactose 
1405 07.09.01 8.02 3.25 201.53 Euro orange None Orange MDMA 124.60 60.10 Lactose 
             
1208 21.10.00 8.06 3.64 237.26 Superman white Yes Superman2-D MDMA 83.63 34.80 Lactose 
             
995b 20.12.99 8.06 5.39 361.41 "S" green Yes   MDMA 123.65 34.50 Lactose (B) 
             
1460 06.04.01 8.09 3.84 297.35 Star white Yes   MDMA 107.84 36.01 Lactose 
             
1306A 17.05.00 8.11 4.75 253.18 Star dirty white None   MDMA 89.49 34.60 Lactose 
1304B 17.05.00 8.10 4.75 255.17 Star dirty white None  MDMA 99.05 37.01 Lactose 
1306C 17.05.00 8.12 4.74 254.54 Star dirty white None   MDMA 87.65 34.08 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
1303 17.05.00 8.11 3.44 222.48 Star beige None   MDMA 99.27 41.83   
1305 17.05.00 8.09 3.45 220.93 Star dirty white None  MDMA 86.39 37.29   
1304C 17.05.00 8.10 3.48 225.19 Star dirty white None   MDMA 99.63 40.49   
1306B 17.05.00 8.09 3.41 221.59 Star dirty white None  MDMA 91.59 36.28   
1306D 17.05.00 8.10 3.36 219.71 Star dirty white None   MDMA 85.83 36.84   
             
1668 26.12.03 8.07 4.57 262.49 Heart rose Yes   MDMA 61.74 22.97 Lactose 
             
1683 10.06.04 8.17 4.07 248.05 Heart dirty white Yes   MDMA 76.28 30.60   
1693 17.02.05 8.20 3.69 216.99 Heart dirty white Yes   MDMA 19.31 28.15   
             
1524 14.04.02 8.15 4.81 287.90 Marlboro rose Yes   MDMA 109.29 37.15   
1528 04.05.02 8.14 4.86 299.65 Marlboro blue Yes   MDMA 102.75 33.79   
             
1708 08.04.05 8.20 3.69 220.35 Heart dirty white Yes   MDMA 53.24 24.20   
             
1327 17.02.01 8.14 5.06 287.00 Superman white Yes   MDMA 80.12 26.81   
             
814 23.08.98 8.16 5.19 300.74 Mitsubishi beige Yes MitsubishiFIX MDMA 98.24 32.00   
             
834 08.08.98 8.13 5.21 299.51 Mitsubishi beige Yes MitsubishiFIT MDMA 121.69 40.70 Sorbitol 
             
Z2a 22.07.98 8.29 4.80 288.73 Elephant beige Yes   MDMA 71.94 24.80 Sorbitol 
             
1003 02.01.00 8.65 4.56 320.02 Mitsubishi dirty white Yes uu MDMA 94.16 29.10 Lactose (tr) 
             
989 21.06.99 8.63 3.40 226.96 Flying bird beige Yes Paix MDMA 89.39 38.20 Lactose 
             
832 29.05.98 9.04 4.76 309.58 Twins beige Yes Jumeaux MDMA 80.80 26.90 Sorbitol 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
1380B 15.07.01 9.08 4.40 314.77 Twins beige Yes Jumeaux MDMA 101.54 31.58 Sorbitol 
             
1473B 29.06.01 9.11 4.41 308.05 Twins brown Yes   MDMA 107.45 34.07 Sorbitol 
             
985c 14.06.99 9.06 4.61 297.08 Rolling Stones beige None   MDMA 87.51 28.90 Sorbitol 
             
985A 14.06.99 9.08 4.63 294.72 Tasmanian Devil dirty white None   MDMA 62.43 21.00 Sorbitol 
             
1317 05.01.01 9.06 3.90 298.11 Star white Yes   MDMA 120.77 39.92 Lactose 
             
1312 31.07.00 9.14 3.87 302.96 Mitsubishi beige Yes   MDMA 118.60 37.41 Lactose 
             
520 21.01.98 9.13 3.95 285.52 Crown white None   MDMA 85.66 30.00 Lactose 
             
894A 16.08.99 9.19 4.35 321.66 Superman dirty white Yes strong Superman2-A MDMA 73.91 22.80 Lactose 
842E 02.06.99 9.12 4.25 317.45 Superman beige Yes strong Superman2-A MDMA 86.37 27.00 Lactose 
             
954 12.08.99 9.08 5.53 390.31 Mitsubishi white None   MDMA     Lactose 
             
1111B 17.09.00 9.19 3.35 261.11 Ferrari beige Yes CavFerra MDMA 92.67 34.10 Lactose 
1309 09.06.00 9.15 3.89 307.71 Ferrari (framed) white None  MDMA 100.60 31.86 Lactose 
1301 02.05.00 9.18 3.91 308.16 Ferrari (framed) white None  MDMA 95.17 30.86 Lactose 
960 05.12.99 9.09 3.84 295.44 Mitsubishi white None  MDMA   Lactose 
970A 04.02.00 9.09 3.77 292.35 Ferrari (framed) white None Ferrari-Red MDMA 73.57 25.60 Lactose 
             
942 05.12.99 9.09 3.67 292.18 Ferrari (framed) white None Ferrari-Red MDMA 72.74 25.00 Lactose 
970C 04.02.00 9.10 3.72 296.43 Ferrari (framed) white None Ferrari-Red MDMA 80.91 27.70 Lactose 
970B 04.02.00 9.11 3.74 300.29 Ferrari (framed) white None Ferrari-Red MDMA 87.78 29.20 Lactose 
             
978A 18.02.00 9.09 3.82 296.44 Mitsubishi white None   MDMA 102.13 35.40 Lactose 
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Sample Date of Diam Thk Weight Logo Colour Breakline Class Illicit Qty Qty Diluent 
  seizure [mm] [mm] [mg]         Substance [mg] [%]   
             
1223 15.10.00 9.12 4.04 294.13 Mitsubishi dirty white Yes   MDMA 80.84 26.30 Lactose 
             
1300 28.03.00 9.04 3.83 297.00 Mitsubishi white Yes MitsubSpots MDMA 87.77 29.07 Lactose 
             
1134A 12.08.00 9.16 3.92 315.42 Heart beige Yes Punchmark MDMA 54.69 16.60 Lactose 
1130 24.07.00 9.18 3.91 315.37 Heart beige Yes Punchmark MDMA 44.19 14.10 Lactose 
             
1314B 13.01.01 9.21 3.94 305.77 Heart beige Yes Punchmark MDMA 51.71 15.66 Lactose 
1345A 29.06.00 9.14 3.87 311.16 Heart beige Yes Punchmark MDMA 63.42 19.86 Lactose 
             
831 26.04.98 9.02 3.58 240.56 None white Yes wBlancStrie MDMA 78.80 32.00 Lactose (B) 
             
Z14B   9.08 4.86 273.24 None white Yes wBlancStrie MDMA 93.03 33.60 Lactose (B) 
             
Z84 14.06.99 9.07 4.65 348.30 Mitsubishi white Yes   MDMA 68.95 19.70 Lactose 
             
788 07.06.98 9.02 3.38 254.31 None rose Yes wRoseStrie MDMA 85.85 35.80 Lactose (B) 
760 19.07.98 9.03 3.56 250.37 None rose Yes wRoseStrie MDMA 76.84 31.50 Lactose (B) 
             
524 12.02.98 9.14 4.01 294.90 Crown white None   MDMA 85.52 29.00 Lactose (B) 
523 12.02.98 9.14 4.04 300.27 Crown white None   MDMA 87.08 29.00 Lactose (B) 
             
z34 04.10.98 9.07 3.22 264.50 Superman beige Yes Superman2-B MDMA, MDEA 27.41 11.50 Lactose 
836A 06.10.98 9.01 3.19 258.75 Superman beige Yes Superman2-B MDMA, MDEA 33.13 11.90 Lactose 
             
1310a 19.06.00 8.07 5.01 292.45 Superman beige Yes strong SupermanDef MDMA, MDEA 86.02 28.74   
             
1079B 16.04.00 8.04 5.05 296.82 Superman dirty white Yes strong SupermanDef MDMA, MDEA 86.51 29.00   
             
z209 23.02.04 8.01 4.22 239.10 "STAR DUST" dirty white Yes MDEA MDMA, MDEA       
 
 
 
 
APPENDIX XII – PREPROCESSING METHODS 
APPLIED TO NIR SPECTRA 
 
 
Reference Pre-processing method 
Krämer and Ebel (2000) MSC, 1st Savitsky-Golay derivative (1pt average, 2nd polynomial order)  
Chalus et al. (2005) SNV, MSC, 2nd  Savitsky-Golay derivative (5pt average, 2nd polynomial order)  
Roggo et al. (2005)  
1st Savitsky-Golay derivative (11pt average, 3d polynomial order), mean 
normalisation  
Schneider (2002) 
SNV, X + 2, 1/X, 2nd  Savitsky-Golay derivative (5pt average, 2nd polynomial 
order)  
Yoon et al. (2004) SNV, 2nd  Savitsky-Golay derivative (11pt average, 2nd polynomial order) 
Brigger et al. (2000)  X + 0.2, Kubelka-Munk transformation, MSC 
Röseler (2004)  MSC, 2nd  Savitsky-Golay derivative (7pt average, 2nd polynomial order) 
New  X + 0.2, Log(X), SNV 
New2  
X + 0.2, Log(1/X), SNV, 2nd  Savitsky-Golay derivative (5pt average, 2nd 
polynomial order) 
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APPENDIX XIII – SAMPLE GROUPS OBSERVED WITH NIR SPECTROSCOPY 
 
Sample Date of Diam Thk Weight Logo Colour Breakline Sample Class Illicit Quantity Diluent 
  seizure [mm] [mm] [mg]         Substance [%]   
            
1112G 17.9.00 7.04 4.37 218.40 "007" orange none JamesBond MDMA 38.40 Lactose (B) 
            
1473A 29.6.01 7.07 5.04 242.37 "FF" yellow none   MDMA 35.98 Sorbitol 
            
1207 16.9.00 7.09 3.80 173.88 "Xhi" white dirty yes   MDMA 58.50   
            
1498 2.2.02 7.06 4.89 230.79 "Xhi" rose yes strong   MDMA 40.92 Lactose 
1619A 13.2.02 7.05 4.86 227.01 "Xhi" rose yes strong   MDMA 42.61 Lactose 
            
Z60 2.1.99 8.03 4.65 278.66 "STAR DUST" white yes Weiss MDMA 27.00 Lactose 
            
949A 31.1.99 8.01 4.85 294.38 "STAR DUST" white yes Weiss MDMA   Lactose 
            
1304A 17.5.00 8.07 5.52 336.74 "STAR DUST" beige yes EP5 MDMA 27.74   
            
1002 2.1.00 8.04 5.47 335.88 "STAR DUST" white dirty yes EP5 MDMA 26.11   
1061 3.4.00 8.11 5.69 345.95 "STAR DUST" beige yes EP5 MDMA 26.60   
949B 31.1.99 8.03 4.93 296.41 "STAR DUST" white yes Weiss MDMA    
Z209 23.2.04 8.01 4.22 239.10 "STAR DUST" white dirty yes MDEA MDMA, MDEA   
Z30 3.10.98 8.06 4.71 291.89 Elephant beige yes   MDMA 30.00   
            
985B 14.6.99 8.03 4.93 303.49 Elephant white yes   MDMA 26.30   
            
Z44 30.8.98 8.05 4.85 291.04 Mitsubishi beige yes strong MitsubishiFIX MDMA 34.20   
Z4A 8.8.98 8.06 5.05 317.67 Mitsubishi beige yes MitsubishiFIX MDMA 36.00   
            
1494D 19.12.01 8.02 5.22 296.95 Elephant white yes strong   MDMA 29.46   
            
1310A 19.6.00 8.07 5.01 292.45 Superman beige yes strong SupermanDef MDMA, MDEA 28.74   
1079B 16.4.00 8.04 5.05 296.82 Superman white dirty yes strong SupermanDef MDMA, MDEA 29.00   
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Sample Date of Diam Thk Weight Logo Colour Breakline Sample Class Illicit Quantity Diluent 
  seizure [mm] [mm] [mg]         Substance [%]   
            
1327 17.2.01 8.14 5.06 287.00 Superman white  yes    MDMA 26.81   
            
1306D 17.5.00 8.10 3.36 219.71 Star white dirty none   MDMA 36.84 Maltose (tr) 
1306B 17.5.00 8.09 3.41 221.59 Star white dirty none  MDMA 36.28 Maltose (tr) 
1303 17.5.00 8.11 3.44 222.48 Star beige none  MDMA 41.83 Maltose (tr) 
1305 17.5.00 8.09 3.45 220.93 Star white dirty none  MDMA 37.29 Maltose (tr) 
1304C 17.5.00 8.10 3.48 225.19 Star white dirty none   MDMA 40.49 Maltose (tr) 
            
1306C 17.5.00 8.12 4.74 254.54 Star white dirty none   MDMA 34.08 Lactose 
            
834 8.8.98 8.13 5.21 299.51 Mitsubishi beige yes MitsubishiFIT MDMA 40.70 Sorbitol 
            
814 23.8.98 8.16 5.19 300.74 Mitsubishi beige yes MitsubishiFIX MDMA 32.00   
            
Z197 2.4.04 8.07 2.79 160.60 Diamond violet none Diamant-E MDA     
            
1528 4.5.02 8.14 4.86 299.65 Marlboro blue yes   MDMA 33.79   
1524 14.4.02 8.15 4.81 287.90 Marlboro rose yes   MDMA 37.15   
            
1693 17.2.05 8.20 3.69 216.99 Heart white dirty yes   MDMA, MA 28.15   
1683 10.6.04 8.17 4.07 248.05 Heart white dirty yes   MDMA 30.60   
            
1003 2.1.00 8.65 4.56 320.02 Mitsubishi white dirty yes   MDMA 29.10 Lactose (tr) 
            
985C 14.6.99 9.06 4.61 297.08 Rolling Stones beige none   MDMA 28.90 Sorbitol 
            
Z14B   9.08 4.86 273.24 None white yes wBlancStrie MDMA 33.60 Lactose (B) 
831 26.4.98 9.02 3.58 240.56 None white yes wBlancStrie MDMA 32.00 Lactose (B) 
788 7.6.98 9.02 3.38 254.31 None rose yes wRoseStrie MDMA 35.80 Lactose (B) 
760 19.7.98 9.03 3.56 250.37 None rose yes wRoseStrie MDMA 31.50 Lactose (B) 
            
954 12.8.99 9.08 5.53 390.31 Mitsubishi white none   MDMA   Lactose 
 
 
